
<html lang="en"     class="pb-page"  data-request-id="2c92f3ab-29c3-4fc1-ba1d-d0861c61e6ac"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2012.55.issue-17;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm3004619;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor" /></meta><meta name="dc.Creator" content="Se-Ho  Kim" /></meta><meta name="dc.Creator" content="Ashok  Bajji" /></meta><meta name="dc.Creator" content="Rajendra  Tangallapally" /></meta><meta name="dc.Creator" content="Benjamin  Markovitz" /></meta><meta name="dc.Creator" content="Richard  Trovato" /></meta><meta name="dc.Creator" content="Mark  Shenderovich" /></meta><meta name="dc.Creator" content="Vijay  Baichwal" /></meta><meta name="dc.Creator" content="Paul  Bartel" /></meta><meta name="dc.Creator" content="Daniel  Cimbora" /></meta><meta name="dc.Creator" content="Rena  McKinnon" /></meta><meta name="dc.Creator" content="Rosann  Robinson" /></meta><meta name="dc.Creator" content="Damon  Papac" /></meta><meta name="dc.Creator" content="Daniel  Wettstein" /></meta><meta name="dc.Creator" content="Robert  Carlson" /></meta><meta name="dc.Creator" content="Kraig M.  Yager" /></meta><meta name="dc.Description" content="Modulation of Hsp90 (heat shock protein 90) function has been recognized as an attractive approach for cancer treatment, since many cancer cells depend on Hsp90 to maintain cellular homeostasis. Th..." /></meta><meta name="Description" content="Modulation of Hsp90 (heat shock protein 90) function has been recognized as an attractive approach for cancer treatment, since many cancer cells depend on Hsp90 to maintain cellular homeostasis. Th..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 31, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3004619" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3004619" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3004619" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3004619" /></link>
        
    
    

<title>Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3004619" /></meta><meta property="og:title" content="Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0026.jpeg" /></meta><meta property="og:description" content="Modulation of Hsp90 (heat shock protein 90) function has been recognized as an attractive approach for cancer treatment, since many cancer cells depend on Hsp90 to maintain cellular homeostasis. This has spurred the search for small-molecule Hsp90 inhibitors. Here we describe our lead optimization studies centered on the purine-based Hsp90 inhibitor 28a containing a piperidine moiety at the purine N9 position. In this study, key SAR was established for the piperidine N-substituent and for the congeners of the 1,3-benzodioxole at C8. These efforts led to the identification of orally bioavailable 28g that exhibits good in vitro profiles and a characteristic molecular biomarker signature of Hsp90 inhibition both in vitro and in vivo. Favorable pharmacokinetic properties along with significant antitumor effects in multiple human cancer xenograft models led to the selection of 28g (MPC-3100) as a clinical candidate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3004619"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3004619">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3004619&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3004619&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3004619&amp;href=/doi/10.1021/jm3004619" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7480-7501</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300459a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300493m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of (2<i>S</i>)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9<i>H</i>-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Se-Ho++Kim">Se-Ho Kim</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ashok++Bajji">Ashok Bajji</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajendra++Tangallapally">Rajendra Tangallapally</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin++Markovitz">Benjamin Markovitz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Trovato">Richard Trovato</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Shenderovich">Mark Shenderovich</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vijay++Baichwal">Vijay Baichwal</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Bartel">Paul Bartel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Cimbora">Daniel Cimbora</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rena++McKinnon">Rena McKinnon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosann++Robinson">Rosann Robinson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Damon++Papac">Damon Papac</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Wettstein">Daniel Wettstein</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Carlson">Robert Carlson</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kraig+M.++Yager">Kraig M. Yager</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Myrexis Inc., 305 Chipeta Way, Salt Lake City, Utah 84108, United States</span></div><div class="corresp-info"><strong>*</strong>For S.-H.K.: phone, 801-733-9791; e-mail, <a href="/cdn-cgi/l/email-protection#3447515c5b1a5f5d595f5d59745359555d581a575b59"><span class="__cf_email__" data-cfemail="6b180e0304450002060002062b0c060a020745080406">[email protected]</span></a>. For K.M.Y.: phone, 801-209-2225; e-mail, <a href="/cdn-cgi/l/email-protection#315a435058561f485056544371565c50585d1f525e5c"><span class="__cf_email__" data-cfemail="7c170e1d151b52051d1b190e3c1b111d1510521f1311">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3004619&amp;href=/doi/10.1021%2Fjm3004619" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7480–7501</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 22, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 April 2012</li><li><span class="item_label"><b>Published</b> online</span>31 August 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3004619" title="DOI URL">https://doi.org/10.1021/jm3004619</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7480%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSe-Ho%2BKim%252C%2BAshok%2BBajji%252C%2BRajendra%2BTangallapally%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D17%26contentID%3Djm3004619%26title%3DDiscovery%2Bof%2B%25282S%2529-1-%255B4-%25282-%257B6-Amino-8-%255B%25286-bromo-1%252C3-benzodioxol-5-yl%2529sulfanyl%255D-9H-purin-9-yl%257Dethyl%2529piperidin-1-yl%255D-2-hydroxypropan-1-one%2B%2528MPC-3100%2529%252C%2Ba%2BPurine-Based%2BHsp90%2BInhibitor%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7501%26publicationDate%3DSeptember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3004619"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2395</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3004619" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Se-Ho&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Ashok&quot;,&quot;last_name&quot;:&quot;Bajji&quot;},{&quot;first_name&quot;:&quot;Rajendra&quot;,&quot;last_name&quot;:&quot;Tangallapally&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;Markovitz&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Trovato&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Shenderovich&quot;},{&quot;first_name&quot;:&quot;Vijay&quot;,&quot;last_name&quot;:&quot;Baichwal&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Bartel&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Cimbora&quot;},{&quot;first_name&quot;:&quot;Rena&quot;,&quot;last_name&quot;:&quot;McKinnon&quot;},{&quot;first_name&quot;:&quot;Rosann&quot;,&quot;last_name&quot;:&quot;Robinson&quot;},{&quot;first_name&quot;:&quot;Damon&quot;,&quot;last_name&quot;:&quot;Papac&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Wettstein&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Carlson&quot;},{&quot;first_name&quot;:&quot;Kraig&quot;,&quot;last_name&quot;:&quot;M. Yager&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;7480-7501&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3004619&quot;},&quot;abstract&quot;:&quot;Modulation of Hsp90 (heat shock protein 90) function has been recognized as an attractive approach for cancer treatment, since many cancer cells depend on Hsp90 to maintain cellular homeostasis. This has spurred the search for small-molecule Hsp90 inhibitors. Here we describe our lead optimization studies centered on the purine-based Hsp90 inhibitor 28a containing a piperidine moiety at the purine N9 position. In this study, key SAR was established for the piperidine N-substituent and for the congeners of the 1,3-benzodioxole at C8. These efforts led to the identification of orally bioavailable 28g that exhibits good in vitro profiles and a characteristic molecular biomarker signature of Hsp90 inhibition both in vitro and in vivo. Favorable pharmacokinetic properties along with significant antitumor effects in multiple human cancer xenograft models led to the selection of 28g (MPC-3100) as a clinical candidate.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3004619&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3004619" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3004619&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3004619" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3004619&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3004619" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3004619&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3004619&amp;href=/doi/10.1021/jm3004619" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3004619" /></input><a href="/doi/pdf/10.1021/jm3004619" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3004619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3004619%26sid%3Dliteratum%253Aachs%26pmid%3D22913511%26genre%3Darticle%26aulast%3DKim%26date%3D2012%26atitle%3DDiscovery%2Bof%2B%25282S%2529-1-%255B4-%25282-%257B6-Amino-8-%255B%25286-bromo-1%252C3-benzodioxol-5-yl%2529sulfanyl%255D-9H-purin-9-yl%257Dethyl%2529piperidin-1-yl%255D-2-hydroxypropan-1-one%2B%2528MPC-3100%2529%252C%2Ba%2BPurine-Based%2BHsp90%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D17%26spage%3D7480%26epage%3D7501%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jmcmar.2012.55.issue-17/production/jmcmar.2012.55.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Modulation of Hsp90 (heat shock protein 90) function has been recognized as an attractive approach for cancer treatment, since many cancer cells depend on Hsp90 to maintain cellular homeostasis. This has spurred the search for small-molecule Hsp90 inhibitors. Here we describe our lead optimization studies centered on the purine-based Hsp90 inhibitor <b>28a</b> containing a piperidine moiety at the purine N9 position. In this study, key SAR was established for the piperidine N-substituent and for the congeners of the 1,3-benzodioxole at C8. These efforts led to the identification of orally bioavailable <b>28g</b> that exhibits good in vitro profiles and a characteristic molecular biomarker signature of Hsp90 inhibition both in vitro and in vivo. Favorable pharmacokinetic properties along with significant antitumor effects in multiple human cancer xenograft models led to the selection of <b>28g</b> (MPC-3100) as a clinical candidate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Heat shock proteins (HSPs) are some of the most abundant intracellular proteins and play critical roles as molecular chaperones in essential cellular functions such as (1) protein maturation, folding, and prevention of aggregation, (2) sorting and translocation, (3) stabilization of proteins involved in signal transduction, and (4) apoptosis and proteasomal degradation.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Hsp90 is one of the major HSPs and exists as a homodimer. Each monomer is composed of three domains: an N-terminal ATP-binding domain, a middle domain, and a C-terminal dimerization domain.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Hsp90 is unique among HSPs because it associates with cochaperones (e.g., Hsp70, Hsp40, cdc37, p23) to form a multichaperone complex that interacts with a large number of cofactors (e.g., HIP, HOP, immunophilins). Because Hsp90 is ubiquitously expressed in both normal and tumor tissue, it was believed that inhibition of the Hsp90 pathway would affect normal cellular function and lead to general toxicity. As a consequence, Hsp90 was not immediately recognized as a viable target for cancer treatment.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Evidence supporting the therapeutic potential of Hsp90 inhibition was provided by reports that Hsp90 is overexpressed in numerous cancer cell types.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, direct evidence for Hsp90 therapeutic value came from the observation that v-Src-mediated transforming activity was abolished by the natural product geldanamycin (<b>1a</b>) via disruption of Src-Hsp90 protein complexes.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This seminal work revealed a critical role of the Hsp90 chaperone machinery in the stability of v-Src and also showed that c-Src is less affected than v-Src by inhibition of Hsp90. Since then, over 200 proteins, known collectively as client proteins, were found to depend on the Hsp90 system for their function and stability and most of these client proteins are involved in signal transduction, including kinases (e.g., Her2, AKT, Bcr-Abl, Cdk4, B-raf), hormone receptors (e.g., androgen, estrogen, glucocorticoid receptors), and transcription factors (e.g., mutant p53, HIF-1α). Importantly, many of these are involved in oncogenesis and contribute to the six well-defined hallmarks of cancer.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Not surprisingly, a number of Hsp90 client proteins have received attention as potential targets for cancer therapy, and this approach has been successful.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> However, the development of drug resistance resulting from target kinase mutations, feedback signaling loops, and alternative survival pathway activation has become a significant therapeutic challenge.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In contrast, the simultaneous targeting of multiple signaling pathways via inhibition of the Hsp90 chaperone system has the potential to be both more efficacious and less vulnerable to resistance mechanisms.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> An important aspect of Hsp90 as a cancer target is the differential effect of Hsp90 inhibitors on cancer cells. In animal models, several different Hsp90 inhibitor classes have shown selective pharmacology in tumor cells and strong anticancer effects at nontoxic levels. Although a complete understanding of the origins of selectivity requires additional studies, mounting evidence suggests that oncogene addiction,<a onclick="showRef(event, 'ref3 ref13'); return false;" href="javascript:void(0);" class="ref ref3 ref13">(3, 13)</a> synthetic lethality,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> activation,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and post-translational modification of Hsp90 in tumors might account for this unique observation.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_p">In contrast to cancer, where Hsp90 inhibition is sought, induction of Hsp90 activity has been proposed as a potential treatment for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis (Lou Gehrig’s disease). These diseases are associated with accumulation of misfolded proteins, which are toxic to neuronal cells. It has been suggested that enhancing protein-folding capacity by pharmacological activation of transcription factor heat shock protein 1 (HSF1) could be a promising strategy for the treatment of neurodegenerative diseases. Paradoxically, because of feedback regulation, Hsp90 inhibitors induce Hsp90 protein levels via HSF1 activation and therefore may have utility in the treatment of neurodegenerative diseases.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a></div><div class="NLM_p">Taken together, it is now evident that Hsp90 is a bona fide cancer target, and the development of Hsp90 inhibitors has become one of the most active areas of research not only for cancer chemotherapy but also potentially for treatment of neurodegenerative disease.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Natural product and natural-product-derived Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sixteen Hsp90 inhibitors have entered clinical development as novel anticancer agents.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24 ref25">(20-25)</a> All of these inhibitors target the N-terminal, ATP-binding site of Hsp90 and effectively block the essential ATPase activity. The first-in-class inhibitor, 17-AAG (<b>1b</b>), a geldanamycin analogue with improved pharmacological properties over the parent geldanamycin, is being evaluated in phase II–III clinical trials by several sponsors (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). However, 17-AAG (<b>1b</b>) presents significant barriers to development, including poor aqueous solubility, P-glycoprotein (P-gp) multidrug resistance efflux pump substrate activity, limited oral bioavailability, and hepatotoxicity which is believed to be a consequence of its benzoquinone moiety and the formation of a drug–glutathione (GSH) adduct upon redox activation.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> The more water-soluble geldanamycin analogues 17-DMAG (<b>1c</b>) and IPI-504 (<b>1d</b>), a prodrug of 17-AAG (<b>1b</b>), have solved some of the aforementioned limitations and are being evaluated in clinical trials.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Radicicol (<b>2a</b>) is a resorcinol-containing natural product inhibitor of Hsp90.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Because of its potent Hsp90 inhibition and resultant antiproliferative activity in cells, this natural product has garnered widespread interest in the synthetic community, and several total syntheses have been reported.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, lack of potency in animal models, believed to be a result of the reactive epoxide and 1,6-dienone moieties, has precluded further development. Efforts to modify the radicicol (<b>2a</b>) core, specifically by replacement of the epoxide ring and attenuation of the 1,6-dieneone reactivity, have led to the identification of more stable cyclopropyl- (<b>2b</b>) and oxime-radicicol analogues <b>3a</b>,<b>b</b> with improved in vitro potency.<a onclick="showRef(event, 'ref25 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref28 ref29">(25, 28, 29)</a> These compounds, however, remain in the preclinical development stage. As a way of overcoming the limitations presented by natural product Hsp90 inhibitors, synthetic hybrids<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> of geldanamycin (<b>1a</b>) and radicicol (<b>2a</b>) have been developed with the aid of structure-based drug design, and the chimeric inhibitors, radester (<b>4</b>) and radanamycin (<b>5</b>), are promising new leads.<a onclick="showRef(event, 'ref25 ref31'); return false;" href="javascript:void(0);" class="ref ref25 ref31">(25, 31)</a></div><div class="NLM_p">The identification and optimization of entirely synthetic, small molecule inhibitors of Hsp90 have been undertaken by several research groups as a way of imparting more druglike properties (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The first synthetic Hsp90 inhibitor, purine derivative PU3 (<b>7</b>), originated from the Chiosis laboratory<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and was designed to bind the N-terminal ATP-binding pocket of Hsp90. PU3 (<b>7</b>) adopts the C-type conformation reminiscent of geldanamycin (<b>1a</b>), and subsequent structure-based optimization resulted in the discovery of the potent, water-soluble inhibitor PU-H71 (<b>8</b>),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> currently being evaluated in phase I clinical trials.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A similar purine-based inhibitor <b>9</b> was developed by Conforma Therapeutics (now Biogen Idec).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> A common structural feature of the optimized purine-based inhibitors <b>8</b> and <b>9</b> is the sulfur atom tethering the purine C8 position and the substituted aryl ring. The PU class (<b>6</b>)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> has received attention by several research groups and has served as a guide for design of new Hsp90 inhibitors. Key PU-class structural features were utilized during the design of BIIB021 (<b>10</b>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In this instance, however, binding elements were rationally and systematically “rotated” around the purine ring, resulting in a unique purine derivative in which the aryl group is connected via the N9 position as opposed to the N8 position. BIIIB021 (<b>10</b>) was advanced into phase I–II clinical trials. Finally, several synthetic non-purine small molecules <b>15</b>–<b>20</b> encompassing diverse structural features have been identified through HTS, fragment-based, and structure-based drug design approaches,<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24 ref36 ref37">(20-24, 36, 37)</a> and these inhibitors are being evaluated in clinical settings (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selected purine-based and purine-like Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selected examples of structurally diverse non-purine Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We believed that the inherent activity of the purine scaffold, in concert with new synthetic methodologies, would provide a good starting point for the synthesis of novel analogues,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and as such, our Hsp90 drug discovery program was also based on the PU class. A shared feature of the majority of purine-based inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) is the presence of pendent hydrophilic N9 substituents. This modification, intended to improve aqueous solubility and other physical properties, demonstrated the utility of the N9 substituent for modulation of molecular properties. Similarly, we investigated the effects of various N9 substituents on ligand potency and ADME properties. Herein we report a novel series of purine-based Hsp90 inhibitors, their synthesis via new C–S bond formation methodology, and the biological evaluations leading to the identification of <b>28g</b> (MPC-3100) as a phase I clinical candidate.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80072" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80072" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthetic routes for preparation of 9-<i>N</i>-alkyl-8-arylsulfanyladenines <b>23</b> are categorized into two classes (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref32 ref40'); return false;" href="javascript:void(0);" class="ref ref32 ref40">(32, 40)</a> Method A involves a two-step procedure consisting of Cu(I)-catalyzed coupling of 8-mercaptoadenine (<b>21</b>) with aryl iodides (ArI),<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> followed by N-alkylation with alkyl halides or mesylates (RX).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Alkylation typically resulted in a ∼2: 1 mixture of N9 and N3 regioisomers. Alternatively, aryldiazonium salts (ArN<sub>2</sub>X) could be used instead of aryl iodides (ArI) as coupling partners during C–S bond formation.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Method B utilizes <i>N</i>-alkylbromoadenines <b>22</b>, which can be prepared regioselectively in high yields.<a onclick="showRef(event, 'ref34 ref43'); return false;" href="javascript:void(0);" class="ref ref34 ref43">(34, 43)</a> Displacement of the bromide in <b>22</b> with arylthiols (ArSH) proceeds under mild conditions to provide <b>23</b> as single regioisomers. A significant drawback to method B, however, is the propensity of arylthiols toward disulfide formation.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthetic approach for our initial SAR studies was based on method A. However, instead of utilization of difficult to source aryl iodides, more readily available aryl bromides were desirable, and as a consequence, a Pd(0)-catalyzed coupling of 8-mercaptoadenine (<b>21</b>)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> with aryl bromides <b>24a</b>–<b>g</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) was developed using catalytic Pd<sub>2</sub>dba<sub>3</sub>, the ligand xantphos, a base (K<sub>2</sub>CO<sub>3</sub> or Cs<sub>2</sub>CO<sub>3</sub>) in dioxane. For the Pd-catalyzed reaction, we chose ortho-substituted aryl bromides <b>24a</b>–<b>g</b> (X = Br, CN) as coupling partners, since early SAR studies revealed the critical nature of the 8-aryl group ortho-substituent (X) for Hsp90 inhibition.<a onclick="showRef(event, 'ref43 ref59'); return false;" href="javascript:void(0);" class="ref ref43 ref59">(43, 58)</a> This synthetic approach eliminates the need for installation of the key ortho-substituent at a later stage. Although yields were modest, this approach allowed the use of readily available ortho-substituted aryl bromides <b>24a</b>–<b>g</b> and was used to prepare key intermediates <b>26a</b>–<b>g</b> in a rapid fashion. Moreover, the coupling of aryl dibromides <b>24a</b>–<b>f</b> (X = Br) with <b>21</b> proceeded without formation of undesired bis-arylsulfanyl products. With 8-arylsulfanyladenines <b>26a</b>–<b>g</b> in hand, alkylation with <b>25b</b> was carried out in the presence of Barton’s base. The desired N9 regioisomers <b>28a</b>, <b>34g</b>, <b>34n</b>, <b>34f</b>, <b>34l</b>, <b>34m</b>, and <b>34q</b> were obtained in 20–51% yield after removal of the minor N3 regioisomers (structures not shown) by silica gel chromatography or preparative scale RP-HPLC. In a similar manner, analogues <b>27a</b> and <b>27c</b>–<b>i</b> were synthesized using <b>25a</b> and <b>25c</b>–<b>i</b> as alkylating agents. The <i>N</i>-Boc group of <b>27a</b> was removed using TFA, and the resulting free piperidine analogue <b>27b</b> was converted into <i>N</i>-acylpiperidine analogues <b>28a</b>–<b>j</b> and <b>28n</b> via EDCI-mediated coupling with the appropriate carboxylic acid (step c, Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Incorporation of <i>N</i>-Boc protected amino acids in the EDCI coupling sequence afforded <b>28k</b> and <b>28l</b>–<b>o</b> (step d, Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><div class="NLM_p">The synthesis of <b>25a</b>–<b>i</b> is shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Compounds <b>30a</b>,<b>b</b> are commercially available or can be conveniently prepared from <b>29</b> by <i>N</i>-Boc protection or N-formylation, respectively. Mesylation of the resulting alcohols <b>30a</b>,<b>b</b> afforded compounds <b>25a</b>,<b>b</b>. Reductive alkylation<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> of <b>29</b> with acetone, isobutyraldehyde, or cyclohexanecarboxaldehyde provided <b>30c</b>,<b>d</b>,<b>f</b> which were then converted to the mesylates <b>25c</b>,<b>d</b>,<b>f</b>. Alternatively, N-alkylation of <b>29</b> with the appropriate alkyl halide could also be used to prepare these intermediates. N-Alkylation of <b>29</b> with CF<sub>3</sub>CH<sub>2</sub>I or propargyl bromide under the standard procedure<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> followed by mesylation afforded <b>25e</b> and <b>25g</b>. Synthesis of tetrazole derivatives <b>25h</b>,<b>i</b> was achieved employing known synthetic methods.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Finally, thioureas <b>31a</b> and <b>31b</b>, derived from <b>29</b> and methyl- or <i>tert</i>-butyl isothiocyanate, were converted to tetrazoles <b>25h</b>,<b>i</b> with NaN<sub>3</sub> and HgCl<sub>2</sub> followed by tosylation.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>24a</b>–<b>g</b>, Pd<sub>2</sub>dba<sub>3</sub>, xantphos, K<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 15–45%; (b) <b>25b</b>, Barton’s base, 80 °C, DMF, 20–51%.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>25a</b> or <b>25c</b>–<b>i</b>, Barton’s base, 80 °C, DMF, 20–51%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, >90%; (c) EDCI, HOBt, DMF, R<sub>2</sub>CO<sub>2</sub>H (R<sub>2</sub> = H, CH<sub>3</sub>, propyl, cyclopropyl, cyclopentyl, CH<sub>2</sub>OH, (<i>S</i> or <i>R</i>)-CH(OH)CH<sub>3</sub>, C(CH<sub>3</sub>)<sub>2</sub>OH, acetyl, CH<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub>); (d) EDCI, HOBt, DMF–THF, rt, R<sub>2</sub>CO<sub>2</sub>H (R<sub>2</sub> = (<i>S</i>)-CH(CH<sub>3</sub>)NHBoc, (<i>S</i>)-CH(<i>i</i>Bu)NHBoc, C(CH<sub>3</sub>)<sub>2</sub>NHBoc or <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline), then 4 M HCl or TFA.</p></p></figure><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc<sub>2</sub>O, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) HCO<sub>2</sub>Me, NaOH, MeOH; (c) acetone, <i>i</i>-Bu-CHO, or <i>c</i>-Hex-CHO, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub> (or NaCNBH<sub>3,</sub> AcOH, MeOH–THF); (d) CF<sub>3</sub>CH<sub>2</sub>I, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux or CF<sub>3</sub>CH<sub>2</sub>OMs, NEt<sub>3</sub>, THF; (e) propargyl bromide, Hünig’s base, THF; (f) MsCl, or TsCl, NEt<sub>3</sub> (or DMAP), CH<sub>2</sub>Cl<sub>2</sub>, rt, 30–95%; (g) SCN-Me or SCN-<i>t</i>-Bu, CH<sub>2</sub>Cl<sub>2</sub>, rt, 80–85%; (h) NaN<sub>3</sub>, HgCl<sub>2</sub>, NEt<sub>3</sub>, DMF, 41–50%.</p></p></figure><div class="NLM_p">Although method A proved adequate for initial SAR studies, separation of the undesired N3 regioisomers and low overall yields presented major hurdles to more extensive SAR studies. Therefore, method B (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was adopted for synthesis of later-stage targets. N9-substitued bromoadenines <b>33a</b>,<b>b</b> were readily prepared in high overall yield by literature procedures.<a onclick="showRef(event, 'ref34 ref43'); return false;" href="javascript:void(0);" class="ref ref34 ref43">(34, 43)</a> The reaction sequence involved alkylation of adenine (<b>32</b>) with alkylating agents <b>25a</b>,<b>b</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>) and bromination in acetic acid buffer. During the alkylation step a small amount (<10%) of N3 isomers were produced but were easily removed by trituration after the bromination step. Our strategy for the synthesis of arylthiols (ArSH) utilized 3-ethylhexyl 3-mercaptopropanoate (<b>52</b>, Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>),<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> a known thiol surrogate, as a means of preventing oxidative disulfide formation of the arylthiol intermediates. The synthetic utility of <b>52</b> as a thiol surrogate has been demonstrated previously for synthesis of benzothiazoles and biaryl compounds,<a onclick="showRef(event, 'cit48b cit48c'); return false;" href="javascript:void(0);" class="ref cit48b cit48c">(48b, 48c)</a> and a similar strategy has been applied to the synthesis of aryl sulfoxides.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Described below is the successful application of the thiol surrogate strategy to the synthesis of structurally diverse 9-<i>N</i>-alkyl-8-arylsulfanyladenines (Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a>–<a class="ref internalNav" href="#sch9" aria-label="9">9</a>).</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>52</b>, Pd<sub>2</sub>dba<sub>3</sub> (5–10 mol %), xantphos (10–20 mol %), Hünig’s base, dioxane, 100 °C, 10 h, >80%; (b) NBS, HBF<sub>4</sub>·Et<sub>2</sub>O, AcCN, −15 to 5 °C, >70%; (c) DDQ, 1,4-dioxane, 100 °C, ∼90%.</p></p></figure><div class="NLM_p">The detailed reaction sequence for synthesis of aryl sulfides is given in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Aryl sulfides <b>43a</b>–<b>c</b> were prepared in a single step using a Pd(0)-catalyzed coupling of aryl dihalides <b>24a</b>,<b>b</b> and <b>41</b> with <b>52</b>. Compounds <b>43a</b>,<b>b</b> could also be obtained from aryl bromides <b>42a</b>,<b>b</b> via a two-step procedure involving Pd(0)-catalyzed coupling and ortho-bromination.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Synthesis of aryl sulfide <b>45</b> was achieved in two steps from the known bromodihydrobenzofuran <b>44</b><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> via Pd(0)-catalyzed coupling of <b>52</b> and subsequent ortho-bromination. Oxidation of dihydrobenzofuran <b>45</b> with DDQ afforded benzofuran <b>46</b>. An identical procedure was applied to the synthesis of <b>48a</b>, a regioisomer of <b>45</b>, using commercially available 5-bromo-2,3-dihydrobenzofuran (<b>47</b>). In the instances of aryl sulfides <b>48a</b> and <b>48b</b>, nonselective bromination afforded ∼1:3 mixtures that were oxidized directly with DDQ to provide benzofurans <b>49a</b> and <b>49b</b>; the undesired regioisomers were removed by preparative RP-HPLC upon reaction with bromoadenine <b>33</b>. Similarly, aryl sulfide <b>51</b> was obtained from <b>50</b> using the two-step sequence of Pd(0)-catalyzed coupling with <b>52</b> and ortho-bromination.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>25a</b> or <b>25b</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h, ∼80%; (b) Br<sub>2</sub>, NaOAc–AcOH (pH 4.6), MeOH/THF, rt, 2 h, ∼67%; (c) <b>43a</b>–<b>c</b>, <b>45</b>, <b>46</b>, <b>48</b>, <b>49</b>, or <b>51</b>, NaOEt, THF/EtOH (10/1, v/v), 60 °C, 3–10 h, 35–80%.</p></p></figure><div class="NLM_p">With the requisite aryl sulfides <b>35</b> in hand, the stage was set for the critical C–S bond forming reaction (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). To this end, a solution of aryl sulfide <b>35</b> in THF was treated with NaOEt (2.2 equiv) and the resulting mixture was stirred at ambient temperatures for 2 h. After concentration to dryness, the crude sodium arylthiolate salt (ArSNa, <b>35</b>-Na) was diluted with a mixture of THF and ethanol (10/1, v/v), combined with bromoadenine <b>33a</b> (or <b>33b</b>), and heated at 60–65 °C for several hours. The reaction proceeded cleanly to yield product <b>37</b> in moderate to good yield after silica gel chromatography. Concentration of the sodium arylthiolate mixture before addition of <b>33a</b>,<b>b</b> is crucial for maximizing the yield of <b>37</b>. Otherwise, <b>37</b> further reacts with ethyl acrylate <b>36</b> (Alk = Et), generated via β-elimination of <b>35</b> and transesterification with ethanol, through an aza-Michael reaction resulting in the formation of varying amounts of side product <b>38</b>. By use of this protocol, aryl sulfides <b>43a</b>–<b>c</b>, <b>45</b>, <b>46</b>, <b>48</b>, <b>49</b>, or <b>51</b> were converted to the corresponding sodium thiolates (ArSNa), which upon reaction with bromoadenine <b>33b</b> afforded <i>N</i>-formylpiperidine analogues <b>28a</b>, <b>34a</b>, <b>34c</b>, <b>34d</b>, <b>34e</b>, <b>34g</b>, <b>34k</b>, and <b>34o</b> in good yields under mild conditions (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). Intermediates <b>27a</b> and <b>39a</b>–<b>d</b> were prepared from <b>33a</b> in a similar fashion (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>). Deprotection of <b>27a</b> and <b>39a</b>–<b>d</b> with TFA gave piperidine intermediates <b>27b</b> and <b>40a</b>–<b>d</b>, respectively, which were conveniently transformed into target molecules <b>28a</b>, <b>28f</b>–<b>h</b>, <b>34b</b>, <b>34g</b>–<b>j</b>, and <b>34p</b> via EDCI-mediated coupling with appropriate carboxylic acids (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>).</div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>43a</b>–<b>c</b>, <b>45</b>, <b>51</b>, NaOEt, THF/EtOH (10/1, v/v), 60 °C, 3–10 h, 35–80%; (b) TFA or 4 M HCl in dioxane, CH<sub>2</sub>Cl<sub>2</sub>, rt, >90%.</p></p></figure><figure id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDCI, HOBt, DMF–THF, R<sub>2</sub>CO<sub>2</sub>H (R<sub>2</sub> = H, CH<sub>2</sub>OH, (<i>S</i> or <i>R</i>)-CH(OH)CH<sub>3</sub>), rt, 10 h, 55–93%.</p></p></figure><figure id="sch10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 10. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C, 16 h, 94%; (b) NBS, AcOH, rt, 73%; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, >90%; (d) EDCI, HOBt, DMF, R<sub>2</sub>CO<sub>2</sub>H (R<sub>2</sub> = H, CH<sub>2</sub>OH, (<i>S</i> or <i>R</i>)-CH(OH)CH<sub>3</sub>), rt, 10 h, 55–93%.</p></p></figure><div class="NLM_p">A scalable, straightforward, and chromatography-free procedure for the preparation of <b>28a</b> and <b>28f</b>–<b>h</b> was also developed. By employment of the stable and readily available 1,3-benzodioxole-5-thiol (<b>53</b>), displacement of bromoadenine <b>33a</b> followed by bromination with NBS provided <b>27a</b>. After removal of the Boc group, <b>27b</b> could be converted into <b>28a</b> and <b>28f</b>–<b>h</b> by EDCI coupling with the appropriate carboxylic acid (Scheme <a class="ref internalNav" href="#sch10" aria-label="10">10</a>).</div><figure id="sch11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We began our study<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(52)</a> by looking for a replacement for the N9 propargyl moiety present in inhibitor <b>54</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> developed by the Chiosis group. Since phenyl groups can serve as bioisosteres of propargyl groups,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(53)</a> analogue <b>55b</b> (<i>n</i> = 2) was initially prepared and the in vitro potency was compared to other analogues having various alkyl chain lengths (zero to three carbon atoms). Consistently, phenethyl analogues <b>55a</b> (<i>n</i> = 1) demonstrated 3- to 6-fold more potent activity than homologues (e.g., <b>55b</b>) in the Hsp90 FP (fluorescence polarization) assay. With the two-carbon linking element considered optimal, varying substituents on the aromatic ring were explored, and it was found that electron-withdrawing groups (R = 2′-F, 2′-Cl, 2′-Br) at the aryl 2′-position were most potent giving IC<sub>50</sub> values in the range 30–50 nM in the Hsp90 FP assay. Potency in both the Her2-luciferase degradation and HCT116 antiproliferative assays was commensurate with the Hsp90 FP assay potencies (IC<sub>50</sub><sup>FP</sup> = 0.04–0.05 μM; IC<sub>50</sub><sup>Her2</sup> = 0.05–0.16 μM; IC<sub>50</sub><sup>HCT116</sup> = 0.2–0.5 μM). However, metabolic stability (<1% parent drug remaining after 40 min of incubation with human liver microsomes (HLM)) was found to be a significant liability for these derivatives. Several structural modifications to the pendent aryl group were explored as a means of improving metabolic stability: blocking potential metabolic sites on the aromatic ring and/or benzylic position, reducing log <i>P</i> by incorporation of heteroaromatic ring systems (for example, pyridine, pyrrole, and imidazole), and bioisosteric substitution of the phenyl ring with thiophene. Unfortunately, none of these modifications proved to be successful and in most cases resulted in a significant potency loss, and consequently a suitable replacement for the phenethyl system was sought. To this end, the aryl moiety was replaced with an aminomethylcyclopropyl group (<b>55</b> → <b>56</b>, Scheme <a class="ref internalNav" href="#sch11" aria-label="11">11</a>). Since increasing the cycloaliphatic ring size and modifications to the amino group failed to improve potency (IC<sub>50</sub><sup>FP</sup> = 0.08 μM), the PK properties of aminomethylcyclopropyl analogue <b>56</b> were evaluated. Despite vastly improved water solubility (>100 μM at pH 7.4 in phosphate buffer) and metabolic stability, <b>56</b> demonstrated unacceptably poor PK including high clearance rates and extremely low oral bioavailability (<i>F</i> = 0.4%), presumably a consequence of low cellular permeability.</div><div class="NLM_p">Efforts to improve oral bioavailability, while preserving inhibitory activity, led to replacement of the aminomethylcyclopropyl moiety in <b>56</b> with a 4-piperidine ring (<b>56</b> → <b>28a</b>, Scheme <a class="ref internalNav" href="#sch11" aria-label="11">11</a>). As part of this strategy, <i>N</i>-formyl analogue <b>28a</b> was prepared and evaluated for both inhibitory potency and PK properties; the oral bioavailability was much improved (<i>F</i> = 35%) and the potency was acceptable (IC<sub>50</sub><sup>FP</sup> = 0.15 μM; IC<sub>50</sub><sup>Her2</sup> = 0.08 μM; IC<sub>50</sub><sup>HCT116</sup> = 0.43 μM). The piperidine group has been frequently utilized during lead identification and optimization<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(54)</a> and in this instance resulted in improved oral bioavailability while providing a versatile platform for the design of new analogues. Along these lines, subsequent work was focused on variations on the piperidine N-substituent with the ultimate goal of improving potency and ADME properties.</div><div class="NLM_table-wrap" id="tbl1">Table 1<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0020.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0021.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Average of at least two experiments. Assay error for FP is ±10% and ±30% for remaining assays.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Metabolic stability in human liver microsomes; percent parent remaining after 40 min of incubation.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">Unsubstituted piperidine analogue <b>27b</b> and <i>N</i>-alkyl substituted analogues <b>27c</b>–<b>f</b>, where R<sub>1</sub> is <i>i</i>-Pr, <i>i</i>-Bu, CH<sub>2</sub>CF<sub>3</sub>, CH<sub>2</sub>-<i>c</i>-Hex, respectively, were prepared, and their potency was evaluated in the Hsp90 FP assay. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, this modification resulted in diminished activity compared to <b>28a</b> (IC<sub>50</sub><sup>FP</sup> = 0.15 μM), with IC<sub>50</sub><sup>FP</sup> values of 0.47, 0.90, 0.70, 0.60, and 0.24 μM, respectively. On the other hand, <i>N</i>-propargyl analogue <b>27g</b> displayed similar biochemical (IC<sub>50</sub><sup>FP</sup> = 0.11 μM) and cellular potencies (IC<sub>50</sub><sup>Her2</sup> = 0.10 μM vs 0.07 μM and IC<sub>50</sub><sup>HCT116</sup> = 0.74 μM vs 0.43 μM, for <b>27g</b> and <b>28a</b>) to <b>28a</b>, but poor predicted metabolic stability (HLM = 10%) precluded its further evaluation in animals. As part of this SAR study, compound cytotoxicity was also determined on the drug-resistant ovarian tumor cell line NCI-ADR-RES, which overexpresses the P-glycoprotein 1 (P-gp1) drug efflux pump relative to the drug-sensitive parental cell line OVCAR8, which lacks P-gp1 overexpression. Compound potency, as determined by cytotoxicity using the drug-sensitive cell lines HCT116 or OVCAR8, was always similar. As a result, comparison of the cytotoxic potency between NCI-ADR-RES and HCT116 or OVCAR8 was used to indicate whether a test compound was a substrate for the P-gp1 drug efflux pump. Cytotoxicity in the NCI-ADR-RES system was found to be dependent on the steric bulk and lipophilicity of the piperidine nitrogen substituent and on the presence of a hydrogen bond donor atom.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(55)</a> Whereas cyclohexylmethyl and propargyl analogues <b>27f</b>,<b>g</b> were equipotent in both the HCT116 and NCI-ADR-RES assays, the free piperidine analogue <b>27b</b> lost complete potency in the latter assay (IC<sub>50</sub><sup>NCI-ADR-RES</sup> ≥ 100 μM). Similarly, isopropyl analogue <b>27c</b> showed a 2- to 3-fold decreased cytotoxicity in NCI-ADR-RES relative to HCT116. For tetrazole analogues <b>27h</b> and <b>27i</b>, the size of the <i>N</i>-alkyl group impacted inhibitory activity; <i>N</i>-methyltetrazole <b>27h</b> exhibited potent inhibitory activity in both the biochemical (IC<sub>50</sub><sup>FP</sup> = 0.045 μM) and cell-based assays (IC<sub>50</sub><sup>Her2</sup> = 0.031 μM; IC<sub>50</sub><sup>HCT116</sup> = 0.062 μM; IC<sub>50</sub><sup>NCI-ADR-RES</sup> = 0.13 μM), whereas <i>N</i>-<i>tert</i>-butyltetrazole, <b>27i</b>, lost significant activity in the FP binding assay (IC<sub>50</sub><sup>FP</sup> = 1.8 μM). Unfortunately, the poor metabolic stability of <b>27h</b> precluded further evaluation. Thus, further SAR studies were undertaken via synthesis of <i>N</i>-acylpiperidine analogues <b>28a</b>–<b>o</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="sch12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As part of this study, other N9 heterocyclic systems were also explored with representative examples illustrated in Scheme <a class="ref internalNav" href="#sch12" aria-label="12">12</a>. The position of the piperidine nitrogen and ring size were modified resulting in 3-piperidine <b>62</b>, 2-piperidine <b>63</b>, and 3-pyrrolidine <b>64</b> analogues that were similar to, or slightly less potent than, the corresponding 4-piperidine analogues (e.g., <b>63</b>, R = CHO, IC<sub>50</sub><sup>FP</sup> = 0.18 μM for the <i>S</i>-isomer, IC<sub>50</sub><sup>FP</sup> = 0.19 μM, for the <i>R</i>-isomer; <b>28a</b>, IC<sub>50</sub><sup>FP</sup> = 0.15 μM). The 4-tetrahydropyran derivative <b>65</b> showed potency comparable to that of <b>28a</b> in the three main assays (IC<sub>50</sub><sup>FP</sup> = 0.057 μM; IC<sub>50</sub><sup>Her2</sup> = 0.09 μM; IC<sub>50</sub><sup>HCT116</sup> = 0.59 μM). Not surprisingly, however, <b>65</b> demonstrated very low metabolic stability (HLM = 0%), likely a result of oxidative ring cleavage.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(56)</a> In an attempt to improve the metabolic stability of <b>65</b>, the known<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(57)</a> ether bioisostere gem-difluorocyclohexane was incorporated providing <b>66</b>. This modification resulted in modestly improved metabolic stability (HLM = 15%) but with concomitant loss in potency (IC<sub>50</sub><sup>FP</sup> ≈ 1.0 μM). The oxa- and aza-bicyclic heterocyclic analogues <b>67a</b>,<b>b</b>, possessing carbon atoms adjacent to the heteroatoms, were also explored as a means of improving the metabolic stability of <b>65</b>. And while they were similar in potency to <b>65</b>, no improvement in metabolic stability was realized.</div><div class="NLM_table-wrap" id="tbl2">Table 2<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0022.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0023.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Average of at least two experiments. Assay error for FP is ±10% and ±30% for remaining assays.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Metabolic stability in human liver microsomes; percent parent remaining after 40 min of incubation.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">For continuation of SAR studies surrounding <i>N</i>-acyl analogues <b>28a</b>–<b>o</b>, three types of R<sub>2</sub> substituent were examined (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>): (1) alkyl or cycloalkyl groups (<b>28b</b>–<b>e</b>); (2) alkyl or cycloalkyl groups containing an oxygen functionality (<b>28f</b>–<b>j</b>); (3) alkyl or cycloalkyl groups containing an amine functionality (<b>28k</b>–<b>o</b>). In the alkyl and cycloalkyl series, alkyl chain length and the ring size were both investigated. Conversion of the formyl group (<b>28a</b>, R<sub>2</sub> = H) to an acetyl (<b>28b</b>, R<sub>2</sub> = CH<sub>3</sub>) resulted in no significant change in potency. Increasing the carbon chain length reduced potency ∼2 fold (IC<sub>50</sub><sup>FP</sup> = 0.15 vs 0.29 μM and IC<sub>50</sub><sup>HCT116</sup> = 0.43 vs 0.85 μM, <b>28a</b> and <b>28c</b>, respectively), and the cyclopropyl analogue <b>28d</b> demonstrated potency comparable to that of the lead <b>28a</b> in biochemical and cell-based assays. Additionally, <b>28d</b> was not a MDR substrate as indicated by equipotency in the NCI-ADR-RES assay, but again, metabolic instability in human microsomal assays obviated further progression of this otherwise promising inhibitor. Inhibitory potency was found to decrease with increasing ring size as illustrated by cyclopentyl analogue <b>28e</b>, which was 2- to 3-fold less potent (IC<sub>50</sub><sup>FP</sup> = 0.25 μM; IC<sub>50</sub><sup>Her2</sup> = 0.25 μM; IC<sub>50</sub><sup>HCT116</sup> = 1.3 μM) than the lead <b>28a</b>. Incorporation of a primary or secondary hydroxyl group into the R<sub>2</sub> substituent improved metabolic stability (HLM = 42–58% for <b>28f</b>–<b>h</b>) while maintaining potency (IC<sub>50</sub><sup>FP</sup> = 0.11–0.14 μM; IC<sub>50</sub><sup>Her2</sup> = 0.06–0.09 μM; IC<sub>50</sub><sup>HCT116</sup> = 0.38–0.64 μM). No significant differences in potency and metabolic stability were observed among the hydroxyl substituted analogues as a group. Although this modification resulted in a moderate decrease in NCI-ADR-RES cytotoxicity, possibly due to hydrogen bonding capacity, they were advanced into PK evaluations given the improved balance between potency and microsomal stability. Interestingly, gem-dimethyl derivative <b>28i</b> lost all binding potency (IC<sub>50</sub><sup>FP</sup> ≥ 5 μM). Propane-1,2-dione analogue <b>28j</b>, the oxidized form of <b>28g</b> and <b>28h</b>, demonstrated improved potency in both the biochemical and cellular assays (IC<sub>50</sub><sup>FP</sup> = 0.11 μM; IC<sub>50</sub><sup>Her2</sup> = 0.034 μM; IC<sub>50</sub><sup>HCT116</sup> = 0.27) while losing all activity against NCI-ADR-RES (IC<sub>50</sub><sup>NCI-ADR-RES</sup> = 100 μM) and inheriting a poor metabolic profile.</div><div class="NLM_p">The SAR was extended to amine containing analogues <b>28k</b>–<b>o</b>. In general, these analogues exhibited decreased potency in cell-based assays. In particular, the marked loss of potency in the NCI-ADR-RES cell line was observed regardless of substitution on the amino group. Tertiary dimethylamino analogue <b>28n</b> (IC<sub>50</sub><sup>NCI-ADR-RES</sup> ≥ 100 μM) and sterically hindered proline analogue <b>28o</b> (IC<sub>50</sub><sup>NCI-ADR-RES</sup> = 34 μM) did not improve the cellular activity, suggesting both low cellular permeability and P-gp substrate susceptibility.</div><div class="NLM_p">From the SAR studies described above, it was determined that modifications to the N9 piperidine substituent can significantly modulate both the potency and metabolic stability of these purine analogues and we concluded that the <i>N</i>-hydroxyacyl moieties present in analogues <b>28f</b>–<b>h</b> represented the optimal piperidine N-substituents, imparting the best balance between potency and metabolic stability.</div><div class="NLM_p">The potential binding mode of these analogues has been examined by molecular modeling methods, and the best docking poses for all active compounds share common features. For example, from molecular modeling with <b>28g</b> and the Hsp90 N-terminal, ATP-binding domain reveals an interaction between the N9 piperidine ring and Ile110 side chain. In addition, H-bond donor–acceptor interactions between the lactamide carbonyl and Lys58 ε-amino group and between the lactamide hydroxyl and the Gly97 backbone carbonyl are key ligand–protein interactions (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Putative binding mode of <b>28g</b> in the ATP-binding site of Hsp90 as determined by molecular modeling with Hsp90 crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYI">1UYI</a>). Protein, ligand, and structured water molecules are rendered with Accelrys DS Visualizer 3.1. Atoms are colored by element: oxygen, red; nitrogen, blue; sulfur, green; ligand carbon, white; protein carbon, gold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By employment of N9-optimized analogues <b>28f</b>–<b>h</b> and initial lead <b>28a</b>, alternatives to the 6-bromo-1,3-benzodioxole moiety were explored next. The binding mode and preference for an <i>s</i>-<i>trans</i> conformation for this aryl moiety within the N-terminal ATP-binding pocket of Hsp90 are well documented.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(58)</a> As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, our modeling with <b>28g</b> reveals a similar predisposition of the 6-bromo-1,3-benzodioxole moiety and, in addition to the conformational biasing imposed by the ligand bromine atom, points to a π–π interaction and edge-to-edge interaction with Phe138 and Trp162 and to a van der Waals interaction with the L107 isobutyl group as being major contributors to favorable binding energetics. Although a great deal of exploratory work has been performed in this region, these studies either were directed at a better understanding of the substituent effects at different positions of the 8-aryl group or were directed at replacement of the 8-aryl group with a benzothiazole ring.<a onclick="showRef(event, 'ref33 ref34 ref43 ref60'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref43 ref60">(33, 34, 43, 59)</a> On the basis of the information from the literature, we carried out further SAR studies on this region by employing congeners of the 6-bromo-1,3-benzodioxole moiety, including bioisosteres, in order to gain insight into the structural features required for optimal potency and physical properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(60-62)</a></div><div class="NLM_table-wrap" id="tbl3">Table 3<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0024.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0025.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Average of at least two experiments. Assay error for FP is ±10% and ±30% for remaining assays.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Metabolic stability in human liver microsomes; percent parent remaining after 40 min of incubation.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Not determined.</p></div></div><div></div></div><div class="NLM_p">First, a series of dihydrobenzofuran and benzofuran analogues was compared. 5-Bromo-2,3-dihydrobenzofuran <b>34a</b> (IC<sub>50</sub><sup>FP</sup> = 0.04 μM) proved to be ∼10 times more potent than 6-bromo-2,3-dihydrobenzofuran <b>34c</b> (IC<sub>50</sub><sup>FP</sup> = 0.4 μM) in the FP assay. The results of the Her2 assay (0.01 μM, <b>34a</b>, and 0.28 μM, <b>34c</b>) and antiproliferative activities on HCT116 cells (0.09 μM, <b>34a</b>, and 1.2 μM, <b>34c</b>) were consistent with the FP results and supported an on-target mechanism of cytotoxicity. The 5-bromo-2,3-dihydroindole <b>34b</b>, (<i>S</i>)-2-methyl-<i>N</i>-hyroxyacylpiperidine at N9, demonstrated potency similar to that of <b>34a</b>. A similar trend was observed with benzofurans <b>34d</b> and <b>34e</b>, where <b>34d</b> was >10-fold more potent than its regioisomer <b>34e</b> in all four assays. Replacing both oxygen atoms in the benzodioxole ring with CH<sub>2</sub> provided indane <b>34f</b> which was found to be very potent with IC<sub>50</sub> of 0.02 μM in both the FP and HCT116 antiproliferative assays. It was encouraging that the non-benzodioxole analogues <b>34a</b>,<b>b</b>, <b>34d</b>, and <b>34f</b> demonstrated comparable to improved activity relative to the corresponding 1,3-benzodioxole analogues. Noteworthy observations from this segment of the developing SAR were the following: (1) the benzodioxole oxygen atoms were not essential for binding affinity (cf., <b>28a</b> vs <b>34f</b>); (2) the effects of the oxygen atoms at the 1- or 3-position of the benzodioxole ring were not equal. The oxygen atom at the 3-position (para to the sulfur atom) was detrimental to potency, where in contrast the oxygen atom at the 1-position (meta to the sulfur atom) was tolerated (<b>34a</b> vs <b>34c</b>; <b>34d</b> vs <b>34e</b>). While additional studies are needed to better understand this phenomenon, it appears that binding affinity is influenced by both conformational preferences and ring system electronic properties; see, for example, difluororo-1,3-benzodioxole analogue <b>34n</b> which lost binding affinity (IC<sub>50</sub><sup>FP</sup> > 5 μM). Interestingly and contrary to our expectations, the metabolic stability of <b>34n</b> was found to be very low (HLM = 0%). Since fluorine substitution at the methylene bridge of 1,3-benzodioxole ring systems can prevent oxidative metabolism,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(63)</a> difluoro-1,3-benzodioxole analogue <b>34n</b> was expected to be metabolically stable.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(64)</a> Although metabolite identification is needed to identify the origins of instability, it is tempting to speculate that the increased lipophilicity of <b>34n</b> (log <i>P</i> = 3.32, 3.42, 4.82, for <b>28g</b>, <b>28a</b>, <b>34n</b>, respectively) is a contributing factor.</div><div class="NLM_p">To further explore the effects of ring size, benzodioxanes <b>34g</b>–<b>j</b> were compared to the corresponding benzodioxoles <b>28a</b> and <b>28f</b>–<b>h</b>. In general, benzodioxanes <b>34g</b>–<b>j</b> had potency similar to that of the corresponding benzodioxoles in the FP assay but were slightly less potent in cell-based assays. Isomeric benzoxazines <b>34k</b> and <b>34l</b> demonstrated similar SAR trends, as evidenced by dihydrobenzofuran and benzofuran analogues <b>34a</b>–<b>e</b>. Thus, benzoxazine <b>34k</b>, with the oxygen atom meta to the sulfur atom, was 4- to 6-fold more potent than its isomer <b>34l</b> (IC<sub>50</sub><sup>FP</sup> = 0.065 and 0.31 μM for <b>34k</b> and <b>34l</b>; IC<sub>50</sub><sup>HCT116</sup> = 0.25 and 1.5 μM for <b>34k</b> and <b>34l</b>). Indanone <b>34m</b>, a nonclassical bioisostere of benzodioxole <b>28a</b>,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(61)</a> exhibited good potency in the FP (IC<sub>50</sub><sup>FP</sup> = 0.06 μM) and cytotoxicity assays (IC<sub>50</sub><sup>Her2</sup> = 0.06 μM; IC<sub>50</sub><sup>HCT116</sup> = 0.27 μM). The non-benzodioxole analogues were subsequently evaluated for metabolic stability. Inhibitors <b>34a</b>–<b>c</b> and <b>34f</b>, bearing benzylic methylene protons, and benzoxazines <b>34k</b>,<b>l</b> exhibited rapid metabolism upon incubation in human microsomes, and benzodioxanes <b>34g</b>–<b>j</b>, benzofurans <b>34d</b>,<b>e</b>, and indanone <b>34m</b> displayed stability similar to that of benzodioxoles <b>28a</b> and <b>28f</b>-<b>h</b>. On the basis of their equivalent potency and metabolic stability to <b>28a</b> and <b>28f</b>–<b>h</b>, benzodioxanes <b>34g</b>–<b>j</b> and benzofuran <b>34d</b> were advanced into PK evaluations. Indanone <b>34m</b> was excluded from PK analyses because of lack of potency in NCI-ADR-RES (IC<sub>50</sub><sup>NCI-ADR-RES</sup> ≥ 100 μM).</div><div class="NLM_p">Analogues <b>34o</b>–<b>q</b>, where the 1,3-benzodioxole ring bromine atom was replaced with a chloro or cyano, were also examined. Not surprisingly and in accord with previous studies, replacement of Br with Cl led to a ∼2-fold decrease in potency.<a onclick="showRef(event, 'ref43 ref59'); return false;" href="javascript:void(0);" class="ref ref43 ref59">(43, 58)</a> Although cyano derivative <b>34q</b> showed significantly enhanced metabolic stability (HLM = 81%), the cellular potency dropped unacceptably by 4- to 46-fold (IC<sub>50</sub><sup>Her2</sup> = 0.25 μM; IC<sub>50</sub><sup>HCT116</sup> = 25 μM).</div><div class="NLM_p">Ultimately, nine inhibitors, <b>28a</b>, <b>28f</b>–<b>h</b>, and <b>34d</b>,<b>g</b>–<b>j</b> were selected for intravenous (2.5 mg/kg) and oral (10 mg/kg) PK evaluations in Swiss nude mice (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Parameters of <b>28a</b>, <b>28f</b>–<b>h</b>, and <b>34d</b>,<b>g</b>–<b>j</b> in Mice</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">iv (2.5 mg/kg)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">po (10 mg/kg)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CL<br /></br>(mL h<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><br /></br>(mL/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub><br /></br>(h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<br /></br>(h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub><br /></br>(ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub><br /></br>(h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<br /></br>(h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><br /></br>(%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28a</b></td><td class="colsep0 rowsep0" align="char" char=".">1899</td><td class="colsep0 rowsep0" align="char" char=".">1452</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1316</td><td class="colsep0 rowsep0" align="char" char=".">354</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1808</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28f</b></td><td class="colsep0 rowsep0" align="char" char=".">4359</td><td class="colsep0 rowsep0" align="char" char=".">3005</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">574</td><td class="colsep0 rowsep0" align="char" char=".">588</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">1318</td><td class="colsep0 rowsep0" align="char" char=".">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28g</b></td><td class="colsep0 rowsep0" align="char" char=".">1187</td><td class="colsep0 rowsep0" align="char" char=".">2438</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">2106</td><td class="colsep0 rowsep0" align="char" char=".">2802</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">3214</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28h</b></td><td class="colsep0 rowsep0" align="char" char=".">1513</td><td class="colsep0 rowsep0" align="char" char=".">1321</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">1653</td><td class="colsep0 rowsep0" align="char" char=".">1429</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">2410</td><td class="colsep0 rowsep0" align="char" char=".">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34g</b></td><td class="colsep0 rowsep0" align="char" char=".">2585</td><td class="colsep0 rowsep0" align="char" char=".">1053</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">967</td><td class="colsep0 rowsep0" align="char" char=".">312</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1175</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34h</b></td><td class="colsep0 rowsep0" align="char" char=".">4833</td><td class="colsep0 rowsep0" align="char" char=".">5927</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">517</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">702</td><td class="colsep0 rowsep0" align="char" char=".">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34i</b></td><td class="colsep0 rowsep0" align="char" char=".">1712</td><td class="colsep0 rowsep0" align="char" char=".">1070</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char=".">1460</td><td class="colsep0 rowsep0" align="char" char=".">564</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1193</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34j</b></td><td class="colsep0 rowsep0" align="char" char=".">1639</td><td class="colsep0 rowsep0" align="char" char=".">1347</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">1526</td><td class="colsep0 rowsep0" align="char" char=".">1183</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1960</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34d</b></td><td class="colsep0 rowsep0" align="char" char=".">2841</td><td class="colsep0 rowsep0" align="char" char=".">1058</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">880</td><td class="colsep0 rowsep0" align="char" char=".">2231</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">4612</td><td class="colsep0 rowsep0" align="char" char=".">131</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Formulation: DMA/PEG300/EtOH/H<sub>2</sub>O (3/40/12/45, v/v/v/v).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Formulation: DMA/PEG300 (5/95, v/v).</p></div></div></div><div class="NLM_p">Several interesting observations were made as result of these initial PK evaluations. First, 1,3-benzodioxole analogues <b>28a</b> and <b>28f</b>–<b>h</b> demonstrated favorable PK profiles in comparison to the corresponding 1,4-benzodioxanes <b>34g</b>–<b>j</b> (<b>28a</b> vs <b>34g</b>; <b>28f</b> vs <b>34h</b>; <b>28g</b> vs <b>34i</b>; <b>28h</b> vs <b>34j</b>). Second, compounds <b>28f</b> and <b>34h</b>, possessing <i>N</i>-hydroxyacetyl substituents on the piperidine nitrogen, suffered from high hepatic clearance (>4300 mL h<sup>–1</sup> kg<sup>–1</sup>)<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(65)</a> and concomitantly low exposure. Third, inhibitor <b>28g</b> displayed superior oral PK profiles with a high <i>C</i><sub>max</sub> (2802 ng/mL, ∼5.1 μM), good overall exposure (3214 h·ng/mL), and a reasonable hepatic clearance rate. Fourth, most compounds showed rapid absorption following oral administration in mice (<i>T</i><sub>max</sub> = 0.25–1 h). Finally, the quantitative oral bioavailability (<i>F</i> > 100%) of benzofuran <b>34d</b> was entirely unexpected given the structural similarity of these purine analogues. Oral bioavailability values of >100% have been reported in literature, and the phenomenon has several contributing factors.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(66)</a> Regardless of mechanism, the uncharacteristic PK behavior for <b>34d</b> led us to eliminate it from further study. For purposes of triaging compounds into human tumor xenograft studies, the mouse PK (100 mg/kg, oral, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) of the eight remaining compounds was evaluated. In the PK study for these analogues, less than expected increases in AUC and <i>C</i><sub>max</sub> were observed in general. This effect is possibly due to the dissolution rate or solubility-limited absorption. Most of these analogues belong to BCS (biopharmaceutics classification system) class II. For example, <b>28g</b> is modestly soluble (∼20 μM at pH 7.4 in phosphate buffer) but highly permeable (>350 x10<sup>–6</sup> cm/s, PAMPA assay). Issues relating to the solubility and absorption properties of drug candidates are frequently encountered during the drug discovery process, and this compound class could be addressed by formulation.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(67)</a> In this instance, formulation in a Captisol (modified cyclodextrin) and phosphate buffer system enhanced oral bioavailability dramatically (e.g., <i>F</i> > 50%, for <b>28a</b>,<b>f</b>–<b>h</b> and <b>34g</b>–<b>j</b>).</div><div class="NLM_p">In these PK studies, HSP70 mRNA induction in liver at 6 h after treatment was also measured. HSP70 is robustly up-regulated in response to Hsp90 inhibition and is a validated pharmacodynamics biomarker. Induction of HSP70 indicates that the drug is both reaching the intended target site and exerting pharmacological effects via the Hsp90 mechanism. Although the effects of Hsp90 inhibitors on HSP70 induction are expected to be different in tumors and normal cells or tissues,<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(68, 69)</a> this experiment would provide early evidence of target modulation in vivo.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters of <b>28a</b>, <b>28f</b>–<b>h</b>, and <b>34g</b>–<b>j</b> (po, 100 mg/kg)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub>(ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (h·ng/mL)</th><th class="colsep0 rowsep0" align="center">Hsp70 induction<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28a</b></td><td class="colsep0 rowsep0" align="char" char=".">10940</td><td class="colsep0 rowsep0" align="char" char=".">63900</td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28f</b></td><td class="colsep0 rowsep0" align="char" char=".">7780</td><td class="colsep0 rowsep0" align="char" char=".">25100</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28g</b></td><td class="colsep0 rowsep0" align="char" char=".">13100</td><td class="colsep0 rowsep0" align="char" char=".">81800</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28h</b></td><td class="colsep0 rowsep0" align="char" char=".">8400</td><td class="colsep0 rowsep0" align="char" char=".">50300</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34g</b></td><td class="colsep0 rowsep0" align="char" char=".">8540</td><td class="colsep0 rowsep0" align="char" char=".">38000</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34h</b></td><td class="colsep0 rowsep0" align="char" char=".">7530</td><td class="colsep0 rowsep0" align="char" char=".">18200</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34i</b></td><td class="colsep0 rowsep0" align="char" char=".">11600</td><td class="colsep0 rowsep0" align="char" char=".">40400</td><td class="colsep0 rowsep0" align="left">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34j</b></td><td class="colsep0 rowsep0" align="char" char=".">9300</td><td class="colsep0 rowsep0" align="char" char=".">32600</td><td class="colsep0 rowsep0" align="left">3.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Formulation: 40% Captisol in phosphate buffer.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Fold over control.</p></div></div></div><div class="NLM_p">In accord with the previous PK studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), <b>28g</b> showed the best PK profile with a <i>C</i><sub>max</sub> of 13100 ng/mL (∼23 μM) and an AUC of 81 800 h·ng/mL with excellent oral bioavailability (97%). The <i>C</i><sub>max</sub> was 20- to 60-fold higher than IC<sub>50</sub> values in representative cancer lines in vitro (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Initial lead compound <b>28a</b> also exhibited a profile fairly similar to that of <b>28g</b>. Benzodioxane analogues <b>34g</b>–<b>j</b> had inferior AUC and <i>C</i><sub>max</sub> values relative to the corresponding 1,3-benzodioxaole analogues. Interestingly, only 2- to 4-fold induction of liver HSP70 levels was observed for benzodioxane analogues <b>34g</b>–<b>j</b> whereas an 18- to 53-fold induction was achieved with 1,3-benzodioxoles <b>28a</b> and <b>28f</b>-<b>h</b>. This phenomenon may reflect differences in cellular potency or PK properties. However, the similarities in potency and PK of benzodioxole <b>28f</b> and benzodioxazines <b>34g</b>–<b>j</b>, the former showing 5- to 10-fold higher HSP70 induction than the latter, suggest that other factors are likely in play. Both the PK and HSP70 induction profiles made analogue <b>28g</b> the most promising candidate for further development.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Antiproliferative Activity for <b>28g</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">cell line</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HT-29 (colon)</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="left">A549 (NSCLC)</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HCT-116 (colon)</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="left">OVCAR8 (ovarian)</td><td class="colsep0 rowsep0" align="char" char=".">0.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LNCaP (prostate)</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="left">NCI-N87 (gastric)</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DU-145 (prostate)</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td><td class="colsep0 rowsep0" align="left">BT-474 (breast)</td><td class="colsep0 rowsep0" align="char" char=".">0.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NCI-H69 (SCLC)</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="left">MV4–11 (leukemia)</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Average of two or more experiments; standard deviation was ±30%.</p></div></div></div><div class="NLM_p">With benzodioxole <b>28g</b> demonstrating optimal PK properties, its antiproliferative activity against an array of cancer cell lines was profiled and revealed broad spectrum activity with IC<sub>50</sub> values ranging from 0.1 to 0.8 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). In order to confirm the cellular mode of action of <b>28g</b>, HCT-116, NCI-N87, and DU-145 cells were exposed to varying concentrations of <b>28g</b> for 24 h and the cell lysates were probed with antibodies to Her2, Akt, and Hsp70. As anticipated, Western blot analysis of <b>28g</b> in NCI-N87, HCT-116, and DU-145 cell lysates revealed dose-dependent client protein degradation (Akt and Her2) and Hsp70 induction (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Importantly, the IC<sub>50</sub> values for client protein degradation (0.1–0.5 μM) were commensurate with cellular cytotoxicity, suggesting a direct relationship between biomarker response and drug exposure. The change in client protein and biomarker levels observed in cells exposed to <b>28g</b> provided evidence that the observed cellular cytotoxicity was a result of Hsp90 inhibition.</div><figure id="fig5" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>28g</b> on Hsp90 client protein (Her2, Hsp70, and Akt) expression in NCI-N87, HCT116, and DU-145 cell lines by Western blot analyses. Cells were exposed to varying concentrations of <b>28g</b> for 24 h, and then cell lysates were probed with Her2-, Hsp70-, and Akt-specific antibodies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) In vivo efficacy data for <b>28g</b> (50, 75, 125, or 200 mg/kg, q.d., po 22 days) in the NCI-N87, Her2<sup>+</sup> human gastric cancer xenograft model. (b) Change in HSP70 expression level in NCI-N87 tumor-bearing mice. Mice with NCI-N87 tumors (median volume, ∼425 mm<sup>3</sup>) were given a single oral dose of <b>28g</b> (200 mg/kg). Blood, tumor, and liver samples (<i>n</i> = 6) were collected at 0.25, 0.5, 1, 2, 4, 8, 12, 36, and 48 h after dose for determination of compound concentrations in plasma and Hsp70 RNA levels in tumor and liver.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of its favorable in vitro profiles and PK properties, <b>28g</b> was evaluated in a human xenograft study in mice (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). In the NCI-N87 gastric cancer xenograft model, <b>28g</b> was administered orally for 22 days at doses of 50, 75, 125, or 200 mg/kg and demonstrated dose-related inhibition of tumor growth. The 50 and 75 mg/kg doses resulted in tumor growth inhibition (<i>p</i> < 0.01) of 37% and 62%, respectively, and the 125 and 200 mg/kg doses resulted in tumor regression (<i>p</i> < 0.0001) of 10% and 48%, respectively. Both the dose level and schedule were well tolerated as evidenced by lack of significant weight loss. Furthermore, robust HSP70 induction in liver and tumor tissue supports on-target, Hsp90-mediated antitumor effects by <b>28g</b> in NCI-N87 tumor-bearing mice (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An extensive SAR study aimed at enhancing potency and druglike properties of lead Hsp90 inhibitor <b>28a</b> was executed. During the course of these studies, new and improved synthetic methods for C–S bond formation were developed that enabled rapid generation of potential inhibitors and dramatically broadened the scope of the SAR. Through a combination of modifications to the pendent purine N-9 piperidine moiety and congeneric series of 1,3-benzodioxole ring at C8, several potent Hsp90 inhibitors were identified. Pharmacokinetic analyses led to selection of <b>28g</b> as the most promising drug candidate. Following oral administration of <b>28g</b> to mice (100 mg/kg), the plasma <i>C</i><sub>max</sub> (∼23 μM) was 20- to 60-fold higher than its IC<sub>50</sub> values for cancer cell lines in vitro and with good systemic exposure (AUC = 81 800 h·ng/mL). Importantly, inhibitor <b>28g</b> showed significant antitumor effects in a human cancer xenograft model with concomitant and robust Hsp70 mRNA induction, a pharmacodynamic marker of Hsp90 inhibition.</div><div class="NLM_p last">Compound <b>28g</b> (MPC-3100) has completed a phase I clinical evaluation in refractory, or recurrent, cancer patients. This clinical study demonstrated that <b>28g</b> was safe and tolerated when administered at doses below 600 mg per day with the most common side effects being of gastrointestinal origin, including diarrhea, nausea, and vomiting.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(70)</a> The results of further clinical evaluation will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53504" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53504" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Biology. Binding Assay</h3><div class="NLM_p last">Compound binding to purified Hsp90 was monitored using BODIPY-labeled geldanamycin (BODIPY-GM) in a fluorescence polarization assay adapted from the literature method.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(71)</a> Compound dilutions (in 100% DMSO) were added to black-bottom 96-well plates (Greiner, 2% DMSO final), and equal volumes of BODIPY-GM (10 nM final) and purified human Hsp90 (Stressgen, SPP-770; 30 nM final) in assay buffer (20 mM HEPES–KOH, pH 7.3, 50 mM KCl, 5 mM MgCl<sub>2</sub>, 20 mM Na<sub>2</sub>MoO<sub>4</sub>, 0.01% NP-40, 0.1 mg/mL bovine γ-globulin [Invitrogen, P2045], 2 mM DTT) were added sequentially to yield a final volume of 50 μL. Plates were incubated overnight at room temperature. Parallel and perpendicular fluorescence measurements were read (LJL BioSystems Analyst AD plate reader) with excitation and emission wavelengths of 485 and 530 nm, respectively. Background fluorescence (buffer only) was subtracted, and fluorescence polarization (FP) values, expressed in mP units, were calculated from parallel and perpendicular fluorescence readings as follows: FP = [(parallel – perpendicular)/(parallel + perpendicular)] × 1000. Percent inhibition was calculated by normalizing the FP values to those obtained in parallel reactions containing DMSO and subtracting these normalized values from 100%. Intrinsic compound fluorescence was independently monitored, and FP data points confounded by compound fluorescence were excluded from the analysis.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Her2-Luciferase Degradation Assay</h3><div class="NLM_p last">The Her2-luciferase construct was constructed by joining sequences encoding the kinase domain (aa 641–975) of Her2 to those encoding firefly luciferase.<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(72, 73)</a> HCT116 cells stably transfected with the Her2 (kinase domain)-luciferase fusion were seeded into black 96-well plates at 10 000 cells per well in 100 μL (DMEM supplemented with 10% serum) and incubated overnight. Compound dilutions (in 100% DMSO) were added to individual wells (0.4% DMSO final), and plates were incubated for 4 h. Plates were equilibrated to room temperature (5 min), 100 μL of Steady-Glo reagent (Promega no. E2520) was added per well, and plates were incubated at room temperature for 5 min. Luminescence was then measured (TopCount, Perkin-Elmer).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cytotoxicity Assay</h3><div class="NLM_p last">Cells were seeded into black 96-well plates at 5000 cells per well in 100 μL (DMEM supplemented with 10% serum) and incubated overnight. Compound dilutions (in 100% DMSO) were added to individual wells (0.4% DMSO final), and plates were incubated for 72 h. Plates were equilibrated to room temperature (5 min). An amount of 50 μL of lysis buffer followed by 50 μL of substrate solution (ATPLite [two-step], Perkin-Elmer, no. 601941) was added to each well, and plates were incubated at room temperature for 5 min. Luminescence was then measured (TopCount, Perkin-Elmer).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Microsomal Stability Assays</h3><div class="NLM_p last">Metabolic stability of the test article was assessed in liver microsomes from multiple species (e.g., mouse, rat, dog, monkey, or human) with and without NADPH. Concentrations of test article were determined by high-performance liquid chromatography combined with electrospray ionization tandem mass spectrometry. The test article was incubated in duplicate in the presence of microsomes diluted to 0.5 mg/mL of total protein in 100 mM potassium phosphate buffer (pH 7.4). NADPH-dependent metabolism was initiated with the addition of 1 mM NADPH. Aliquots of sample were removed at 0, 10, 20, and 40 min after NADPH addition, and the reaction was stopped by addition of acetonitrile. Following centrifugation, supernatants were dried under a stream of nitrogen and reconstituted in an appropriate solvent. Samples were quantified by determining peak area from LC–MS/MS analysis. Typically, analytes were ionized by positive-ion electrospray ionization and detected by multiple-reaction monitoring on an ABI Q-Trap mass spectrometer. Peak areas of the duplicates at the various time points were integrated, and the percent of compound remaining at 10, 20, and 40 min was compared to the peak area at 0 min. “No NADPH” control samples were incubated for 40 min and analyzed in the same manner.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> PAMPA Permeability Assay</h3><div class="NLM_p last">Permeability of a test compound was determined using the double-sink parallel artificial membrane permeability analysis (PAMPA) method (pION Inc.). Donor solutions were prepared at three pH levels of 5.0, 6.2, and 7.4. pION’s ASB 7.4 buffer was placed in the permeation plate, and the filter plate was painted with a phospholipid mixture dissolved in dodecane. Test compounds were then added to the filter plate, which was then placed on top of the permeation plate to form the PAMPA sandwich. The sandwich was incubated for 30 min at 37 °C with a mixing speed equivalent to an aqueous boundary layer of 40 μm. Spectra were collected from 250 to 490 nm (Spectra-Max, Molecular Devices). Permeability was calculated from the spectra using pION’s software. Verapamil was analyzed at the same time and served as positive control.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharamacokinetic Studies</h3><div class="NLM_p last">All pharmacokinetic studies of test articles were conducted in mice. Plasma and tissue concentrations of the test article were quantified by LC–ESI-MS/MS using an internal standard and calibration curve with quality control samples. Animals were dosed intravenously or orally. The basic pharmacokinetics of the test article was determined in female CD-1 or Nu<sup>±</sup> mice dosed at 2.5 mg/kg intravenously. The dosing vehicle consisted of DMA/PEG300 (<i>N</i>,<i>N</i>-dimethylacetamide, polyethylene glycol 300, ethanol, and water in a ratio of 3/40/12/45, respectively). Three or five animals were used per time point, and the time points collected were 5, 15, 30, 60, 120, 240, 480, and 720 minutes after administration. Blood samples were collected through cardiac puncture, and plasma was obtained with EDTA as the anticoagulant. Plasma was submitted for bioanalysis (described below). For oral dosing, the test article was administered via oral gavage formulated in one of the following: DMA/PEG300 (<i>N</i>,<i>N</i>-dimethylacetamide and polyethylene glycol 300 in a ratio of 5/95 or 10/90), CMC/Tween 80 (2% carboxymethylcellulose, low viscosity with 0.05% Tween 80 in HPLC grade water), or 40% Captisol in phosphate. Concentrations of the test article were determined by adding 10 μL of internal standard to 50 μL of sample and then precipitating protein with 1 mL of acetonitrile. The supernatant was injected onto a reverse-phase HPLC column. Separation was achieved by gradient elution. Analytes were ionized by positive-ion electrospray ionization and detected by multiple-reaction monitoring on an ABI Q-Trap. Peak area ratios of the test article and internal standard were compared to those from a multipoint standard curve spanning a range from 10 to 10 000 ng/mL. To confirm accuracy, quality control samples were analyzed in duplicate at four different concentrations. Bioanalytical run acceptance required that at least three-fourths of the calibration standards were within 15% of theoretical and that greater than <sup>2</sup>/<sub>3</sub> of all quality control samples were within 25% of theoretical. Plasma concentration data were fit with WinNonLin using noncompartmental analysis.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Xenograft Study (NCI-N87 Xenograft)</h3><div class="NLM_p last">Five million NCI-N87 cells were implanted subcutaneously in the right flank of female nude mice (Crl:NU-Fox1nu). When the median tumor volume was approximately >100 mm<sup>3</sup>, mice were randomized into 5 cohorts of 10 animals each. Cohort 1 was dosed once daily with vehicle (40% w/w Captisol), cohort 2 with 200 mg/kg, <b>28g</b> once daily, cohort 3 with 125 mg/kg, <b>28g</b> once daily, cohort 4 with 75 mg/kg, <b>28g</b> once daily, and cohort 5 with 50 mg/kg, <b>28g</b> once daily. All cohorts were dosed for 22 days. Tumor measurements and body weight determinations were performed a minimum of 2 times weekly.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p">All solvents and reagents were purchased from commercial sources and used without further purification unless otherwise noted. Reactions were monitored by TLC (thin layer chromatography) using 0.25 mm silica gel 60 F254 plates purchased from EMD chemicals or LC–MS (ESI) using an Agilent 1100 series LC/MSD ion-trap instrument with an Xterra MS C18 (Waters) 4.6 mm × 50 mm, 5 μm column. Purification was performed with either ISCO CombiFlash (Foxy Jr. fraction collector, UA-6 detector) or a reverse phase HPLC (RP-HPLC) on an Agilent 1100 Prep-LC with various columns. <sup>1</sup>H NMR spectra were recorded on a Bruker Mercury 400 MHz instrument. Proton chemical shifts are expressed in parts per million (ppm) relative to TMS and calibrated using residual undeuterated solvent as internal reference. High-resolution mass spectra (HRMS) were recorded on an Agilent 6210 TOF LC–MS instrument using electronspray ionization (ESI). GC–MS analysis was performed on an Agilent Technology 6890N. Determination of the enantiomeric purity of chiral compounds was performed on a Chiralcel OJ-RH column, using 100% MeOH with 0.01% TEA (isocratic, 0.5 mL/min). Compound purity was determined by an Agilent HP1100 instrument with a 4.6 mm × 150 mm Xterra C18 3.5 μm column. The flow rate was 1.2 mL/min, and the injection volume was 5 μL. HPLC conditions were as follows: mobile phase A, HPLC grade water (0.01% TFA); mobile phase B, HPLC grade acetonitrile (0.01% TFA); UV detector, 203 and 280 nm; gradient, 95% A/5% B to 0% A/100% B in 10 min, 100% B in 10–11 min, 100% B to 95% A/5% B in 11–13 min, 95% A/5% B in 13–15 min. All final compounds were ≥95% pure by HPLC at both 203 and 280 nm unless otherwise stated.</div><div class="NLM_p last">Intermediates <b>24a</b>–<b>c</b>,<b>f</b>,<b>g</b>, <b>25a</b>, <b>29</b>, <b>30a</b>,<b>b</b>, <b>41</b>, <b>42</b>, <b>47</b>, and <b>50</b> were purchased from commercial vendors, and <b>24d</b>,<b>e</b> were prepared by adapting literature procedures (in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The log <i>P</i> value was calculated using Chemdraw software.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 8-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]-9<i>H</i>-purin-6-amine (<b>26a</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></h3><div class="NLM_p last">To a 250 mL round-bottomed flask was added 8-mercaptoadenine (<b>21</b>) (2.00 g, 12.0 mmol), 5,6-dibromobenzo[1,3]dioxole (<b>24a</b>) (6.70 g, 24.0 mmol), Pd<sub>2</sub>dba<sub>3</sub> (0.548 g, 0.599 mmol), xantphos (0.693 g, 1.20 mmol), K<sub>2</sub>CO<sub>3</sub> (3.31 g, 24.0 mmol), and dry, degassed dioxane (25 mL). The mixture was heated at 100 °C for 16 h under nitrogen, cooled to room temperature, filtered, and washed with a mixture of CH<sub>2</sub>Cl<sub>2</sub>, EtOAc, and MeOH (2/2/0.5 (v/v/v)). The combined filtrates were concentrated in vacuo. The dark brown residue was purified by chromatography on SiO<sub>2</sub> (CH<sub>2</sub>Cl<sub>2</sub>/EtOAc/MeOH, 2/2/0.5), and subsequent recrystallization from MeOH provided <b>26a</b> (1.4 g, 32%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.08 (s, 1H), 7.38 (s, 1H), 7.23 (s, 1H), 6.12 (s, 2H); LC–MS [M + H<sup>+</sup>] 365.9; HPLC purity, 94.2% (<i>t</i><sub>R</sub> = 4.20 min).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 5-[(6-Amino-9<i>H</i>-purin-8-yl)thio]-6-bromoindan-1-one (<b>26f</b>)</h3><div class="NLM_p last">The title compound was prepared in 24% yield from <b>21</b> and <b>24f</b> in a manner similar to that described for <b>26a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (s, 1H), 7.87 (s, 1H), 7.58–7.44 (brs, 2H), 7.14 (s, 1H), 2.95–2.91 (m, 2H), 2.63–2.60 (m, 2H); HRMS (ESI-TOF) calcd for C<sub>14</sub>H<sub>10</sub>BrN<sub>5</sub>OS [M + H<sup>+</sup>] 375.9862, found 375.9857.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 6-[(6-Amino-9<i>H</i>-purin-8-yl)thio]-1,3-benzodioxole-5-carbonitrile (<b>26g</b>)</h3><div class="NLM_p last">The title compound was prepared in 15% yield from <b>21</b> and <b>24g</b> in a manner similar to that described for <b>26a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.08 (s, 1H), 7.59 (s, 1H), 7.29 (s, 1H), 7.26–7.16 (brs, 2H), 6.23 (s, 2H); HRMS (ESI-TOF) calcd for C<sub>13</sub>H<sub>8</sub>N<sub>6</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 313.0502, found 313.0509.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>tert</i>-Butyl 4-{2-[(Methylsulfonyl)oxy]ethyl}piperidine-1-carboxylate (<b>25a</b>)</h3><div class="NLM_p last">To a solution of <b>30a</b> (15.0 g, 65.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) were added MsCl (11.0 mL, 131 mmol) and NEt<sub>3</sub> (23 mL, 164.0 mmol) at ∼5 °C, and the mixture was stirred at room temperature for ∼16 h. Upon completion, the mixtue was diluted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and washed with water (100 mL × 2), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to provide <b>25a</b> (20.0 g) in quantitative yield. LC–MS [M + H<sup>+</sup>] 347.1.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-(1-Formyl-4-piperidyl)ethyl 4-Methylbenzenesulfonate (<b>25b</b>)</h3><div class="NLM_p last">To a solution of <b>30b</b> (3.00 g, 19.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) were added NEt<sub>3</sub> (8.00 mL, 57.3 mmol) and DMAP (23 mg, 0.19 mmol), followed by TsCl (3.64 g, 19.1 mmol). After being stirred for 10 h at room temperature, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. Purification of the residue by column chromatography (SiO<sub>2</sub>, EtOAc/hexane, 50–100%) provided <b>25b</b> (2.22 g, 37%). LC–MS [M + H<sup>+</sup>] 311.9.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-{1-(1-Methyl-1<i>H</i>-tetrazol-5-yl)piperidin-4-yl}ethyl 4-Methylbenzenesulfonate (<b>25h</b>)</h3><div class="NLM_p last">To a solution of <b>29</b> (864 mg, 6.70 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (22 mL) was added methyl isothiocyanate (490 μL, 6.70 mmol). After being stirred for 10 h at room temperature, the mixture was concentrated in vacuo and the residue was purified by SiO<sub>2</sub> column chromatography (EtOAc) to provide <b>31a</b> (1.04 g, 77%). To a mixture of <b>31a</b> (1.63 g, 8.07 mmol), HgCl<sub>2</sub> (2.41 g, 8.88 mmol), and NaN<sub>3</sub> (1.57 g, 24.2 mmol) in DMF (20 mL) was added NEt<sub>3</sub> (3.37 mL, 24.2 mmol). After being stirred for 10 h at room temperature, the reaction mixture was filtered and the filter cake was washed with CH<sub>2</sub>Cl<sub>2</sub>. The combined filtrates and washings were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated in vacuo, and the residue purified by SiO<sub>2</sub> chromatography (60% EtOAc in hexane) to afford 2-{1-(1-methyl-1<i>H</i>-tetrazol-5-yl)piperidin-4-yl}ethanol (0.720 g, 42%). LC–MS [M + Na<sup>+</sup>] 234.0. <b>25h</b> (0.417 g, 80%) was obtained from 2-{1-(1-methyl-1<i>H</i>-tetrazol-5-yl)piperidin-4-yl}ethanol (0.399 g, 1.42 mmol) in a manner similar to that described for <b>25a</b>. HRMS (ESI-TOF) calcd for C<sub>16</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 366.1594, found 366.1593.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>28a</b>)</h3><div class="NLM_p last">To a solution of <b>26a</b> (1.00 g, 2.73 mmol) and tosylate <b>25b</b> (1.02 g, 3.28 mmol) in DMF (6.8 mL) was added Barton’s base (677 μL, 3.28 mmol). After being stirred at 80 °C for 10 h, the mixture was cooled to room temperature and diluted with EtOAc and water. The precipitate was filtered, washed with water and EtOAc, and dried to yield <b>28a</b> (400 mg, 29%). The combined filtrates were concentrated in vacuo, and the residue was purified by preparative RP-HPLC to afford additional <b>28a</b> (151 mg) and N3 regisomer (281 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1H), 7.94 (s, 1H), 7.46–7.41 (brs, 2H), 7.39 (s, 1H), 6.81 (s, 1H), 6.09 (s, 2H), 4.18 (t, <i>J</i> = 7.2 Hz, 1H), 4.10 (brd, <i>J</i> = 13.2 Hz, 1H), 3.62 (brd, <i>J</i> = 12.8 Hz, 1H), 2.95 (td, <i>J</i> = 12.4, 2.8 Hz, 1H), 2.44 (m, 1H), 1.78–1.67 (m, 2H), 1.61 (q, <i>J</i> = 7.2 Hz, 2H), 1.44 (m, 1H), 1.01 (m, 1H), 0.91 (m, 1H); HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>21</sub>BrN<sub>6</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 505.0652, found 505.0662; HPLC purity, 96.7% (<i>t</i><sub>R</sub> = 7.32 min).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 8-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-(1-isopropyl-4-piperidyl)ethyl]purin-6-amine (<b>27c</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26a</b> and <b>25c</b> in a manner smilar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.23 (s, 1H), 7.27 (s,1H), 7.13 (s, 1H), 6.08 (s, 2H), 4.38–4.30 (m, 2H), 3.62–3.52 (m, 2H), 3.36–3.26 (m, 1H), 3.05–2.98 (m, 2H), 2.96–2.84 (m, 2H), 1.80–0.80 (m, 11H); LC–MS [M + H<sup>+</sup>] 519.1; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 6.10 min).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 8-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-(1-isobutyl-4-piperidyl)ethyl]purin-6-amine (<b>27d</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26a</b> and <b>25d</b> in a manner smilar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.22 (s, 1H), 7.30 (s, 1H), 7.10 (s, 1H), 6.10 (s, 2H), 4.40 (t, <i>J</i> = 7.2 Hz, 2H), 3.60–3.58 (m, 2H), 3.00–2.90 (m, 2H), 2.15–2.10 (m, 2H), 2.00–1.90 (m, 2H), 1.90–1.80 (m, 2H), 1.60–1.50 (m, 2H), 1.30–1.20 (m, 2H), 1.10–1.00 (m, 6H); LC–MS [M + H<sup>+</sup>] 533.1; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 6.31 min).</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 8-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-[1-(2,2,2-trifluoroethyl)-4-piperidyl]ethyl]purin-6-amine (<b>27e</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26a</b> and <b>25e</b> in a manner similar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.29 (s, 1H), 7.28 (s, 1H), 7.18 (s, 1H), 6.09 (s, 2H), 4.35 (t, <i>J</i> = 7.2 Hz, 2H), 3.56–3.50 (m, 2H), 3.35 (s, 2H), 3.30–3.25 (m, 2H), 2.69–2.59 (m, 3H), 2.00–1.40 (m, 4H); LC–MS [M + H<sup>+</sup>] 559.0; HPLC purity, 97.0% (<i>t</i><sub>R</sub> = 7.16 min).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 8-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-[1-(cyclohexylmethyl)-4-piperidyl]ethyl]purin-6-amine (<b>27f</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26a</b> and <b>25f</b> in a manner similar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.20 (s, 1H), 7.10 (s, 1H), 6.08 (s, 2H), 4.35–4.30 (m, 2H), 3.60–3.53 (m, 2H), 2.93–2.84 (m, 4H), 2.16–0.80 (m, 18H); HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 6.75 min).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 8-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-(1-prop-2-ynyl-4-piperidyl)ethyl]purin-6-amine (<b>27g</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26a</b> and <b>25g</b> in a manner similar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.26 (s, 1H), 7.28 (s, 1H), 7.16 (s, 1H), 6.09 (s, 2H), 4.36 (t, <i>J</i> = 7.6 Hz, 2H), 4.10–4.02 (m, 2H), 3.68 (brd, <i>J</i> = 14.0 Hz, 2H), 3.02 (brt, <i>J</i> = 12.4 Hz, 2H), 2.66 (s, 1H), 2.21 (brd, <i>J</i> = 14.8 Hz, 2H), 1.90–1.81 (m, 2H), 1.62–1.60 (m, 1H), 1.56–1.44 (m, 2H); LC–MS [M + H<sup>+</sup>] 515.1; HPLC purity, 97.9% (<i>t</i><sub>R</sub> = 6.15 min).</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 8-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-[1-(1-methyltetrazol-5-yl)-4-piperidyl]ethyl]purin-6-amine (<b>27h</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26a</b> and <b>25h</b> in a manner similar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (s, 1H), 7.65–7.50 (brs, 2H), 7.40 (s, 1H), 6.85 (s, 1H), 6.10 (s, 2H), 4.22 (t, <i>J</i> = 7.6 Hz, 2H), 3.85 (s, 3H), 3.55 (brd, <i>J</i> = 12.8 Hz, 2H), 2.85 (t, <i>J</i> = 12.8 Hz, 2H), 1.78 (brd, <i>J</i> = 12.8 Hz, 2H), 1.70–1.62 (m, 2H), 1.43 (m, 1H), 1.35–1.22 (m, 2H); HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>23</sub>BrN<sub>10</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 559.0982, found 559.0974; HPLC purity, 95.1% (<i>t</i><sub>R</sub> = 7.56 min).</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 8-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-[1-(1-<i>tert</i>-butyltetrazol-5-yl)-4-piperidyl]ethyl]purin-6-amine (<b>27i</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26a</b> and <b>25i</b> in a manner similar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.21 (s, 1H), 7.27 (s, 1H), 7.10 (s, 1H), 6.08 (s, 2H), 4.35 (t, <i>J</i> = 7.6 Hz, 2H), 3.14 (brd, <i>J</i> = 12.4 Hz, 2H), 2.92 (t, <i>J</i> = 12.0 Hz, 2H), 1.92 (brd, <i>J</i> = 10.0 Hz, 2H), 1.83 (brq, <i>J</i> = 8.0 Hz, 2H), 1.73 (s, 9H), 1.58–1.42 (m, 3H); HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>29</sub>BrN<sub>10</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 601.1452, found 601.1461; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 8.65 min).</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl 4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carboxylate (<b>27a</b>)</h3><div class="NLM_p"><i>Method A.</i> The title compound was prepared from <b>26a</b> and <b>25a</b> in a manner similar to that described for <b>28a</b>. HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>29</sub>BrN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 577.1227, found 577.1279; HPLC purity, 97.3% (<i>t</i><sub>R</sub> = 7.02 min).</div><div class="NLM_p"><i>Method B.</i> The title compound was prepared from <b>33a</b> and aryl sulfide <b>43a</b> in a manner similar to that described for <b>34a</b>.</div><div class="NLM_p last"><i>Method C.</i> To a solution of <b>33a</b> (13.2 g, 31.1 mmol) and 1,3-benzodioxol-5-thiol (<b>58</b>) (7.17 g, 46.6 mmol) in DMF (60 mL) was added K<sub>2</sub>CO<sub>3</sub> (93.17 mmol, 12.87 g). After being stirred at 100 °C for 3–6 h, the mixture was cooled to room temperature, filtered, and washed with EtOAc. The combined filtrates were diluted with EtOAc (120 mL), washed with water (100 mL × 2), brine (100 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to 30 mL. The solid was precipitated by adding hexane (50 mL), filtered, and washed with a 1:2 (v/v) mixture of EtOAc/hexanes to afford the product (14.5 g, 94%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.30 (s, 1H), 7.02 (dd, <i>J</i> = 7.8, 1.9 Hz, 1H), 6.96 (d, <i>J</i> = 1.9 Hz, 1H), 6.80 (d, <i>J</i> = 7.8 Hz, 1H), 5.99 (s, 2H), 4.23 (t, <i>J</i> = 7.4 Hz, 2H), 4.38–3.98 (m, 2H), 2.3–2.15 (m, 2H), 1.82–1.66 (m, 4H), 1.49–1.35 (m, 10H), 1.22–1.1 (m, 2H); LC–MS [M + H<sup>+</sup>] 499.1. A mixture of the above product (10.0 g, 20.0 mmol) in acetic acid (37 mL) was cooled to 10 °C and treated with NBS (4.28 g, 24.1 mmol) in portions. After the mixture was stirred for 1 h at room temperature, additional NBS (∼2 g) was added. The mixture was stirred for 4 h. Upon completion, the mixture was cooled to 15 °C, quenched with aqueous sodium bisulfate (prepared from 11 g of sodium metasulfite and 100 mL of water), stirred at room temperature overnight, filtered, washed with water, and air-dried to give the crude product. The crude was crystallized from methanol to afford <b>27a</b> (8.5 g, 73% yield).</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 8-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-(4-piperidyl)ethyl]purin-6-amine (<b>27b</b>)</h3><div class="NLM_p last">To a suspension of <b>27a</b> (14.0 g, 0.025 mol) in CH<sub>2</sub>Cl<sub>2</sub> (82 mL) was added TFA (27 mL, 0.37 mol) at 10 °C. After being stirred for 2 h at room temperature, the mixture was concentrated in vacuo and the residual TFA was removed by azeotropic distillation with AcCN. The remaining oil was dissolved in AcCN (11 mL), and the solution was added to a NH<sub>4</sub>OH solution (29%, w/w, 71 mL) at 10 °C. The solid was filtered, washed with water, and air-dried (11.8 g, 99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1H), 7.52–7.43 (brs, 2H), 7.39 (s, 1H), 6.81 (s, 1H), 6.09 (s, 2H), 4.18 (t, <i>J</i> = 7.0 Hz, 2H), 3.23 (d, <i>J</i> = 11.2 Hz, 2H), 3.16 (m, 1H), 2.83–2.70 (m, 1H), 1.86 (d, <i>J</i> = 12.5 Hz, 2H), 1.64 (q, <i>J</i> = 7.0 Hz, 2H), 1.50–1.39 (m, 1H), 1.32–1.20 (m, 2H); HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>21</sub>BrN<sub>6</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 477.0703, found 477.0789; HPLC purity, 99.2% (<i>t</i><sub>R</sub> = 3.95 min).</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]ethanone (<b>28b</b>)</h3><div class="NLM_p last">The title compound was prepared by the EDCI coupling method described for the preparation of <b>28g</b> using <b>27b</b> and AcOH. HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>23</sub>BrN<sub>6</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 519.0809, found 519.0555; HPLC purity, 95.9% (<i>t</i><sub>R</sub> = 7.56 min).</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]butan-1-one (<b>28c</b>)</h3><div class="NLM_p last">The title compound was prepared according to the EDCI coupling method described for the preparation of <b>28g</b> using <b>27b</b> and butyric acid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.16 (s, 1H), 7.44 (brs, 2H), 7.39 (s, 1H), 6.81 (s, 1H), 6.01 (s, 2H), 4.32 (brd, <i>J</i> = 12.4 Hz, 1H), 4.18 (t, <i>J</i> = 6.8 Hz, 2H), 3.81 (brd, <i>J</i> = 12.4 Hz, 1H), 2.86 (brt, <i>J</i> = 10.8 Hz, 1H), 2.39 (brt, <i>J</i> = 10.8 Hz, 1H), 2.24 (t, <i>J</i> = 6.8 Hz, 2H), 1.76–1.65 (m, 2H), 1.69 (q, <i>J</i> = 7.2 Hz, 2H), 1.48 (m, 2H), 1.40 (m, 1H), 1.01 (m, 1H), 0.92 (m, 1H), 0.87 (t, <i>J</i> = 7.6 Hz, 3H); HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>27</sub>BrN<sub>6</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 547.1122, found 547.1109; HPLC purity, 97.0% (<i>t</i><sub>R</sub> = 7.86 min).</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> [4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]cyclopropylmethanone (<b>28d</b>)</h3><div class="NLM_p last">The title compound was prepared according to the general EDCI coupling method using cyclopropanecarboxylic acid. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>25</sub>BrN<sub>6</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 545.0965, found 545.0956; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 5.10 min).</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> [4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]cyclopentylmethanone (<b>28e</b>)</h3><div class="NLM_p last">The title compound was prepared according to the general EDCI coupling method using cyclopentanecarboxylic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1H), 7.49 (s, 1H), 7.05 (s, 1H), 6.06 (s, 2H), 4.50 (d, <i>J</i> = 13.2 Hz, 1H), 4.29 (t, <i>J</i> = 7.2 Hz, 2H), 4.07 (d, <i>J</i> = 14.0 Hz, 1H), 3.07–2.98 (m, 2H), 2.57 (dd, <i>J</i> = 12.9 Hz, 3.1 Hz, 1H), 1.92–1.50 (m, 9H), 1.38–1.25 (m, 4H), 1.22–1.00 (m, 2H); LC–MS [M + H<sup>+</sup>] 573.2; HPLC purity, 96.6% (<i>t</i><sub>R</sub> = 5.68 min).</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-hydroxyethanone (<b>28f</b>)</h3><div class="NLM_p last">The title compound was prepared in 59% yield according to the general EDCI coupling method using glycolic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.20 (s, 1H), 7.74–7.58 (brs, 2H), 7.39 (s, 1H), 6.84 (s, 1H), 6.09 (s, 2H), 4.29 (d, <i>J</i> = 12.5 Hz, 1H), 4.19 (t, <i>J</i> = 7.4 Hz, 2H), 4.07 (d, <i>J</i> = 14.4 Hz, 1H), 4.02 (d, <i>J</i> = 14.4 Hz, 1H), 3.60 (d, <i>J</i> = 13.6 Hz, 1H), 2.82 (t, <i>J</i> = 11.7 Hz, 1H), 2.56–2.44 (m, 1H), 1.74–1.67 (m, 2H), 1.61 (q, <i>J</i> = 7.0 Hz, 2H), 1.42 (m, 1H), 1.06 (m, 1H), 0.96 (m, 1H); HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>23</sub>BrN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 535.0758, found 535.0754; HPLC purity, 98.4% (<i>t</i><sub>R</sub> = 7.26 min).</div></div><div id="sec5_2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (2<i>S</i>)-1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-hydroxypropan-1-one (<b>28g</b>)</h3><div class="NLM_p last"><i>General Procedure for EDCI Coupling Method.</i> To a mixture of <b>27b</b> (10.0 g, 21.0 mmol), HOBt (3.54 g, 23.1 mmol), <span class="smallcaps smallerCapital">l</span>-lactic acid (2.26 g, 23.1 mmol), and NEt<sub>3</sub> (11.7 mL, 83.9 mmol) was added a mixture of DMF (50 mL) and THF (50 mL) at room temperature, followed by EDCI (6.02 g, 31.4 mmol). The mixture was stirred for 10 h at room temperature. Upon compeletion of reaction as judged by HPLC, water (350 mL) was added to the mixture. After being stirred for 1 h, the mixture was filtered, washed with a mixture of water and THF (50 mL, 4/1, v/v), and air-dried to afford a crude product. The crude was purified by repetitive trituration with MeOH (or hot EtOH) to <b>28g</b> (7.5 g, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1H), 7.44 (brs, 2H), 7.39 (s, 1H), 6.81 (s, 1H), 6.09 (s, 2H), 4.76 (d, <i>J</i> = 7.2 Hz, 1H), 4.39 (m, 1H), 4.30 (m, 1H), 4.18 (t, <i>J</i> = 7.2 Hz, 2H), 3.91 (m, 1H), 2.86 (m, 1H), 1.78–1.66 (m, 2H), 1.64–1.56 (m, 2H), 1.43 (m, 1H), 1.18–1.12 (m, 3H), 1.08 (m, 1H), 0.95 (m, 1H); HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>25</sub>BrN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 549.0914, found 549.0913; HPLC purity, 99.0% (<i>t</i><sub>R</sub> = 7.14 min); HPLC (Chiralcel OJ-RH column, 100% MeOH with 0.01% TEA, isocratic, 0.5 mL/min) single peak observed at 11.7 min; no peak at 7.6 min (<b>28h</b>).</div></div><div id="sec5_2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (2<i>R</i>)-1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-hydroxypropan-1-one (<b>28h</b>)</h3><div class="NLM_p last">The title compound was prepared in 62% yield according to the general EDCI coupling method using <i>R</i>-sodium lactate. HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>25</sub>BrN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 549.0914, found 549.0899; HPLC purity, 99.0%; HPLC (Chiralcel OJ-RH column, 100% MeOH with 0.01% TEA, isocratic, 0.5 mL/min) single peak observed at 7.6 min; no peak at 11.7 min (<b>28f</b>).</div></div><div id="sec5_2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-[4-[2-[6-Amino-8-(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-hydroxy-2-methylpropan-1-one (<b>28i</b>)</h3><div class="NLM_p last">The title compound was prepared according to the general EDCI coupling method using 2-hydroxy-2-methylproanoic acid. LC–MS [M + H<sup>+</sup>] 563.1.</div></div><div id="sec5_2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-[4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]propane-1,2-dione (<b>28j</b>)</h3><div class="NLM_p last">The title compound was prepared according to the general EDCI coupling method using pyruvic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (s, 1H), 7.27 (s, 1H), 7.09 (s, 1H), 6.82 (s, 1H), 6.00 (s, 2H), 4.69 (bs, 2H), 4.56 (m, 1H), 4.48 (bd, <i>J</i> = 13.2 Hz, 1H), 4.26 (t, <i>J</i> = 7.6 Hz, 2H), 3.75 (bd, <i>J</i> = 13.6 Hz, 1H), 2.98 (td, <i>J</i> = 10.4, 2.8 Hz, 1H), 2.63 (bd, <i>J</i> = 12.8, 2.8 Hz, 1H), 1.87 (brt, <i>J</i> = 14.0 Hz, 2H), 1.78–1.71 (m, 2H), 1.55 (m, 1H), 1.31–1.20 (m, 2H); HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>23</sub>BrN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 547.0758, found 547.0756; HPLC purity, 97.3% (<i>t</i><sub>R</sub> = 8.09 min).</div></div><div id="sec5_2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (2<i>S</i>)-2-Amino-1-[4-[2-[6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]propan-1-one (<b>28k</b>)</h3><div class="NLM_p last">The title compound was prepared in 42% yield according to the general EDCI coupling method using Boc-<span class="smallcaps smallerCapital">l</span>-alanine and subsequent deprotection of the Boc group with 4 M HCl in dioxane. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.34 (s, 1H), 7.28 (s, 1H), 7.23 (s, 1H), 6.09 (s, 2H), 4.54–4.44 (m, 2H), 4.39 (t, <i>J</i> = 7.4 Hz, 2H), 3.85 (brd, <i>J</i> = 13.2 Hz, 1H), 3.19–3.08 (m, 1H), 2.75–2.63 (m, 1H), 2.00–1.80 (m, 4H), 1.70–1.58 (m, 1H), 1.44 (dd, <i>J</i> = 14.8, 7.0 Hz, 3H), 1.35–1.13 (m, 2H); LC–MS [M + H<sup>+</sup>] 548.2; HPLC purity, 95.1% (<i>t</i><sub>R</sub> = 6.32 min).</div></div><div id="sec5_2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (2<i>S</i>)-2-Amino-1-[4-[2-[6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-4-methylpentan-1-one (<b>28l</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>27b</b> with Boc-<span class="smallcaps smallerCapital">l</span>-leucine in a manner similar to that described for <b>28k</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.34 (s, 1H), 7.28 (s, 1H), 7.22 (s, 1H), 6.09 (s, 2H), 4.58–4.28 (m, 4H), 3.79 (brd, <i>J</i> = 13.2 Hz, 1H), 3.13 (t, <i>J</i> = 12.8 Hz, 1H), 2.76–2.62 (m, 1H), 2.00–1.50 (m, 7H), 1.35–1.10 (m, 3H), 1.08–0.95 (m, 6H); LC–MS [M + H<sup>+</sup>] = 590.1.</div></div><div id="sec5_2_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-Amino-1-[4-[2-[6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-methylpropan-1-one (<b>28m</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner similar to that described for <b>28k</b> using <b>27b</b> and <i>N</i>-Boc-2-amino-2-methylpropanoic acid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.34 (s, 1H), 7.28 (s, 1H), 7.22 (s, 1H), 6.09 (s, 2H), 4.45–4.16 (m, 4H), 3.10–2.80 (m, 2H), 1.94 (d, <i>J</i> = 12.8 Hz, 2H), 1.84 (q, <i>J</i> = 7.0 Hz, 2H), 1.67–1.65 (m, 7H), 1.32–1.15 (m, 2H); LC–MS [M + H]<sup>+</sup> = 562.0.</div></div><div id="sec5_2_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> [4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-(dimethylamino)ethanone (<b>28n</b>)</h3><div class="NLM_p last">The title compound was prepared according to the general EDCI coupling method using 2-(dimethylamino)acetic acid. HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>28</sub>BrN<sub>7</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 562.4980, found 562.1173; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 6.28 min).</div></div><div id="sec5_2_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> [4-[2-[6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-[(2<i>S</i>)-pyrrolidin-2-yl]methanone (<b>28o</b>)</h3><div class="NLM_p last">The title compound was prepared in 35% yield in a manner similar to that described for <b>28k</b> using <b>27b</b> and <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.31 (s, 1H), 7.29 (s, 1H), 7.20 (s, 1H), 6.09 (s, 2H), 4.63 (m, 1H), 4.59 (m, 1H), 4.38 (t, <i>J</i> = 8.0 Hz, 2H), 3.87 (m, 1H), 3.40 (m, 1H), 3.13 (m, 1H), 2.73 (m, 1H), 2.49 (m, 1H), 2.10–1.82 (m, 6H), 1.65 (m, 1H), 1.30–1.16 (m, 3H), 0.88 (m, 1H); HRMS (ESI-TOF) calcd for C<sub>24</sub>H<sub>28</sub>BrN<sub>7</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 574.1231, found 574.1234; HPLC purity, 95.4% (<i>t</i><sub>R</sub> = 6.69 min).</div></div><div id="sec5_2_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl 4-[2-(6-Amino-9<i>H</i>-purin-9-yl)ethyl]piperidine-1-carboxylate (<b>33a</b>)</h3><div class="NLM_p last">To a mixture of adenine (<b>32</b>) (11.1 g, 82.1 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (44.60 g, 136.9 mmol) in DMF (100 mL) was added mesylate <b>25a</b> (25.2 g, 82.1 mmol). After being stirred for 12 h at room temperature, the mixture was filtered and washed with CHCl<sub>3</sub>. The combined filtrates were diluted with CHCl<sub>3</sub>, washed with water and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to afford a 9:1 mixture of N9 and N3 isomers (19.2 g, 82%) (LC/MS [M + H<sup>+</sup>] 347.1), which was used for the next step without further purification. To a clear solution of the product in NaOAc–AcOH buffer (pH 4.6) and MeOH/THF (60 mL, 1:1 v/v) was added bromine (5.13 mL, 99.8 mmol) dropwise while maintaining the temperature at ∼20 °C. After being stirred for 2 h at room temperature, the mixture was quenched with sodium metabisulfite and the pH of the reaction mixture was adjusted to ∼8 by addition of saturated Na<sub>2</sub>CO<sub>3</sub> solution. The product portion was extracted with CH<sub>2</sub>Cl<sub>2</sub>, washed with H<sub>2</sub>O/brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The crude was purified by crystallization from CH<sub>2</sub>Cl<sub>2</sub>/hexane to give <b>33a</b> (16 g, 67%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.13 (s, 1H), 7.5–7.38 (brs, 2H), 4.15 (t, <i>J</i> = 7.4 Hz, 2H), 3.95–3.84 (m, 2H), 2.74–2.33 (m, 2H), 1.73 (d, <i>J</i> = 12.8 Hz, 2H), 1.67 (q, <i>J</i> = 6.6 Hz, 2H), 1.44–1.34 (m, 10 H), 1.02 (dq, <i>J</i> = 8.2, 3.5 Hz, 2H); HRMS (ESI-TOF) calcd for C<sub>17</sub>H<sub>25</sub>BrN<sub>6</sub>O<sub>2</sub> [M + H<sup>+</sup>] 425.1295, found 425.1352; HPLC purity, 98.0% (<i>t</i><sub>R</sub> = 5.91 min).</div></div><div id="sec5_2_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>tert</i>-Butyl 4-[2-[6-Amino-8-[(5-bromo-2,3-dihydrobenzofuran-6-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carboxylate (<b>39a</b>)</h3><div class="NLM_p last">To a solution of aryl sulfide <b>45</b> (195 mg, 0.470 mmol) in THF (2.4 mL) and EtOH (0.2 mL) was added NaOEt (34 mg). The mixture was stirred for 2 h at room temperature and concentrated in vacuo. The crude sodium thiolate was dissolved in THF (2.4 mL)–EtOH (0.2 mL), and 8-bromopurine <b>33a</b> was added. After heating at 70 °C for 10 h, the mixture was cooled to room temperature, diluted with EtOAc, washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. Purification of the residue by column chromatography (SiO<sub>2</sub>, EtOAc/hexane, 50–100%) provided <b>39a</b> (83 mg, 62%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.36 (s, 1H) 7.40 (t, <i>J</i> = 0.8 Hz, 1H), 6.49 (s, 1H), 5.64–5.57 (brs, 2H), 4.56 (t, <i>J</i> = 8.8 Hz, 2H), 4.24 (t, <i>J</i> = 7.2 Hz, 2H), 4.11–3.96 (m, 2H), 3.19 (td, <i>J</i> = 8.8, 0.8 Hz, 2H), 2.68–2.54 (m, 2H), 1.74–1.66 (m, 5H), 1.45 (s, 9H), 1.17–1.04 (m, 2H); HRMS (ESI-TOF) calcd for C<sub>25</sub>H<sub>31</sub>BrN<sub>6</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 575.1435, found 575.1439; HPLC purity, 96.6% (<i>t</i><sub>R</sub> = 9.15 min).</div></div><div id="sec5_2_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>tert</i>-Butyl 4-[2-[6-Amino-8-[(6-bromo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carboxylate (<b>39b</b>)</h3><div class="NLM_p last">The title compound was prepared in 59% yield in a manner similar to that described for <b>39a</b>. HRMS (ESI-TOF) calcd for C<sub>25</sub>H<sub>31</sub>BrN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 591.1384, found 591.1390; HPLC purity, 93.0% (<i>t</i><sub>R</sub> = 8.52 min).</div></div><div id="sec5_2_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 8-[(5-Bromo-2,3-dihydrobenzofuran-6-yl)sulfanyl]-9-[2-(4-piperidyl)ethyl]purin-6-amine (<b>40a</b>)</h3><div class="NLM_p last">To a solution of of <b>39a</b> (77 mg, 0.14 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added TFA (200 μL) at 0 °C, and the mixture was stirred at room temperature for 2 h. Removal of solvent in vacuo and azeotropic removal of residual TFA with toluene gave the title compound (∼100 mg) that was used for the next step without further purificaiton. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>23</sub>BrN<sub>6</sub>OS [M + H<sup>+</sup>] 475.0910, found 475.0905.</div></div><div id="sec5_2_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 8-[(6-Bromo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]-9-[2-(4-piperidyl)ethyl]purin-6-amine (<b>40b</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner similar to that described for <b>40a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1H), 7.52–7.40 (broad s, 2H), 7.28 (s, 1H), 6.69 (s, 1H), 4.28–4.15 (m, 6H), 3.23 (d, <i>J</i> = 12.5 Hz, 2H), 2.82–2.70 (m, 2H), 1.85 (d, <i>J</i> = 12.5 Hz, 2H), 1.62 (q, <i>J</i> = 6.6 Hz, 2H), 1.48–1.36 (m, 1H), 1.33–1.20 (m, 2H); LC–MS [M + H<sup>+</sup>] 491.2.</div></div><div id="sec5_2_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 4-[2-[6-Amino-8-[(5-bromo-2,3-dihydrobenzofuran-6-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34a</b>)</h3><div class="NLM_p last">To solution of aryl sulfide <b>45</b> (235 mg, 0.566 mmol) in THF (2.8 mL) and EtOH (0.28 mL) was added NaOEt (41 mg, 0.57 mmol). The mixture was stirred for ∼2 h at room temperature and concentrated in vacuo. The crude sodium thiolate was dissolved in THF (2.8 mL)–EtOH (0.28 mL), and 8-bromopurine <b>33b</b> (100 mg, 0.283 mmol) was added. After being stirred for 10 h at 70 °C, the mixtue was quenched with water and the product portion was extracted with EtOAc. The combined organic layers were washed with water, brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was triturated with EtOAc to provide <b>34a</b> (87 mg, 61%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.19 (s, 1H), 7.93 (s, 1H), 7.57 (s, 1H), 7.56–7.46 (brs, 2H), 6.33 (s, 1H), 4.52 (t, <i>J</i> = 8.0 Hz, 2H), 4.17 (t, <i>J</i> = 7.2 Hz, 2H), 4.07 (brd, <i>J</i> = 13.2 Hz, 1H), 3.60 (brd, <i>J</i> = 12.8 Hz, 1H), 3.17 (t, <i>J</i> = 8.0 Hz, 2H), 2.86 (td, <i>J</i> = 12.8, 2.8 Hz, 1H), 2.44 (td, <i>J</i> = 12.4, 3.2 Hz, 1H), 1.76–1.64 (m, 2H), 1.59 (q, <i>J</i> = 6.8 Hz, 2H), 1.39 (m, 1H), 0.97 (qd, <i>J</i> = 12.8, 4.4 Hz, 1H), 0.87 (qd, <i>J</i> = 12.4, 4.4 Hz, 1H); HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>23</sub>BrN<sub>6</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 503.0859, found 503.0857; HPLC purity, 95.4% (<i>t</i><sub>R</sub> = 7.28 min).</div></div><div id="sec5_2_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (2<i>S</i>)-1-[4-[2-[6-Amino-8-[(5-bromo-2,3-dihydrobenzofuran-6-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-hydroxypropan-1-one (<b>34b</b>)</h3><div class="NLM_p last">The title compound was prepared in 55% yield by the EDCI coupling method described for the preparation of <b>34j</b> using <b>40a</b> and <span class="smallcaps smallerCapital">l</span>-lactic acid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.18 (s, 1H), 7.54 (s, 1H), 6.68 (s, 1H), 4.57 (t, <i>J</i> = 8.0 Hz, 2H), 4.53 (m, 1H), 4.44 (br d, <i>J</i> = 11.6 Hz, 1H), 4.29 (t, <i>J</i> = 7.6 Hz, 2H), 3.97 (br t, <i>J</i> = 14.0 Hz, 1H), 3.23 (t, <i>J</i> = 8.0 Hz, 2H), 2.97 (m, 1H), 2.58 (m, 1H), 1.88–1.76 (m, 2H), 1.75–1.67 (m, 2H), 1.55 (m, 1H), 1.31–1.25 (m, 3H), 1.24–1.04 (m, 2H); HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>27</sub>BrN<sub>6</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 547.1122, found 547.1126; HPLC purity, 93.3% (<i>t</i><sub>R</sub> = 7.25 min).</div></div><div id="sec5_2_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 4-[2-[6-Amino-8-[(6-bromo-2,3-dihydrobenzofuran-5-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34c</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>33b</b> and <b>48</b> in a manner similar to that described for <b>34a</b> except that the purification was performed by preperative RP-HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.28 (s, 1H), 7.99 (s, 1H), 7.60 (s, 1H), 7.19 (s, 1H), 4.67 (t, <i>J</i> = 9.7 Hz, 2H), 4.37 (t, <i>J</i> = 7.2 Hz, 2H), 4.31 (brd, <i>J</i> = 13.2 Hz, 1H), 3.72 (brd, <i>J</i> = 13.6 Hz, 1H), 3.22 (t, <i>J</i> = 9.7 Hz, 2H), 3.10 (td, <i>J</i> = 12.8, 2.8 Hz, 1H), 2.66 (td, <i>J</i> = 12.8, 3.2 Hz, 1H), 1.98–1.85 (m, 2H), 1.79 (q, <i>J</i> = 7.2, Hz, 2H), 1.64 (m, 1H), 1.22 (qd, <i>J</i> = 11.6, 4.8 Hz, 1H), 1.13 (qd, <i>J</i> = 12.0, 4.4 Hz, 1H); HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>23</sub>BrN<sub>6</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 503.0859, found 503.0860; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 7.29 min).</div></div><div id="sec5_2_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 4-[2-[6-Amino-8-(5-bromobenzofuran-6-yl)sulfanyl-purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34d</b>)</h3><div class="NLM_p last">The title compound was prepared in 65% yield from <b>33b</b> and <b>46</b> in a manner similar to that described for <b>34a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (s, 1H), 8.07 (s, 1H), 8.05 (d, <i>J</i> = 2.0 Hz, 1H), 7.89 (s, 1H), 7.48–7.43 (brs, 2H), 7.42 (d, <i>J</i> = 0.8 Hz, 1H), 6.95 (dd, <i>J</i> = 2.0, 0.8 Hz, 1H), 4.19 (t, <i>J</i> = 6.8 Hz, 2H), 4.03 (brd, <i>J</i> = 12.4, 1H), 3.55 (br d, <i>J</i> = 13.5 1H), 2.81 (td, <i>J</i> = 12.4, 2.8 Hz, 1H), 2.39 (td, <i>J</i> = 12.4, 2.8 Hz, 1H), 1.67–1.55 (m, 4H), 1.37 (m, 1H), 0.92 (qd, <i>J</i> = 12.4, 4.0 Hz, 1H), 0.83 (qd, <i>J</i> = 12.4, 3.6 Hz, 1H); HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>21</sub>BrN<sub>6</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 501.0728, found 501.0698; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 7.42 min).</div></div><div id="sec5_2_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 4-[2-[6-Amino-8-(6-bromobenzofuran-5-yl)sulfanyl-purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34e</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>33b</b> and <b>49</b> in a manner similar to that described for <b>34a</b> except that the purification was performed by preperative RP-HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.31 (s, 1H), 8.09 (s, 1H), 8.05 (d, <i>J</i> = 1.2 Hz, 1H), 7.98 (s, 1H), 7.90 (d, <i>J</i> = 2.4 Hz, 1H), 6.94 (dd, <i>J</i> = 2.4, 1.2 Hz, 1H), 4.41 (t, <i>J</i> = 7.6 Hz, 2H), 4.30 (brd, <i>J</i> = 13.6, 1H), 3.71 (brd, <i>J</i> = 13.6 1H), 3.09 (td, <i>J</i> = 12.8, 2.8 Hz, 1H), 2.64 (td, <i>J</i> = 12.4, 2.8 Hz, 1H), 1.95–1.84 (m, 4H), 1.63 (m, 1H), 1.21 (qd, <i>J</i> = 12.0, 4.0 Hz, 1H), 1.13 (qd, <i>J</i> = 12.4, 4.4 Hz, 1H); HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>21</sub>BrN<sub>6</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 501.0728, found 501.0705; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 7.45 min).</div></div><div id="sec5_2_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 4-[2-[6-Amino-8-(6-bromoindan-5-yl)sulfanylpurin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34f</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26d</b> and <b>25b</b> in a manner similar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (s, 1H), 7.92 (s, 1H), 7.59 (s, 1H), 7.56–7.45 (brs, 2H), 6.91 (s, 1H), 4.16 (t, <i>J</i> = 6.8 Hz, 2H), 4.05 (m, 1H), 3.60 (m, 1H), 2.88–2.81 (m, 3H), 2.69 (t, <i>J</i> = 7.2 Hz, 2H), 2.44 (m, 1H), 1.96 (qn, <i>J</i> = 7.2 Hz, 2H), 1.72–1.61 (m, 2H), 1.61–1.55 (m, 2H), 0.98 (m, 1H), 0.96 (qd, <i>J</i> = 12.4, 4.4 Hz, 1H), 0.85 (qd, <i>J</i> = 11.6, 2.8 Hz, 1H); HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>25</sub>BrN<sub>6</sub>OS [M + H<sup>+</sup>] 501.10667, found 501.1067; HPLC purity, 99.0% (<i>t</i><sub>R</sub> = 7.7 min).</div></div><div id="sec5_2_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-[2-[6-Amino-8-[(6-bromo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34g</b>)</h3><div class="NLM_p last">The title compound was prepared in 75% yield from <b>26b</b> and <b>25b</b> in a manner similar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (s, 1H), 7.93 (s, 1H), 7.62–7.44 (brs, 2H), 7.28 (s, 1H), 6.68 (s, 1H), 4.25–4.15 (m, 6H), 4.09 (d, <i>J</i> = 13.6 Hz, 1H), 3.62 (d, <i>J</i> = 13.2 Hz, 1H), 2.88 (td, <i>J</i> = 12.4, 2.4 Hz, 1H), 2.47 (td, <i>J</i> = 12.4, 2.8 Hz, 1H), 1.76–1.65 (m, 2H), 1.58 (q, <i>J</i> = 7.2 Hz, 2H), 1.39 (m, 1H), 0.99 (qd, <i>J</i> = 12.0, 4.4 Hz, 1H), 0.89 (qd, <i>J</i> = 11.2, 4.0 Hz, 1H); HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>23</sub>BrN<sub>6</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 519.0809, found 519.0797, HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 7.19 min).</div></div><div id="sec5_2_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-[4-[2-[6-Amino-8-[(6-bromo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-hydroxyethanone (<b>34h</b>)</h3><div class="NLM_p last">The title compound was prepared in 64% yield by the EDCI coupling method described for the preparation of <b>34j</b> using <b>40b</b> with 2-hydroxyacetic acid. <sup>1</sup>H NMR (400 MHz, DMOS-<i>d</i><sub>6</sub>) δ 8.16 (s, 1H), 7.52–7.42 (brs, 2H), 7.29 (s, 1H), 6.68 (s, 1H), 4.44 (brs, 1H), 4.29 (m, 1H), 4.27–4.15 (m, 6H), 4.07 (d, <i>J</i> = 14.4 Hz, 1H), 4.02 (d, <i>J</i> = 14.4 Hz, 1H), 3.59 (brd, <i>J</i> = 13.2 Hz, 1H), 2.80 (brt, <i>J</i> = 12.0, 1H), 2.50 (m, 1H), 1.72–1.65 (m, 2H), 1.58 (q, <i>J</i> = 6.8 Hz, 2H), 1.38 (m, 1H), 1.04 (m, 1H), 0.94 (m, 1H); HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>25</sub>BrN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 549.0914, found 549.0913; HPLC purity, 95.0% (<i>t</i><sub>R</sub> = 7.03 min).</div></div><div id="sec5_2_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (2<i>S</i>)-1-[4-[2-[6-Amino-8-[(6-bromo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-hydroxypropan-1-one (<b>34i</b>)</h3><div class="NLM_p last">The title compound was prepared in 77% yield by the EDCI coupling method described for the preparation of <b>34j</b> using <b>40b</b> and <span class="smallcaps smallerCapital">l</span>-lactic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (s, 1H), 8.14–7.90 (brs, 2H), 7.30 (s, 1H), 6.79 (s, 1H), 4.39 (m, 1H), 4.30 (m, 1H), 4.26–4.17 (m, 6H), 3.91 (m, 1H), 2.85 (m, 1H), 2.45 (m, 1H), 1.77–1.65 (m, 2H), 1.63–1.56 (m, 2H), 1.41 (m, 1H), 1.17–1.15 (m, 3H), 1.09–0.88 (m, 2H); HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>27</sub>BrN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 563.1071, found 563.1071; HPLC purity, 98.3% (<i>t</i><sub>R</sub> = 8.21 min).</div></div><div id="sec5_2_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (2<i>R</i>)-1-[4-[2-[6-Amino-8-[(6-bromo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-hydroxypropan-1-one (<b>34j</b>)</h3><div class="NLM_p last">To a mixture of <b>40b</b> (5.0 g, 10.18 mmol) in a 1:1 (v/v) mixture of DMF/THF (45 mL) were added (<i>R</i>)-sodium lactate (1.36 g, 12.21 mmol), HOBt (1.60 g, 12.2 mmol), and EDCI (2.90 g, 15.3 mmol) at room temperature, and the mixture was stirred overnight. Upon completion, the mixture was diluted with water (200 mL) and stirred for 15 min at room temperature. The solid was collected by filtration, washed with water, and air-dried to give the crude product that was purified by trituration with MeOH to provide <b>34j</b> (89%, 5.15 g). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.28 (s, 1H), 7.27 (s, 1H), 7.23 (s, 1H), 4.55 (m, 1H), 4.48 (m, 1H), 4.36 (t, <i>J</i> = 7.4 Hz, 2H), 4.32–4.26 (m, 4H), 4.00 (brd, <i>J</i> = 14.4 Hz, 1H), 3.03 (m, 1H), 2.63 (m, 1H), 1.94–1.85 (m, 2H), 1.85–1.78 (m, 2H), 1.67–1.54 (m, 1H), 1.32 (m, 3H), 1.28–1.1 (m, 2H); HRMS (ESI-TOF) calcd for C<sub>23</sub>H<sub>27</sub>BrN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 563.1071, found 563.1055; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 7.21 min).</div></div><div id="sec5_2_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 4-[2-[6-Amino-8-[(6-bromo-4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34k</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>33b</b> and <b>51</b> in a manner similar to that described for <b>34a</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.24 (s, 1H), 7.94 (s, 1H), 6.95 (s, 1H), 6.68 (s, 1H), 4.22–4.15 (m, 4H), 4.12–4.08 (m, 2H), 3.64–3.57 (m, 1H), 3.29–3.26 (m, 2H), 2.95–2.87 (m, 1H), 2.86 (s, 3H), 1.86–1.40 (m, 5H), 1.34–0.80 (m, 2H); LC–MS [M + H<sup>+</sup>] 532.1.</div></div><div id="sec5_2_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 4-[2-[6-Amino-8-[(7-bromo-4-methyl-2,3-dihydro-1,4-benzoxazin-6-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34l</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26e</b> and <b>25b</b> in a manner similar to that described for <b>28a</b>. HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>26</sub>BrN<sub>7</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 532.1125, found 532.1119; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 7.30 min).</div></div><div id="sec5_2_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 4-[2-[6-Amino-8-(6-bromo-1-oxoindan-5-yl)sulfanylpurin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34m</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26f</b> and <b>25b</b> in a manner similar to that described for <b>28a</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.32 (s, 1H), 7.97 (s, 1H), 7.95 (s, 1H), 7.34 (s, 1H), 4.36 (t, <i>J</i> = 6.8 Hz, 2H), 4.26 (brd, <i>J</i> = 12.8 Hz, 1H), 3.68 (brd, <i>J</i> = 13.2 Hz, 1H), 3.07–2.99 (m, 3H), 2.70–2.67 (m, 2H), 2.59 (td, <i>J</i> = 12.8, 2.4 Hz, 1H), 1.88–1.74 (m, 4H), 1.57 (m, 1H), 1.15 (m, 1H), 1.06 (m, 1H); HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>23</sub>BrN<sub>6</sub>O<sub>2</sub>S [M + H<sup>+</sup>] 515.0859, found 515.0850; HPLC purity, 98.1% (<i>t</i><sub>R</sub> = 7.03 min).</div></div><div id="sec5_2_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 4-[2-[6-Amino-8-[(6-bromo-2,2-difluoro-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34n</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>26c</b> and <b>25b</b> in a manner similar to that described for <b>28a</b>. HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>19</sub>BrF<sub>2</sub>N<sub>6</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 541.0464, found 541.0460; HPLC purity, 96.9% (<i>t</i><sub>R</sub> = 7.50 min).</div></div><div id="sec5_2_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 4-[2-[6-Amino-8-[(6-chloro-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]piperidine-1-carbaldehyde (<b>34o</b>)</h3><div class="NLM_p last">The title compound was prepared in 55% yield from <b>33b</b> and <b>43c</b> in a manner similar to that described for <b>34a</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.21 (s, 1H), 7.94 (s, 1H), 7.29 (s, 1H), 6.91 (s, 1H), 6.11 (s, 2H), 4.25–4.19 (m, 2H), 4.12–4.05 (m, 1H), 3.66–3.60 (m, 1H), 2.99–2.85 (m, 1H), 1.90–0.95 (m, 8H); HRMS (ESI-TOF) calcd for C<sub>20</sub>H<sub>21</sub>ClN<sub>6</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 461.1157, found 461.1156; HPLC purity, 99.9% (<i>t</i><sub>R</sub> = 7.11 min).</div></div><div id="sec5_2_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (2<i>S</i>)-1-[4-[2-[6-Amino-8-[(6-chloro-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]-1-piperidyl]-2-hydroxypropan-1-one (<b>34p</b>)</h3><div class="NLM_p last">The title compound was prepared in 80% yield by the EDCI coupling method described for the preparation of <b>34j</b> using <b>40d</b> and <span class="smallcaps smallerCapital">l</span>-lactic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (s, 1H), 7.30 (s, 1H), 6.96 (s, 1H), 6.12 (s, 2H), 4.39 (m, 1H), 4.31 (m, 1H), 4.22 (t, <i>J</i> = 7.6 Hz, 2H), 3.92 (m, 1H), 2.88 (m, 1H), 2.48 (m, 1H), 1.78–1.68 (m, 2H), 1.66–1.58 (m, 2H), 1.45 (m, 1H), 1.17–1.12 (m, 3H), 1.10–0.90 (m, 2H); HRMS (ESI-TOF) calcd for C<sub>22</sub>H<sub>25</sub>ClN<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 505.1419, found 505.1428; HPLC purity, 99.8% (<i>t</i><sub>R</sub> = 6.98 min).</div></div><div id="sec5_2_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 6-[6-Amino-9-[2-(1-formyl-4-piperidyl)ethyl]purin-8-yl]sulfanyl-1,3-benzodioxole-5-carbonitrile (<b>34q</b>)</h3><div class="NLM_p last">The title compound was prepared in 22% yield from <b>26g</b> and <b>25b</b> in a manner similar to that described for <b>28a</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 8.31 (s, 1H), 7.98 (s, 1H), 7.39 (s, 1H), 7.38 (s, 1H), 6.21 (s, 2H), 4.41 (t, <i>J</i> = 6.8 Hz, 2H), 4.31 (brd, <i>J</i> = 13.6 Hz, 1H), 3.71 (brd, <i>J</i> = 13.2 Hz, 1H), 3.11 (td, <i>J</i> = 12.8, 3.2 Hz, 1H), 2.67 (td, <i>J</i> = 13.2, 3.2 Hz, 1H), 1.99–1.92 (m, 2H), 1.88 (q, <i>J</i> = 7.2 Hz, 2H), 1.65 (m, 1H), 1.21 (qd, <i>J</i> = 12.4, 4.4 Hz, 1H), 1.14 (qd, <i>J</i> = 12.4, 4.0 Hz, 1H); HRMS (ESI-TOF) calcd for C<sub>21</sub>H<sub>21</sub>N<sub>7</sub>O<sub>3</sub>S [M + H<sup>+</sup>] 452.1499, found 452.1503; HPLC purity, 99.6% (<i>t</i><sub>R</sub> = 11.53 min).</div></div><div id="sec5_2_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 2-Ethylhexyl 3-[(6-Bromo-1,3-benzodioxol-5-yl)sulfanyl]propanoate (<b>43a</b>)</h3><div class="NLM_p last">The title compound was prepared in 50% yield from <b>24a</b> and <b>52</b> in a manner similar to that described for <b>45</b>, step 1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.06 (s, 1H), 6.95 (s, 1H), 6.00 (s, 2H), 4.02 (dd, <i>J</i> = 12.8, 6.0 Hz, 1H), 4.00 (dd, <i>J</i> = 12.8, 5.6 Hz, 1H), 3.11 (t, <i>J</i> = 6.8 Hz, 2H), 2.62 (t, <i>J</i> = 6.8 Hz, 2H), 1.57 (m, 1H), 1.39–1.26 (m, 8H), 0.89 (two t, <i>J</i> = 7.2 Hz, 6H); HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>25</sub>Br<sub>6</sub>O<sub>4</sub>S [M + H<sup>+</sup>] 417.0730, found 417.0713.</div></div><div id="sec5_2_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-Ethylhexyl 3-[(6-Bromo-2,3-dihydro-1,4-benzodioxin-7-yl)sulfanyl]propanoate (<b>43b</b>)</h3><div class="NLM_p last">The title compound was prepared in 55% yield from <b>24b</b> and <b>52</b> in a manner similar to that described for <b>45</b>, step 1. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.12 (s, 1H), 6.97 (s, 1H), 4.25 (s, 4H), 4.02 (dd, <i>J</i> = 12.8, 6.0 Hz, 1H), 4.00 (dd, <i>J</i> = 12.8, 6.0 Hz, 1H), 3.10 (t, <i>J</i> = 7.6 Hz, 2H), 2.62 (t, <i>J</i> = 7.6 Hz, 2H), 1.56 (m, 1H), 1.39–1.26 (m, 8H), 0.89 (two t, <i>J</i> = 7.2 Hz, 6H).</div></div><div id="sec5_2_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2-Ethylhexyl 3-[(6-Chloro-1,3-benzodioxol-5-yl)sulfanyl]propanoate (<b>43c</b>)</h3><div class="NLM_p last">The title compound was prepared in 92% yield from <b>41c</b> and <b>52</b> in a manner similar to that described for <b>45</b>, step 1. HRMS (ESI-TOF) calcd for C<sub>18</sub>H<sub>25</sub>ClO<sub>4</sub>S [M + H<sup>+</sup>] 372.1162, found 372.1162.</div></div><div id="sec5_2_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 2-Ethylhexyl 3-[(5-Bromo-2,3-dihydrobenzofuran-6-yl)sulfanyl]propanoate (<b>45</b>)</h3><div class="NLM_p"><i>Step 1.</i> 6-Bromodihydrobenzofuran (<b>44</b>) (2.39 g, 12.02 mmol), 3-mercaptopropionic acid 2-ethyhexyl ester (<b>52</b>) (2.76 g, 12.6 mmol), Pd<sub>2</sub>dba<sub>3</sub> (165 mg, 0.180 mmol), and xantphos (279 mg, 0.481 mmol) were placed in a flask followed by degassed dioxane (40 mL) and Hünig’s base (4.2 mL, 0.18 mol) under nitrogen. The mixture was heated at 100 °C for 10 h, cooled to room temperature, diluted with CH<sub>2</sub>Cl<sub>2</sub>, filtered, and concentrated in vacuo. The residue was purified by SiO<sub>2</sub> chromatography (EtOAc/hexane, 0–30%) to afford 3.1 g (83%) of 2-ethylhexyl 3-(2,3-dihydro-1-benzofuran-6-ylthio)propanoate. HRMS (ESI-TOF) calcd for C<sub>19</sub>H<sub>28</sub>O<sub>3</sub> [M + H<sup>+</sup>] 337.1832, found 337.1795.</div><div class="NLM_p last"><i>Step 2.</i> To a solution of 2-ethylhexyl 3-(2,3-dihydro-1-benzofuran-6-ylthio)propanoate (500 mg, 1.49 mmol) in AcCN (3 mL) was added HBF<sub>4</sub>OEt<sub>2</sub> (204 μL, 1.50 mmol) at −20 °C, followed by NBS (267 mg, 1.50 mmol) portionwise. The reaction mixture was slowly warmed to 5–10 °C, quenched with 10% aqueous NaHSO<sub>3</sub> (7 mL), and extracted with Et<sub>2</sub>O. The combined extracts were washed with H<sub>2</sub>O, brine, and the organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was purified by SiO<sub>2</sub> chromatography (EtOAc/hexane, 0–30%) to afford <b>45</b> (0.455 g, 71%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (t, <i>J</i> = 0.8 Hz, 1H), 6.76 (s, 1H), 4.59 (t, <i>J</i> = 8.8 Hz, 2H), 4.03 (dd, <i>J</i> = 12.8, 6.0 Hz, 1H), 4.01 (dd, <i>J</i> = 12.8, 6.0 Hz, 1H), 3.19 (td, <i>J</i> = 8.8, 0.8 Hz, 2H), 3.16 (t, <i>J</i> = 7.2 Hz, 2H), 2.67 (t, <i>J</i> = 7.2 Hz, 2H), 1.56 (m, 1H), 1.39–1.25 (m, 8H), 0.89 (two t, <i>J</i> = 6.8 Hz, 6H); GC–MS (EI), <i>m</i>/<i>z</i> 414.</div></div><div id="sec5_2_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 2-Ethylhexyl 3-(5-Bromobenzofuran-6-yl)sulfanylpropanoate (<b>46</b>)</h3><div class="NLM_p last">To a solution of <b>45</b> (114 mg, 0.274 mmol) in dioxane (1.7 mL) was added DDQ (81 mg, 0.36 mmol), and the mixture was heated at 100 °C. After 10 h, the mixture was cooled to room temperature, diluted with Et<sub>2</sub>O, filtered, and concentrated in vacuo. The residue was purified by SiO<sub>2</sub> chromatography (EtOAc/hexane, 0–10%) to afford <b>46</b> (92 mg, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.83 (s, 1H), 7.60 (d, <i>J</i> = 2.0 Hz, 1H), 7.56 (d, <i>J</i> = 0.8 Hz, 1H), 6.70 (dd, <i>J</i> = 2.0 Hz, 0.8 Hz, 1H), 4.03 (dd, <i>J</i> = 12.8, 6.0 Hz, 1H), 4.01 (dd, <i>J</i> = 12.8, 6.0 Hz, 1H), 3.23 (t, <i>J</i> = 7.6 Hz, 2H), 2.69 (t, <i>J</i> = 7.6 Hz, 2H), 1.59 (m, 1H), 1.42–1.25 (m, 8H), 0.89 (two t, <i>J</i> = 7.6 Hz, 6H); GC–MS (EI), <i>m</i>/<i>z</i> 412.</div></div><div id="sec5_2_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 2-Ethylhexyl 3-[(6-Bromo-4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)sulfanyl]propanoate (<b>51</b>)</h3><div class="NLM_p last">The title compound was prepared in 56% yield (two steps) from <b>50</b> and <b>52</b> in a manner smilar to that described above for <b>45</b>. GC–MS (EI), <i>m</i>/<i>z</i> 445.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75"><a href="/doi/suppl/10.1021/jm3004619">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71774" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71774" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Procedures for molecular modeling, synthesis of compounds <b>24d</b>–<b>e</b>, and <sup>1</sup>H NMR spectra and HPLC traces for selected compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3004619/suppl_file/jm3004619_si_001.pdf">jm3004619_si_001.pdf (935.46 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3004619" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Se-Ho Kim</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9ae9fff2f5b4f1f3f7f1f3f7dafdf7fbf3f6b4f9f5f7baf1e8fbf3fdb4e3fbfdffe8dafdf7fbf3f6b4f9f5f7"><span class="__cf_email__" data-cfemail="5427313c3b7a3f3d393f3d39143339353d387a373b39">[email protected]</span> <span class="__cf_email__" data-cfemail="abc0d9cac2cc85d2caccced9ebccc6cac2c785c8c4c6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kraig M. Yager</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#97e4f2fff8b9fcfefafcfefad7f0faf6fefbb9f4f8fab7fce5f6fef0b9eef6f0f2e5d7f0faf6fefbb9f4f8fa"><span class="__cf_email__" data-cfemail="700315181f5e1b191d1b191d30171d11191c5e131f1d">[email protected]</span> <span class="__cf_email__" data-cfemail="7e150c1f171950071f191b0c3e19131f1712501d1113">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashok Bajji</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajendra Tangallapally</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin Markovitz</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Trovato</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Shenderovich</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vijay Baichwal</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Bartel</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Cimbora</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rena McKinnon</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosann Robinson</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Damon Papac</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Wettstein</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Carlson</span> - <span class="hlFld-Affiliation affiliation">Myrexis
Inc., 305 Chipeta
Way, Salt Lake City, Utah 84108, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d330e6684-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23774" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23774" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the analytical chemistry group of Myrexis, Inc. for analytical support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i78" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i78"> Abbreviations Used</h2><tr><td class="NLM_term">17-AAG</td><td class="NLM_def"><p class="first last">17-allylamino-17-demethoxygeldanamycin</p></td></tr><tr><td class="NLM_term">AcCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">Barton’s base</td><td class="NLM_def"><p class="first last">2-<i>tert</i>-butyl-1,1,3,3-tetramethylguanidine</p></td></tr><tr><td class="NLM_term">cdc37</td><td class="NLM_def"><p class="first last">cell division cycle 37</p></td></tr><tr><td class="NLM_term">CDK4</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase 4</p></td></tr><tr><td class="NLM_term">DDQ</td><td class="NLM_def"><p class="first last">2,3-dichloro-5,6-dicyano-1,4-benzoquinone</p></td></tr><tr><td class="NLM_term">17-DMAG</td><td class="NLM_def"><p class="first last">17-desmethoxy-17-<i>N</i>,<i>N</i>-dimethylaminoethylaminogeldanamycin</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">Her2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor 1α</p></td></tr><tr><td class="NLM_term">HIP</td><td class="NLM_def"><p class="first last">Hsp70 interacting protein</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HOP</td><td class="NLM_def"><p class="first last">Hsp70-Hsp90 organizing protein</p></td></tr><tr><td class="NLM_term">HSF1</td><td class="NLM_def"><p class="first last">heat shock protein 1</p></td></tr><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">90 kDa heat shock protein</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">Hünig’s base</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">Pd<sub>2</sub>dba<sub>2</sub></td><td class="NLM_def"><p class="first last">tris(dibenzylideneacetone)dipalladium(0)</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">RP-HPLC</td><td class="NLM_def"><p class="first last">reversed-phase high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">xantphos</td><td class="NLM_def"><p class="first last">4,5-bis(diphenylphosphino)-9,9-dimethylxanthene</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 73 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Walter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Molecular chaperones—cellular machines for protein folding</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=1098-1113&author=S.+Walterauthor=J.+Buchner&title=Molecular+chaperones%E2%80%94cellular+machines+for+protein+folding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DMolecular%2520chaperones%25E2%2580%2594cellular%2520machines%2520for%2520protein%2520folding%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D1098%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Calderwood, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaleque, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciocca, D. R.</span><span> </span><span class="NLM_article-title">Heat shock proteins in cancer: chaperones of tumorigenesis</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2Fj.tibs.2006.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=16483782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ymsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=164-172&author=S.+K.+Calderwoodauthor=M.+A.+Khalequeauthor=D.+B.+Sawyerauthor=D.+R.+Ciocca&title=Heat+shock+proteins+in+cancer%3A+chaperones+of+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins in cancer: chaperones of tumorigenesis</span></div><div class="casAuthors">Calderwood, Stuart K.; Khaleque, Md Abdul; Sawyer, Douglas B.; Ciocca, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-172</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The heat shock proteins (HSPs) induced by cell stress are expressed at high levels in a wide range of tumors and are closely assocd. with a poor prognosis and resistance to therapy.  The increased transcription of HSPs in tumor cells is due to loss of p53 function and to higher expression of the proto-oncogenes HER2 and c-Myc, and is crucial to tumorigenesis.  The HSP family members play overlapping, essential roles in tumor growth both by promoting autonomous cell proliferation and by inhibiting death pathways.  The HSPs have thus become targets for rational anti-cancer drug design: HSP90 inhibitors are currently showing much promise in clin. trials, whereas the increased expression of HSPs in tumors is forming the basis of chaperone-based immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxhSfR-fO787Vg90H21EOLACvtfcHk0liXK4LXUiv6Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ymsL4%253D&md5=6780e2b46a19edac2e52edc0afafafff</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2006.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2006.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26aulast%3DKhaleque%26aufirst%3DM.%2BA.%26aulast%3DSawyer%26aufirst%3DD.%2BB.%26aulast%3DCiocca%26aufirst%3DD.%2BR.%26atitle%3DHeat%2520shock%2520proteins%2520in%2520cancer%253A%2520chaperones%2520of%2520tumorigenesis%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2006%26volume%3D31%26spage%3D164%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S. L.</span><span> </span><span class="NLM_article-title">HSP90 and the chaperoning of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=HSP90+and+the+chaperoning+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0li4hK1Wc6M_Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHSP90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ali, M. M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1017</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnature04716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=16625188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1agtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=1013-1017&author=M.+M.+U.+Aliauthor=S.+M.+Roeauthor=C.+K.+Vaughanauthor=P.+Meyerauthor=B.+Panaretouauthor=P.+W.+Piperauthor=C.+Prodromouauthor=L.+H.+Pearl&title=Crystal+structure+of+an+Hsp90-nucleotide-p23%2FSba1+closed+chaperone+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex</span></div><div class="casAuthors">Ali, Maruf M. U.; Roe, S. Mark; Vaughan, Cara K.; Meyer, Phillipe; Panaretou, Barry; Piper, Peter W.; Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7087</span>),
    <span class="NLM_cas:pages">1013-1017</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hsp90 (heat shock protein of 90 kDa) is a ubiquitous mol. chaperone responsible for the assembly and regulation of many eukaryotic signaling systems and is an emerging target for rational chemotherapy of many cancers.  Although the structures of isolated domains of Hsp90 have been detd., the arrangement and ATP-dependent dynamics of these in the full Hsp90 dimer have been elusive and contentious.  Here we present the crystal structure of full-length yeast Hsp90 in complex with an ATP analog and the co-chaperone p23/Sba1.  The structure reveals the complex architecture of the closed' state of the Hsp90 chaperone, the extensive interactions between domains and between protein chains, the detailed conformational changes in the amino-terminal domain that accompany ATP binding, and the structural basis for stabilization of the closed state by p23/Sba1.  Contrary to expectations, the closed Hsp90 would not enclose its client proteins but provides a bipartite binding surface whose formation and disruption are coupled to the chaperone ATPase cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcaj34ODndPbVg90H21EOLACvtfcHk0li4hK1Wc6M_Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1agtLw%253D&md5=15ea0bcf7cbf297b3f4a7005c7798fb0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature04716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04716%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DM.%2BM.%2BU.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DVaughan%26aufirst%3DC.%2BK.%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520an%2520Hsp90-nucleotide-p23%252FSba1%2520closed%2520chaperone%2520complex%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D1013%26epage%3D1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southworth, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, D. A.</span><span> </span><span class="NLM_article-title">Structural analysis of <i>E. coli</i> hsp90 reveals dramatic nucleotide-dependent conformational rearrangements</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=329-340&author=A.+K.+Shiauauthor=S.+F.+Harrisauthor=D.+R.+Southworthauthor=D.+A.+Agard&title=Structural+analysis+of+E.+coli+hsp90+reveals+dramatic+nucleotide-dependent+conformational+rearrangements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DSouthworth%26aufirst%3DD.%2BR.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26atitle%3DStructural%2520analysis%2520of%2520E.%2520coli%2520hsp90%2520reveals%2520dramatic%2520nucleotide-dependent%2520conformational%2520rearrangements%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D329%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Overview: translating Hsp90 biology into Hsp90 drugs</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F1568009033481868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=14529382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2isro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=297-300&author=P.+Workman&title=Overview%3A+translating+Hsp90+biology+into+Hsp90+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Overview: translating Hsp90 biology into Hsp90 drugs</span></div><div class="casAuthors">Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">297-300</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 mol. chaperone has emerged as one of the most exciting targets for cancer drug development.  Hsp90 is overexpressed in many malignancies, very likely as a result of the stress that is induced both by the hostile cancer microenvironment and also by the mutation and aberrant expression of oncoproteins.  A particularly attractive feature of Hsp90 as a cancer drug target is that it is required for the conformational stability and function of a wide range of oncogenic "client" proteins, including c-Raf-1, Cdk4, ErbB2, mutant p53, c-Met, Polo-1 and telomerase hTERT.  Inhibition of Hsp90 should therefore block multiple mission crit. oncogenic pathways in the cancer cell, leading to inhibition of all the hallmark traits of malignancy.  This combinatorial blockade of oncogenic targets should give rise to board spectrum antitumor activity across multiple cancer types.  The "drugability" of Hsp90 was confirmed by the discovery that the natural products geldanamycin and radicicol, which have anticancer activity, exert their biol. effects by inhibiting the essential ATPase activity assocd. with the N-terminal domain of the protein.  The first-in-class Hsp90 inhibitor has entered clin. trial and provided proof of concept that Hsp90 can be inhibited and clin. benefit seen at non-toxic doses.  Further development is underway and a related analog 17DMAG also shows promise in preclin. models.  In addn., novel Hsp90 inhibitors have been identified using methods such as high throughput screening and x-ray crystallog.  The opportunities and challenges involved in translating the fast moving biol. of Hsp90 into patient benefit is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplxhiU6T39gbVg90H21EOLACvtfcHk0lhqP3oWGo3VuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2isro%253D&md5=432b5cd2c5ce72ac7dfce9c5c8ae91fe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1568009033481868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481868%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DOverview%253A%2520translating%2520Hsp90%2520biology%2520into%2520Hsp90%2520drugs%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D297%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yufu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawata, H.</span><span> </span><span class="NLM_article-title">High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2F0145-2126%2892%2990008-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=1635378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADyaK38zktFOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1992&pages=597-605&author=Y.+Yufuauthor=J.+Nishimuraauthor=H.+Nawata&title=High+constitutive+expression+of+heat+shock+protein+90+alpha+in+human+acute+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells</span></div><div class="casAuthors">Yufu Y; Nishimura J; Nawata H</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">597-605</span>
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    </div><div class="casAbstract">The constitutive expression of the genes for four heat shock proteins (hsps) was studied in leukemia cell lines, cells obtained from patients with acute leukemia, and normal blood cells by means of Northern-blot analysis.  Western-blot analysis with hsp90 antibody showed that the leukemia cells contained larger amounts of hsp90 than the normal peripheral mononuclear cells.  The expression of the hsp90 alpha gene was enhanced in the leukemia cell lines and the acute leukemia cells from patients as compared with the normal blood cells.  In contrast, the expression of the hsp90 beta gene could hardly be recognized in either the acute leukemia cells or the normal blood cells.  An increased expression of hsp70 gene was observed in only one patient.  The expression of the hsp27 gene was enhanced in one-half the patients with common acute lymphoblastic leukemia.  Thus, exclusively the hsp90 alpha gene was expressed highly in the leukemia cells, indicating its association with cellular proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5VwdQU7f4_OxsqfvU0ziafW6udTcc2eZZAw6P_kM_Z7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zktFOgtw%253D%253D&md5=1a8f482a0bf97db922baf3b698bacbef</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2F0145-2126%2892%2990008-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0145-2126%252892%252990008-U%26sid%3Dliteratum%253Aachs%26aulast%3DYufu%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DJ.%26aulast%3DNawata%26aufirst%3DH.%26atitle%3DHigh%2520constitutive%2520expression%2520of%2520heat%2520shock%2520protein%252090%2520alpha%2520in%2520human%2520acute%2520leukemia%2520cells%26jtitle%3DLeuk.%2520Res.%26date%3D1992%26volume%3D16%26spage%3D597%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ciocca, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuqua, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock-Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, W. L.</span><span> </span><span class="NLM_article-title">Response of human breast cancer cells to heat shock chemotherapeutic drugs</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3648</span><span class="NLM_x">–</span> <span class="NLM_lpage">3654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=3648-3654&author=D.+R.+Cioccaauthor=S.+A.+Fuquaauthor=S.+Lock-Limauthor=D.+O.+Toftauthor=W.+J.+Welchauthor=W.+L.+McGuire&title=Response+of+human+breast+cancer+cells+to+heat+shock+chemotherapeutic+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiocca%26aufirst%3DD.%2BR.%26aulast%3DFuqua%26aufirst%3DS.%2BA.%26aulast%3DLock-Lim%26aufirst%3DS.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DWelch%26aufirst%3DW.%2BJ.%26aulast%3DMcGuire%26aufirst%3DW.%2BL.%26atitle%3DResponse%2520of%2520human%2520breast%2520cancer%2520cells%2520to%2520heat%2520shock%2520chemotherapeutic%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D3648%26epage%3D3654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shifrin, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=1721-1728&author=L.+Whitesellauthor=S.+D.+Shifrinauthor=G.+Schwabauthor=L.+M.+Neckers&title=Benzoquinonoid+ansamycins+possess+selective+tumoricidal+activity+unrelated+to+src+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DShifrin%26aufirst%3DS.%2BD.%26aulast%3DSchwab%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DBenzoquinonoid%2520ansamycins%2520possess%2520selective%2520tumoricidal%2520activity%2520unrelated%2520to%2520src%2520kinase%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D1721%26epage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">8324</span><span class="NLM_x">–</span> <span class="NLM_lpage">8328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1073%2Fpnas.91.18.8324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=8078881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8324-8328&author=L.+Whitesellauthor=E.+G.+Mimnaughauthor=B.+De+Costaauthor=C.+E.+Myersauthor=L.+M.+Neckers&title=Inhibition+of+heat+shock+protein+HSP90-pp60v-src+heteroprotein+complex+formation+by+benzoquinone+ansamycins%3A+essential+role+for+stress+proteins+in+oncogenic+transformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span></div><div class="casAuthors">Whitesell, Luke; Mimnaugh, Edward G.; De Costa, Brian; Myers, Charles E.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8324-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The mol. mechanisms by which oncogenic tyrosine kinases induce cellular transformation are unclear.  Herbimycin A, geldanamycin, and certain other benzoquinone ansamycins display an unusual capacity to revert tyrosine kinase-induced oncogenic transformation.  As an approach to the study of v-src-mediated transformation, the authors examd. ansamycin action in transformed cells and found that drug-induced reversion could be achieved without direct inhibition of src phosphorylating activity.  To identify mechanisms other than kinase inhibition for drug-mediated reversion, the authors prepd. a solid phase-immobilized geldanamycin deriv. and affinity pptd. the mol. targets with which the drug interacted.  In a range of cell lines, immobilized geldanamycin bound elements of a major class of heat shock protein (HSP90) in a stable and pharmacol. specific manner.  Consistent with these binding data, the authors found that sol. geldanamycin and herbimycin A inhibited specifically the formation of a previously described src-HSP90 heteroprotein complex.  A related benzoquinone ansamycin that failed to revert transformed cells did not inhibit the formation of this complex.  These results demonstrate that HSP participation in multimol. complex formation is required for src-mediated transformation and can provide a target for drug modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTW8DJOglQLVg90H21EOLACvtfcHk0lj5T_3CQtoJDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D&md5=18f1cad01698df44adaa05ef3da9f850</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8324%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DDe%2BCosta%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%2520HSP90-pp60v-src%2520heteroprotein%2520complex%2520formation%2520by%2520benzoquinone%2520ansamycins%253A%2520essential%2520role%2520for%2520stress%2520proteins%2520in%2520oncogenic%2520transformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D8324%26epage%3D8328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lj5T_3CQtoJDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sawyers, C.</span><span> </span><span class="NLM_article-title">Targeted cancer therapy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnature03095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=15549090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=294-297&author=C.+Sawyers&title=Targeted+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted cancer therapy</span></div><div class="casAuthors">Sawyers, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7015</span>),
    <span class="NLM_cas:pages">294-297</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Disruption of the normal regulation of cell-cycle progression and division lies at the heart of the events leading to cancer.  Complex networks of regulatory factors, the tumor microenvironment and stress signals, such as those resulting from damaged DNA, dictate whether cancer cells proliferate or die.  Recent progress in understanding the mol. changes that underlie cancer development offer the prospect of specifically targeting malfunctioning mols. and pathways to achieve more effective and rational cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAGMTW2TYsubVg90H21EOLACvtfcHk0lj_BkvDM4x5QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtL8%253D&md5=5bd377d2c9ddcffc136d5cf181facd02</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature03095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03095%26sid%3Dliteratum%253Aachs%26aulast%3DSawyers%26aufirst%3DC.%26atitle%3DTargeted%2520cancer%2520therapy%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D294%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ji, H.</span><span> </span><span class="NLM_article-title">Mechanistic insights into acquired drug resistance in epidermal growth factor receptor mutation-targeted lung cancer therapy</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2010&pages=1993&author=H.+Ji&title=Mechanistic+insights+into+acquired+drug+resistance+in+epidermal+growth+factor+receptor+mutation-targeted+lung+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26atitle%3DMechanistic%2520insights%2520into%2520acquired%2520drug%2520resistance%2520in%2520epidermal%2520growth%2520factor%2520receptor%2520mutation-targeted%2520lung%2520cancer%2520therapy%26jtitle%3DCancer%2520Sci.%26date%3D2010%26volume%3D101%26spage%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sierra, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cepero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1186%2F1476-4598-9-75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20385023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADC%252BC3czhtVelsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=75&author=J.+R.+Sierraauthor=V.+Ceperoauthor=S.+Giordano&title=Molecular+mechanisms+of+acquired+resistance+to+tyrosine+kinase+targeted+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy</span></div><div class="casAuthors">Sierra J Rafael; Cepero Virna; Giordano Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In recent years, tyrosine kinases (TKs) have been recognized as central players and regulators of cancer cell proliferation, apoptosis, and angiogenesis, and are therefore considered suitable potential targets for anti-cancer therapies.  Several strategies for targeting TKs have been developed, the most successful being monoclonal antibodies and small molecule tyrosine kinase inhibitors.  However, increasing evidence of acquired resistance to these drugs has been documented, and extensive preclinical studies are ongoing to try to understand the molecular mechanisms by which cancer cells are able to bypass their inhibitory activity.This review intends to present the most recently identified molecular mechanisms that mediate acquired resistance to tyrosine kinase inhibitors, identified through the use of in vitro models or the analysis of patient samples.  The knowledge obtained from these studies will help to design better therapies that prevent and overcome resistance to treatment in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmF8Wk15sVr2xpATR2EQURfW6udTcc2ea3wQSRjeTZtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czhtVelsQ%253D%253D&md5=89d75465d845f4bc04159d114fe57488</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-9-75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-9-75%26sid%3Dliteratum%253Aachs%26aulast%3DSierra%26aufirst%3DJ.%2BR.%26aulast%3DCepero%26aufirst%3DV.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DMolecular%2520mechanisms%2520of%2520acquired%2520resistance%2520to%2520tyrosine%2520kinase%2520targeted%2520therapy%26jtitle%3DMol.%2520Cancer%26date%3D2010%26volume%3D9%26spage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Goldie, J. H.</span><span> </span><span class="NLM_article-title">Drug resistance in cancer: a perspective</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1023%2FA%3A1013164609041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=11831649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVWlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=63-68&author=J.+H.+Goldie&title=Drug+resistance+in+cancer%3A+a+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance in cancer: A perspective</span></div><div class="casAuthors">Goldie, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">63-68</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review. Drug resistance remains the thorniest obstacle in developing improved systemic therapies for disseminated cancer.  The combination of genetic instability together with the great mol. heterogeneity that are displayed by malignant cells makes constructing effective, rational treatment programs difficult in the extreme.  However, new insights into the action of antitumor agents at the mol. level plus greater understanding of the relationship of drug-resistant states to the fundamental abnormalities that generate malignancy point the way to producing therapies that are more specific and therapeutically effective.  However, a nontrivial problem is the drug-development system itself which is currently poorly set up to yield patient-specific drug programs in a timely fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmR10o7PHtCLVg90H21EOLACvtfcHk0lj_BkvDM4x5QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVWlur0%253D&md5=df96aee242d4ae829135d53ade71d856</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1023%2FA%3A1013164609041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1013164609041%26sid%3Dliteratum%253Aachs%26aulast%3DGoldie%26aufirst%3DJ.%2BH.%26atitle%3DDrug%2520resistance%2520in%2520cancer%253A%2520a%2520perspective%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2001%26volume%3D20%26spage%3D63%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Altered states: selectively drugging the Hsp90 cancer chaperone</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=47-51&author=P.+Workman&title=Altered+states%3A+selectively+drugging+the+Hsp90+cancer+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DAltered%2520states%253A%2520selectively%2520drugging%2520the%2520Hsp90%2520cancer%2520chaperone%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D47%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Weinstein, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joe, A.</span><span> </span><span class="NLM_article-title">Oncogene addiction</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3077</span><span class="NLM_x">–</span> <span class="NLM_lpage">3080</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3077-3080&author=I.+B.+Weinsteinauthor=A.+Joe&title=Oncogene+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DI.%2BB.%26aulast%3DJoe%26aufirst%3DA.%26atitle%3DOncogene%2520addiction%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D3077%26epage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Garber, K.</span><span> </span><span class="NLM_article-title">Synthetic lethality: killing cancer with cancer</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1666</span><span class="NLM_x">–</span> <span class="NLM_lpage">1668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1093%2Fjnci%2F94.22.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=12441317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADC%252BD38notFWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2002&pages=1666-1668&author=K.+Garber&title=Synthetic+lethality%3A+killing+cancer+with+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethality: killing cancer with cancer</span></div><div class="casAuthors">Garber Ken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1666-8</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcmhyNfLgktl1C8OJBvdfbfW6udTcc2ea1CFhwGzRhTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38notFWitg%253D%253D&md5=5a85a414a3b9183584c9771c79052e98</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F94.22.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F94.22.1666%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DK.%26atitle%3DSynthetic%2520lethality%253A%2520killing%2520cancer%2520with%2520cancer%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2002%26volume%3D94%26spage%3D1666%26epage%3D1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0ljA3LVDKt4xtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb600224w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=279-284&author=G.+Chiosisauthor=L.+Neckers&title=Tumor+selectivity+of+Hsp90+inhibitors%3A+the+explanation+remains+elusive"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcb600224w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb600224w%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTumor%2520selectivity%2520of%2520Hsp90%2520inhibitors%253A%2520the%2520explanation%2520remains%2520elusive%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2006%26volume%3D1%26spage%3D279%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Trepel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0liSUc5Mbi4c8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 in neurodegenerative diseases</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1186%2F1750-1326-5-24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20525284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADC%252BC3cnkslCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=24&author=W.+Luoauthor=W.+Sunauthor=T.+Taldoneauthor=A.+Rodinaauthor=G.+Chiosis&title=Heat+shock+protein+90+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90 in neurodegenerative diseases</span></div><div class="casAuthors">Luo Wenjie; Sun Weilin; Taldone Tony; Rodina Anna; Chiosis Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hsp90 is a molecular chaperone with important roles in regulating pathogenic transformation.  In addition to its well-characterized functions in malignancy, recent evidence from several laboratories suggests a role for Hsp90 in maintaining the functional stability of neuronal proteins of aberrant capacity, whether mutated or over-activated, allowing and sustaining the accumulation of toxic aggregates.  In addition, Hsp90 regulates the activity of the transcription factor heat shock factor-1 (HSF-1), the master regulator of the heat shock response, mechanism that cells use for protection when exposed to conditions of stress.  These biological functions therefore propose Hsp90 inhibition as a dual therapeutic modality in neurodegenerative diseases.  First, by suppressing aberrant neuronal activity, Hsp90 inhibitors may ameliorate protein aggregation and its associated toxicity.  Second, by activation of HSF-1 and the subsequent induction of heat shock proteins, such as Hsp70, Hsp90 inhibitors may redirect neuronal aggregate formation, and protect against protein toxicity.  This mini-review will summarize our current knowledge on Hsp90 in neurodegeneration and will focus on the potential beneficial application of Hsp90 inhibitors in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYuS3z9s_ui5dYoSR9eyvsfW6udTcc2eZUu2cUhrnUe7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnkslCruw%253D%253D&md5=dd686137ecbf1860adf2d5607eb9b229</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-5-24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-5-24%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHeat%2520shock%2520protein%252090%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMol.%2520Neurodegener.%26date%3D2010%26volume%3D5%26spage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Neef, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, D. J.</span><span> </span><span class="NLM_article-title">Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=930-944&author=D.+W.+Neefauthor=A.+M.+Jaegerauthor=D.+J.+Thiele&title=Heat+shock+transcription+factor+1+as+a+therapeutic+target+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeef%26aufirst%3DD.%2BW.%26aulast%3DJaeger%26aufirst%3DA.%2BM.%26aulast%3DThiele%26aufirst%3DD.%2BJ.%26atitle%3DHeat%2520shock%2520transcription%2520factor%25201%2520as%2520a%2520therapeutic%2520target%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D930%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chaudhury, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S. J.</span><span> </span><span class="NLM_article-title">Hsp90 as a target for drug development</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1331-1340&author=S.+Chaudhuryauthor=T.+R.+Welchauthor=B.+S.+J.+Blagg&title=Hsp90+as+a+target+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhury%26aufirst%3DS.%26aulast%3DWelch%26aufirst%3DT.%2BR.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DHsp90%2520as%2520a%2520target%2520for%2520drug%2520development%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D1331%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Jhaveri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+in+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D90%26spage%3D742%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">ATPase inhibitors of heat-shock protein 90, second season</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=342-353&author=Y.+L.+Janin&title=ATPase+inhibitors+of+heat-shock+protein+90%2C+second+season"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DATPase%2520inhibitors%2520of%2520heat-shock%2520protein%252090%252C%2520second%2520season%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depew, K. M.</span><span> </span><span class="NLM_article-title">Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2Fj.cbpa.2010.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20409745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=412-420&author=J.+R.+Porterauthor=C.+C.+Fritzauthor=K.+M.+Depew&title=Discovery+and+development+of+Hsp90+inhibitors%3A+a+promising+pathway+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy</span></div><div class="casAuthors">Porter, James R.; Fritz, Christian C.; Depew, Kristopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-420</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 chaperone is a master regulator of the stability and activity of multiple oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF.  The promise of inhibition of such a master regulator for cancer therapy is the potential to cause combinatorial inhibition of multiple oncogenic signaling pathways simultaneously.  With the recent discovery of feedback loops that effectively negate the efficacy of selectively targeted anti-cancer agents, there is renewed interest in such a multi-pronged approach.  There are now 14 drug candidates that target Hsp90 undergoing clin. trials in multiple indications as single agents or combination therapy.  These compds. represent a diverse array of chem. matter stemming from natural product scaffolds to synthetic structure-based design.  Although the compds. fall into distinct classes with unique properties, each inhibitor binds in the N-terminal ATP pocket and accumulates in tumor tissue while being rapidly cleared from circulation and normal tissue.  The most advanced candidates are now in Phase 2 clin. trials and defining the therapeutic window, dosing schedule, and indication are the primary challenges for these potential first-in-class inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSHW-vNCZ49rVg90H21EOLACvtfcHk0ljzCZ_Qxu_dxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsbw%253D&md5=628b4d92e4ff4cd8d831e51674501001</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DFritz%26aufirst%3DC.%2BC.%26aulast%3DDepew%26aufirst%3DK.%2BM.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Hsp90%2520inhibitors%253A%2520a%2520promising%2520pathway%2520for%2520cancer%2520therapy%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D412%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Water, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perret, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-C.</span><span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.-C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0ljzCZ_Qxu_dxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.-C.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarcon, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J. B.</span><span> </span><span class="NLM_article-title">Update on Hsp90 inhibitors in clinical trial</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1479</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F156802609789895728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=19860730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1479-1492&author=Y.+S.+Kimauthor=S.+V.+Alarconauthor=S.+Leeauthor=M.-J.+Leeauthor=G.+Giacconeauthor=L.+Neckersauthor=J.+B.+Trepel&title=Update+on+Hsp90+inhibitors+in+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Hsp90 inhibitors in clinical trial</span></div><div class="casAuthors">Kim, Y. S.; Alarcon, S. V.; Lee, S.; Lee, M.-J.; Giaccone, G.; Neckers, L.; Trepel, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1479-1492</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Twenty-five years ago the first small mol. inhibitors of Hsp90 were identified.  In the intervening years there has been dramatic progress in basic scientific understanding of the Hsp90 chaperone machinery and in the role of Hsp90 in malignancy.  The first-in-class Hsp90 inhibitor 17-AAG entered into Phase I clin. trials in 1999.  There are now 13 Hsp90 inhibitors in clin. trial, representing multiple drug classes, and hundreds of patients have been treated in adult oncol. and pediatric oncol. trials.  This review will provide an overview of the clin. trial results thus far.  In addn., pivotal issues in further development of Hsp90 inhibitors as anticancer drugs will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMNnAHRqUDCbVg90H21EOLACvtfcHk0lhFGBKwgBfkfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakurc%253D&md5=7b375c5935176b38d0eeab68d3a0d0e8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F156802609789895728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789895728%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DAlarcon%26aufirst%3DS.%2BV.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.-J.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26atitle%3DUpdate%2520on%2520Hsp90%2520inhibitors%2520in%2520clinical%2520trial%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1479%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Amolins, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S. J.</span><span> </span><span class="NLM_article-title">Natural product inhibitors of Hsp90: potential leads for drug discovery</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=140-152&author=M.+W.+Amolinsauthor=B.+S.+J.+Blagg&title=Natural+product+inhibitors+of+Hsp90%3A+potential+leads+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmolins%26aufirst%3DM.%2BW.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DNatural%2520product%2520inhibitors%2520of%2520Hsp90%253A%2520potential%2520leads%2520for%2520drug%2520discovery%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D140%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Samuni, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyodo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuni, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span> </span><span class="NLM_article-title">Reactive oxygen species mediated hepatotoxicity induced by the Hsp90 inhibiting anti-cancer geldanamycin and its analogs</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1559</span><span class="NLM_x">–</span> <span class="NLM_lpage">1563</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2Fj.freeradbiomed.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20211249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=1559-1563&author=Y.+Samuniauthor=H.+Ishiiauthor=F.+Hyodoauthor=U.+Samuniauthor=M.+C.+Krishnaauthor=S.+Goldsteinauthor=J.+B.+Mitchell&title=Reactive+oxygen+species+mediated+hepatotoxicity+induced+by+the+Hsp90+inhibiting+anti-cancer+geldanamycin+and+its+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs</span></div><div class="casAuthors">Samuni, Yuval; Ishii, Hisanari; Hyodo, Fuminori; Samuni, Uri; Krishna, Murali C.; Goldstein, Sara; Mitchell, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1559-1563</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Geldanamycin (GM), a benzoquinone ansamycin antibiotic, is a natural product inhibitor of Hsp90 with potent and broad anti-cancer properties.  Because of its adverse effects on liver, its less toxic derivs. 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) are currently being evaluated for the treatment of cancer.  Previously, it was demonstrated that the redox cycling of GM by NADPH-cytochrome P 450 reductase leads to the formation of the GM semiquinone and superoxide radicals, the latter being identified using spin-trapping.  We hypothesized that the different hepatotoxicity induced by GM, 17-AAG, and 17-DMAG reflects the redox active properties of the quinone moiety and possibly the extent of superoxide formation, which may stimulate cellular oxidative injury.  Our data demonstrate that superoxide can be efficiently trapped during the redn. of GM, 17-AAG, and 17-DMAG by NADPH-cytochrome P 450 reductase, and that superoxide formation rate followed the order 17-DMAG > 17-AAG > GM.  In the absence of superoxide scavengers, the rate of NADPH oxidn. followed the order 17-DMAG > GM > 17-AAG.  The half-wave one-electron redn. potentials (E1/2) of GM, 17-AAG, and 17-DMAG in DMSO were detd. to be -0.37, -0.13 and -0.015 V (vs. Ag/AgCl), resp.  If the same order of E1/2 follows in neutral aq. media, thermodn. considerations imply that 17-DMAG is more readily reduced by the P 450 reductase as well as by superoxide.  The order of the drug cytotoxicity toward rat primary hepatocytes, as detd. by their effect on cell viability and on intracellular oxidant level, was opposite to the order of E1/2 of the resp. quinone/semiquinone couples.  These results suggest that hepatotoxicity exhibited by the Hsp90 inhibitors belonging to benzoquinone ansamycins could be attributed to superoxide.  The apparent discrepancy between the order of toxicity and the orders of superoxide formation rate, which is correlated with E1/2, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpruuvDYz3MwbVg90H21EOLACvtfcHk0lhFGBKwgBfkfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGru7Y%253D&md5=25d6f75c0c010667a4d9d9be51f67c21</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DSamuni%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DHyodo%26aufirst%3DF.%26aulast%3DSamuni%26aufirst%3DU.%26aulast%3DKrishna%26aufirst%3DM.%2BC.%26aulast%3DGoldstein%26aufirst%3DS.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DReactive%2520oxygen%2520species%2520mediated%2520hepatotoxicity%2520induced%2520by%2520the%2520Hsp90%2520inhibiting%2520anti-cancer%2520geldanamycin%2520and%2520its%2520analogs%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26spage%3D1559%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Cysyk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strong, J. M.</span><span> </span><span class="NLM_article-title">Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx050237e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=376-381&author=R.+L.+Cysykauthor=R.+J.+Parkerauthor=J.+J.+Barchiauthor=P.+S.+Steegauthor=N.+R.+Hartmanauthor=J.+M.+Strong&title=Reaction+of+geldanamycin+and+C17-substituted+analogues+with+glutathione%3A+product+identifications+and+pharmacological+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Ftx050237e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx050237e%26sid%3Dliteratum%253Aachs%26aulast%3DCysyk%26aufirst%3DR.%2BL.%26aulast%3DParker%26aufirst%3DR.%2BJ.%26aulast%3DBarchi%26aufirst%3DJ.%2BJ.%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DHartman%26aufirst%3DN.%2BR.%26aulast%3DStrong%26aufirst%3DJ.%2BM.%26atitle%3DReaction%2520of%2520geldanamycin%2520and%2520C17-substituted%2520analogues%2520with%2520glutathione%253A%2520product%2520identifications%2520and%2520pharmacological%2520implications%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2006%26volume%3D19%26spage%3D376%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span> </span><span class="NLM_article-title">Development of radicicol analogues</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F1568009033481859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=14529387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=359-369&author=S.+Sogaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=S.+Sharma&title=Development+of+radicicol+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radicicol analogues</span></div><div class="casAuthors">Soga, Shiro; Shiotsu, Yukimasa; Akinaga, Shiro; Sharma, Sreenath V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Radicicol, a macrocyclic antibiotic produced by fungi, was originally isolated many years ago, and was described as tyrosine kinase inhibitor.  We also rediscovered radicicol as an inhibitor of signal transduction of oncogene products, such as K-ras and v-Src, using yeast and mammalian cell-based assays.  In a study of mechanisms of action, it was revealed that radicicol depletes the Hsp90 client signaling mols. in cells, and thus inhibit the signal transduction pathway.  In addn., direct binding of radicicol to the N-terminal ATP/ADP binding site of Hsp90 was shown, and thus radicicol has been recognized as a structurally unique antibiotic that binds and inhibits the mol. chaperone Hsp90.  Although radicicol itself has little or no activity in animals because of instability in animals, its oxime derivs. showed potent antitumor activities against human tumor xenograft models.  Hsp90 client proteins were depleted and apoptosis was induced in the tumor specimen treated with radicicol oxime derivs.  Taken together, these results suggest that the antitumor activity of radicicol oxime derivs. is mediated by binding to Hsp90 and destabilization of Hsp90 client proteins in the tumor.  Among Hsp90 clients, we focused on ErbB2 and Bcr-Abl as examples of important targets of Hsp90 inhibitors.  Radicicol oxime showed potent antitumor activity against ER neg./ErbB2 overexpressing breast cancer and Bcr-Abl expressing CML.  Putative mechanisms of action and future directions of radicicol oxime against these kinds of tumor are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uapkd0TYQrVg90H21EOLACvtfcHk0lhhHeZR2CyoMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D&md5=59ef4ec5535cec06665a164be0b12305</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1568009033481859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481859%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520radicicol%2520analogues%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D359%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Winssinger, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barluenga, S.</span><span> </span><span class="NLM_article-title">Chemistry and biology of resorcylic acid lactones</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=22-36&author=N.+Winssingerauthor=S.+Barluenga&title=Chemistry+and+biology+of+resorcylic+acid+lactones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWinssinger%26aufirst%3DN.%26aulast%3DBarluenga%26aufirst%3DS.%26atitle%3DChemistry%2520and%2520biology%2520of%2520resorcylic%2520acid%2520lactones%26jtitle%3DChem.%2520Commun.%26date%3D2007%26spage%3D22%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Geng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danishefsky, S. J.</span><span> </span><span class="NLM_article-title">Synthetic development of radicicol and cycloproparadicicol: highly promising anticancer agents targeting Hsp90</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1325-1333&author=X.+Gengauthor=Z.-Q.+Yangauthor=S.+J.+Danishefsky&title=Synthetic+development+of+radicicol+and+cycloproparadicicol%3A+highly+promising+anticancer+agents+targeting+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DZ.-Q.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26atitle%3DSynthetic%2520development%2520of%2520radicicol%2520and%2520cycloproparadicicol%253A%2520highly%2520promising%2520anticancer%2520agents%2520targeting%2520Hsp90%26jtitle%3DSynlett%26date%3D2004%26spage%3D1325%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Tietze, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span> </span><span class="NLM_article-title">Natural product hybrids as new leads for drug discovery</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3996</span><span class="NLM_x">–</span> <span class="NLM_lpage">4028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1002%2Fanie.200200553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslSlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=3996-4028&author=L.+F.+Tietzeauthor=H.+P.+Bellauthor=S.+Chandrasekhar&title=Natural+product+hybrids+as+new+leads+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product hybrids as new leads for drug discovery</span></div><div class="casAuthors">Tietze, Lutz F.; Bell, Hubertus P.; Chandrasekhar, Srivari</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">3996-4028</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Natural products play an important role in the development of drugs, esp. for the treatment of infections and cancer, as well as immunosuppressive compds.  However, the no. of natural products is limited, whereas millions of hybrids as combinations of parts of different natural products can be prepd.  This new approach seems to be very promising in the development of leads for both medicinal and agrochem. applications, as the biol. activity of several new hybrids exceeds that of the parent compds.  The advantage of this concept over a combinatorial chem. approach is the high diversity and the inherent biol. activity of the hybrids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGTkEzD4p1YbVg90H21EOLACvtfcHk0lhhHeZR2CyoMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslSlsrk%253D&md5=b0582d7a40ce53ce5b957b287b74d750</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fanie.200200553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200200553%26sid%3Dliteratum%253Aachs%26aulast%3DTietze%26aufirst%3DL.%2BF.%26aulast%3DBell%26aufirst%3DH.%2BP.%26aulast%3DChandrasekhar%26aufirst%3DS.%26atitle%3DNatural%2520product%2520hybrids%2520as%2520new%2520leads%2520for%2520drug%2520discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D3996%26epage%3D4028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationships for chimeric inhibitors of Hsp90</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">7618</span><span class="NLM_x">–</span> <span class="NLM_lpage">7631</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo061054f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=7618-7631&author=G.+Shenauthor=M.+Wangauthor=T.+R.+Welchauthor=B.+S.+J.+Blagg&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+for+chimeric+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo061054f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061054f%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWelch%26aufirst%3DT.%2BR.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520for%2520chimeric%2520inhibitors%2520of%2520Hsp90%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D7618%26epage%3D7631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Purine-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1436</span><span class="NLM_x">–</span> <span class="NLM_lpage">1446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F156802609789895737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=19860732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1436-1446&author=T.+Taldoneauthor=G.+Chiosis&title=Purine-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Purine-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">Taldone, Tony; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1436-1446</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a mol. chaperone with important roles in regulating the function of several proteins with potential pathogenic activity.  Because many of these proteins are involved in cancer and neurodegenerative promoting pathways, Hsp90 has emerged as an attractive therapeutic target in these diseases.  Mols. that bind to the N-terminal nucleotide pocket of Hsp90 inhibit its activity, and consequently, disrupt client protein function.  A no. of these inhibitors from several chem. classes are now known, and some are already in clin. trials.  This review focuses on the purine class of Hsp90 inhibitors, their discovery through rational design, and on efforts aimed towards their optimization and development into clin. viable drugs for the treatment of cancer.  Their potential towards neurodegenerative diseases will also be touched upon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLlJs6fJ--rVg90H21EOLACvtfcHk0liUs7t00Ks8KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakurg%253D&md5=346a3ef4c1503aee2d918074c1ecb46c</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.2174%2F156802609789895737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789895737%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DPurine-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1436%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Discovery and development of purine-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F156802606777812013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=16842155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1183-1191&author=G.+Chiosis&title=Discovery+and+development+of+purine-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of purine-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1191</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 allows cancer cells to tolerate the many components of dysregulated pathways in a transformation-specific manner by interacting with several client substrates, such as kinases, hormone receptors and transcription factors that are directly involved in driving multistep malignancy, and also with mutated oncogenic proteins required for the transformed phenotype.  This distinctive broad involvement in maintaining the transformed phenotype has suggested Hsp90 as an important target in cancer therapy.  Discovery of pharmacol. agents that selectively inhibit its function have aided in probing the biol. functions of Hsp90 at the mol. level and in validating it as a novel target for anticancer drug action.  Two natural product derivs., 17-allylamino-17-desmethoxy-geldanamycin (17AAG) and 17-dimethylaminoethylamino-17-desmethoxy-geldanamycin (17DMAG) have further entered clin. trials, proving that Hsp90 may be modulated pharmacol. without causing target related toxicities in humans.  In spite of their usefulness as proof-of-principle compds., the clin. use of these two agents has been encumbered with some limitations due to their structural characteristics and also to less than optimal pharmacol. profiles.  Thus, the identification of Hsp90 inhibitors with improved structural characteristics and better pharmacol. profiles is a major focus of interest in the field.  One such emerging class is the purine-scaffold series.  This review intends to inform the reader on efforts ranging from the discovery to their clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtpMNMTF3zyLVg90H21EOLACvtfcHk0liUs7t00Ks8KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D&md5=f619bbb69cd7ac43a2112d56e5a904f2</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.2174%2F156802606777812013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812013%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520purine-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1183%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0lhdrwDkj79Mwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Orally active purine-based inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=817-828&author=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Hongauthor=D.+C.+Hurstauthor=L.+Zhangauthor=J.+Fanauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=A.+A.+Maldonadoauthor=J.+L.+Sensintaffarauthor=Y.-C.+Yangauthor=A.+Kamalauthor=R.+E.+Loughauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=G.+A.+Timonyauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Orally+active+purine-based+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0503087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503087%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DHurst%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DMaldonado%26aufirst%3DA.%2BA.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.-C.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DOrally%2520active%2520purine-based%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D817%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767-2778&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Zehnder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braganza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovalsantos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wythes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span> </span><span class="NLM_article-title">Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1<i>H</i>-pyrazol-1-yl)ethoxy]-6-methylphenyl}-<i>N</i>-(2,2-difluoropropyl)-5,7-dihydro-6<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxamide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3368</span><span class="NLM_x">–</span> <span class="NLM_lpage">3385</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200128m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3368-3385&author=L.+Zehnderauthor=M.+Bennettauthor=J.+Mengauthor=B.+Huangauthor=S.+Ninkovicauthor=F.+Wangauthor=J.+Braganzaauthor=J.+Tatlockauthor=T.+Jewellauthor=J.+Z.+Zhouauthor=B.+Burkeauthor=J.+Wangauthor=K.+Maegleyauthor=P.+P.+Mehtaauthor=M.-J.+Yinauthor=K.+S.+Gajiwalaauthor=M.+J.+Hickeyauthor=S.+Yamazakiauthor=E.+Smithauthor=P.+Kangauthor=A.+Sistlaauthor=E.+Dovalsantosauthor=M.+R.+Gehringauthor=R.+Kaniaauthor=M.+Wythesauthor=P.-P.+Kung&title=Optimization+of+potent%2C+selective%2C+and+orally+bioavailable+pyrrolodinopyrimidine-containing+inhibitors+of+heat+shock+protein+90.+Identification+of+development+candidate+2-amino-4-%7B4-chloro-2-%5B2-%284-fluoro-1H-pyrazol-1-yl%29ethoxy%5D-6-methylphenyl%7D-N-%282%2C2-difluoropropyl%29-5%2C7-dihydro-6H-pyrrolo%5B3%2C4-d%5Dpyrimidine-6-carboxamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm200128m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200128m%26sid%3Dliteratum%253Aachs%26aulast%3DZehnder%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DBraganza%26aufirst%3DJ.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DJewell%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DJ.%2BZ.%26aulast%3DBurke%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DYin%26aufirst%3DM.-J.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DDovalsantos%26aufirst%3DE.%26aulast%3DGehring%26aufirst%3DM.%2BR.%26aulast%3DKania%26aufirst%3DR.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.-P.%26atitle%3DOptimization%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520pyrrolodinopyrimidine-containing%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090.%2520Identification%2520of%2520development%2520candidate%25202-amino-4-%257B4-chloro-2-%255B2-%25284-fluoro-1H-pyrazol-1-yl%2529ethoxy%255D-6-methylphenyl%257D-N-%25282%252C2-difluoropropyl%2529-5%252C7-dihydro-6H-pyrrolo%255B3%252C4-d%255Dpyrimidine-6-carboxamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3368%26epage%3D3385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackman, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acquaviva, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, K.</span><span> </span><span class="NLM_article-title">Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1158%2F1535-7163.MCT-11-0755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=22144665" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=475-484&author=W.+Yingauthor=Z.+Duauthor=L.+Sunauthor=K.+P.+Foleyauthor=D.+A.+Proiaauthor=R.+K.+Blackmanauthor=D.+Zhouauthor=T.+Inoueauthor=N.+Tatsutaauthor=J.+Sangauthor=S.+Yeauthor=J.+Acquavivaauthor=L.+S.+Ogawaauthor=Y.+Wadaauthor=J.+Barsoumauthor=K.+Koya&title=Ganetespib%2C+a+unique+triazolone-containing+Hsp90+inhibitor%2C+exhibits+potent+antitumor+activity+and+a+superior+safety+profile+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0755%26sid%3Dliteratum%253Aachs%26aulast%3DYing%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DProia%26aufirst%3DD.%2BA.%26aulast%3DBlackman%26aufirst%3DR.%2BK.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DAcquaviva%26aufirst%3DJ.%26aulast%3DOgawa%26aufirst%3DL.%2BS.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DKoya%26aufirst%3DK.%26atitle%3DGanetespib%252C%2520a%2520unique%2520triazolone-containing%2520Hsp90%2520inhibitor%252C%2520exhibits%2520potent%2520antitumor%2520activity%2520and%2520a%2520superior%2520safety%2520profile%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D11%26spage%3D475%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span> </span><span class="NLM_article-title">Medicinal chemistry strategies in follow-on drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=516-522&author=H.+Zhaoauthor=Z.+Guo&title=Medicinal+chemistry+strategies+in+follow-on+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DMedicinal%2520chemistry%2520strategies%2520in%2520follow-on%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D516%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bajji, A.; Kim, S.-H.; Tangallapally, R.; Markovitz, B.; Trovato, R.; Anderson, M. B.; Wettstein, D.; Shenderovich, M.</span><span> </span><span class="NLM_article-title">Therapeutic Compounds and Their Use in Treating Diseases and Disorders</span>. WO 2009/065035,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+Bajji&author=S.-H.+Kim&author=R.+Tangallapally&author=B.+Markovitz&author=R.+Trovato&author=M.+B.+Anderson&author=D.+Wettstein&author=M.+Shenderovich&title=Therapeutic+Compounds+and+Their+Use+in+Treating+Diseases+and+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBajji%26aufirst%3DA.%26atitle%3DTherapeutic%2520Compounds%2520and%2520Their%2520Use%2520in%2520Treating%2520Diseases%2520and%2520Disorders%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bajji, A.; Kim, S.-H.; Markovitz, B.; Trovato, R.; Tangallapally, R.; Anderson, M. B.; Wettstein, D.; Shenderovich, M.; Vanecko, J. A.</span><span> </span><span class="NLM_article-title">Therapeutic Compounds and Their Use in Cancer</span>. WO 2007/134298,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Bajji&author=S.-H.+Kim&author=B.+Markovitz&author=R.+Trovato&author=R.+Tangallapally&author=M.+B.+Anderson&author=D.+Wettstein&author=M.+Shenderovich&author=J.+A.+Vanecko&title=Therapeutic+Compounds+and+Their+Use+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBajji%26aufirst%3DA.%26atitle%3DTherapeutic%2520Compounds%2520and%2520Their%2520Use%2520in%2520Cancer%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Legraverend, M.</span><span> </span><span class="NLM_article-title">Recent advances in the synthesis of purine derivatives and their precursors</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">8585</span><span class="NLM_x">–</span> <span class="NLM_lpage">8603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=8585-8603&author=M.+Legraverend&title=Recent+advances+in+the+synthesis+of+purine+derivatives+and+their+precursors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegraverend%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520the%2520synthesis%2520of%2520purine%2520derivatives%2520and%2520their%2520precursors%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26spage%3D8585%26epage%3D8603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">General method for the synthesis of 8-arylsulfanyl adenine derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3230</span><span class="NLM_x">–</span> <span class="NLM_lpage">3232</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049875c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3230-3232&author=H.+Heauthor=L.+Llaugerauthor=N.+Rosenauthor=G.+Chiosis&title=General+method+for+the+synthesis+of+8-arylsulfanyl+adenine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo049875c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049875c%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DGeneral%2520method%2520for%2520the%2520synthesis%2520of%25208-arylsulfanyl%2520adenine%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D3230%26epage%3D3232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Preparation of 8-(arylsulfanyl)adenines with diazonium salts under mild, aerobic conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">720</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo048522a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=717-720&author=M.+A.+Biamonteauthor=J.+Shiauthor=D.+Hurstauthor=K.+Hongauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Preparation+of+8-%28arylsulfanyl%29adenines+with+diazonium+salts+under+mild%2C+aerobic+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo048522a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo048522a%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DPreparation%2520of%25208-%2528arylsulfanyl%2529adenines%2520with%2520diazonium%2520salts%2520under%2520mild%252C%2520aerobic%2520conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D717%26epage%3D720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2892</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049012b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2892-2905&author=L.+Llaugerauthor=H.+Heauthor=J.+Kimauthor=J.+Aguirreauthor=N.+Rosenauthor=U.+Petersauthor=P.+Daviesauthor=G.+Chiosis&title=Evaluation+of+8-arylsulfanyl%2C+8-arylsulfoxyl%2C+and+8-arylsulfonyl+adenine+derivatives+as+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm049012b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049012b%26sid%3Dliteratum%253Aachs%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DEvaluation%2520of%25208-arylsulfanyl%252C%25208-arylsulfoxyl%252C%2520and%25208-arylsulfonyl%2520adenine%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2892%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Takamuro, I.; Sekine, Y.; Tsuboi, Y.; Nogi, K.; Taniguchi, H.</span><span> </span><span class="NLM_article-title">Preparation of Pyrazolopyrimidines as a Small Conductance Potassium Channel (SK Channel) Blocking Agents</span>. WO 2004064721,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=I.+Takamuro&author=Y.+Sekine&author=Y.+Tsuboi&author=K.+Nogi&author=H.+Taniguchi&title=Preparation+of+Pyrazolopyrimidines+as+a+Small+Conductance+Potassium+Channel+%28SK+Channel%29+Blocking+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakamuro%26aufirst%3DI.%26atitle%3DPreparation%2520of%2520Pyrazolopyrimidines%2520as%2520a%2520Small%2520Conductance%2520Potassium%2520Channel%2520%2528SK%2520Channel%2529%2520Blocking%2520Agents%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jablonowski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. K.</span><span> </span><span class="NLM_article-title">A scalable synthesis of a histamine H3 receptor antagonist</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8115</span><span class="NLM_x">–</span> <span class="NLM_lpage">8117</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo040225i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=8115-8117&author=N.+Maniauthor=J.+A.+Jablonowskiauthor=T.+K.+Jones&title=A+scalable+synthesis+of+a+histamine+H3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=10.1021%2Fjo040225i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo040225i%26sid%3Dliteratum%253Aachs%26aulast%3DMani%26aufirst%3DN.%26aulast%3DJablonowski%26aufirst%3DJ.%2BA.%26aulast%3DJones%26aufirst%3DT.%2BK.%26atitle%3DA%2520scalable%2520synthesis%2520of%2520a%2520histamine%2520H3%2520receptor%2520antagonist%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D8115%26epage%3D8117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Brown, T. H.; Cooper, D. G.</span><span> </span><span class="NLM_article-title"><i>N</i>-Hydrocarbyl-4-Substituted Piperidines, Their Preparation and Use as Calcium Blocking Agents</span>. WO 9202502,<span class="NLM_x"> </span><span class="NLM_year">1992</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&author=T.+H.+Brown&author=D.+G.+Cooper&title=N-Hydrocarbyl-4-Substituted+Piperidines%2C+Their+Preparation+and+Use+as+Calcium+Blocking+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DT.%2BH.%26atitle%3DN-Hydrocarbyl-4-Substituted%2520Piperidines%252C%2520Their%2520Preparation%2520and%2520Use%2520as%2520Calcium%2520Blocking%2520Agents%26date%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sonesson, C.; Swanson, L.; Waters, N.</span><span> </span><span class="NLM_article-title">Preparation of Disubstituted Phenylpiperidines/Piperazines as Modulators of Dopamine Neurotransmission</span>. WO 2005121087,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=C.+Sonesson&author=L.+Swanson&author=N.+Waters&title=Preparation+of+Disubstituted+Phenylpiperidines%2FPiperazines+as+Modulators+of+Dopamine+Neurotransmission"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSonesson%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520Disubstituted%2520Phenylpiperidines%252FPiperazines%2520as%2520Modulators%2520of%2520Dopamine%2520Neurotransmission%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lemoine, R.; Melville, C. R.; Rotstein, D. M.; Wanner, J.</span><span> </span><span class="NLM_article-title">Octahydropyrrolo[3,4-<i>c</i>]pyrrole Derivatives as Antiviral Agents and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of HIV Infection</span>. WO 2008034731,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=R.+Lemoine&author=C.+R.+Melville&author=D.+M.+Rotstein&author=J.+Wanner&title=Octahydropyrrolo%5B3%2C4-c%5Dpyrrole+Derivatives+as+Antiviral+Agents+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+HIV+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLemoine%26aufirst%3DR.%26atitle%3DOctahydropyrrolo%255B3%252C4-c%255Dpyrrole%2520Derivatives%2520as%2520Antiviral%2520Agents%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520HIV%2520Infection%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Blake, J.; Boyd, S.; De Meese, J.; Gaudino, J. J.; Marlow, A.; Seo, J.; Thomas, A.; Tian, H.</span><span> </span><span class="NLM_article-title">Heterobicyclic Thiophene Compounds as Tyrosine Kinase Inhibitors and Their Preparation and Use</span>. U.S. Patent 20070197537 A1, August 23,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+Blake&author=S.+Boyd&author=J.+De+Meese&author=J.+J.+Gaudino&author=A.+Marlow&author=J.+Seo&author=A.+Thomas&author=H.+Tian&title=Heterobicyclic+Thiophene+Compounds+as+Tyrosine+Kinase+Inhibitors+and+Their+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DJ.%26atitle%3DHeterobicyclic%2520Thiophene%2520Compounds%2520as%2520Tyrosine%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Batey, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. A.</span><span> </span><span class="NLM_article-title">A general synthetic method for the formation of substituted 5-aminotetrazoles from thioureas: a strategy for diversity amplication</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3237</span><span class="NLM_x">–</span> <span class="NLM_lpage">3240</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol006465b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3237-3240&author=R.+A.+Bateyauthor=D.+A.+Powell&title=A+general+synthetic+method+for+the+formation+of+substituted+5-aminotetrazoles+from+thioureas%3A+a+strategy+for+diversity+amplication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fol006465b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006465b%26sid%3Dliteratum%253Aachs%26aulast%3DBatey%26aufirst%3DR.%2BA.%26aulast%3DPowell%26aufirst%3DD.%2BA.%26atitle%3DA%2520general%2520synthetic%2520method%2520for%2520the%2520formation%2520of%2520substituted%25205-aminotetrazoles%2520from%2520thioureas%253A%2520a%2520strategy%2520for%2520diversity%2520amplication%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D3237%26epage%3D3240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">A general palladium-catalyzed coupling of aryl bromides/triflates and thiols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4587</span><span class="NLM_x">–</span> <span class="NLM_lpage">4590</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol047996t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVartbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4587-4590&author=T.+Itohauthor=T.+Mase&title=A+general+palladium-catalyzed+coupling+of+aryl+bromides%2Ftriflates+and+thiols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">A general palladium-catalyzed coupling of aryl bromides/triflates and thiols</span></div><div class="casAuthors">Itoh, Takahiro; Mase, Toshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4587-4590</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient palladium-catalyzed carbon-sulfur bond formation reaction of aryl bromides, triflates, and activated aryl chloride have been developed.  The reaction showed tolerance to a wide variety of aryl thiols and alkyl thiols which gave aryl sulfides, e.g., I, in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ47wzYjppQ7Vg90H21EOLACvtfcHk0ljlfg23pWQMJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVartbg%253D&md5=a58e03f1934099065cf2500c276d89a1</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1021%2Fol047996t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol047996t%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DA%2520general%2520palladium-catalyzed%2520coupling%2520of%2520aryl%2520bromides%252Ftriflates%2520and%2520thiols%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4587%26epage%3D4590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">A novel practical synthesis of benzothiazoles via Pd-catalyzed thiol cross-coupling</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3687</span><span class="NLM_x">–</span> <span class="NLM_lpage">3689</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol7015737" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3687-3689&author=T.+Itohauthor=T.+Mase&title=A+novel+practical+synthesis+of+benzothiazoles+via+Pd-catalyzed+thiol+cross-coupling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1021%2Fol7015737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol7015737%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DA%2520novel%2520practical%2520synthesis%2520of%2520benzothiazoles%2520via%2520Pd-catalyzed%2520thiol%2520cross-coupling%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D3687%26epage%3D3689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">Practical thiol surrogates and protective groups for arylthiols for Suzuki–Miyaura conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2206</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo052624z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=2203-2206&author=T.+Itohauthor=T.+Mase&title=Practical+thiol+surrogates+and+protective+groups+for+arylthiols+for+Suzuki%E2%80%93Miyaura+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48c&amp;dbid=16384&amp;doi=10.1021%2Fjo052624z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052624z%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DPractical%2520thiol%2520surrogates%2520and%2520protective%2520groups%2520for%2520arylthiols%2520for%2520Suzuki%25E2%2580%2593Miyaura%2520conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D2203%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Maitro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madec, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, G.</span><span> </span><span class="NLM_article-title">Aryl sulfoxides via palladium-catalyzed arylation of sulfenate anions</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">5951</span><span class="NLM_x">–</span> <span class="NLM_lpage">5954</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol062315a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Clu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=5951-5954&author=G.+Maitroauthor=S.+Vogelauthor=G.+Prestatauthor=D.+Madecauthor=G.+Poli&title=Aryl+sulfoxides+via+palladium-catalyzed+arylation+of+sulfenate+anions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl sulfoxides via palladium-catalyzed arylation of sulfenate anions</span></div><div class="casAuthors">Maitro, Guillaume; Vogel, Sophie; Prestat, Guillaume; Madec, David; Poli, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">5951-5954</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Palladium-catalyzed arylation of sulfenate anions generated from β-sulfinyl esters could take place under biphasic conditions.  This hitherto unknown reaction provided a simple, mild, and efficient route to aryl sulfoxides in good yields.  The development of a new pseudo-domino type I procedure involving a sulfinylation followed by a Mizoroki-Heck coupling was also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzlq8BhIJoBbVg90H21EOLACvtfcHk0lglkCemfAtRGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Clu73E&md5=f7ec863ab9c9efa434421a53921db94a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol062315a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol062315a%26sid%3Dliteratum%253Aachs%26aulast%3DMaitro%26aufirst%3DG.%26aulast%3DVogel%26aufirst%3DS.%26aulast%3DPrestat%26aufirst%3DG.%26aulast%3DMadec%26aufirst%3DD.%26aulast%3DPoli%26aufirst%3DG.%26atitle%3DAryl%2520sulfoxides%2520via%2520palladium-catalyzed%2520arylation%2520of%2520sulfenate%2520anions%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D5951%26epage%3D5954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Oberhauser, T. A</span><span> </span><span class="NLM_article-title">New bromination method for phenols and anisoles: NBS/HBF<sub>4</sub>·Et<sub>2</sub>O in AcCN</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4504</span><span class="NLM_x">–</span> <span class="NLM_lpage">4506</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9622993" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=4504-4506&author=T.+A+Oberhauser&title=New+bromination+method+for+phenols+and+anisoles%3A+NBS%2FHBF4%C2%B7Et2O+in+AcCN"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo9622993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9622993%26sid%3Dliteratum%253Aachs%26aulast%3DOberhauser%26aufirst%3DT.%2BA%26atitle%3DNew%2520bromination%2520method%2520for%2520phenols%2520and%2520anisoles%253A%2520NBS%252FHBF4%25C2%25B7Et2O%2520in%2520AcCN%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D4504%26epage%3D4506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Song, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschaen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabowski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volante, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">Practical asymmetric synthesis of a selective endothelin A receptor (ETA) antagonist</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">3357</span><span class="NLM_x">–</span> <span class="NLM_lpage">3360</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol016601s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=3357-3360&author=Z.+J.+Songauthor=M.+Zhaoauthor=L.+Freyauthor=J.+Liauthor=L.+Tanauthor=C.+Y.+Chenauthor=D.+M.+Tschaenauthor=R.+Tillyerauthor=E.+J.+Grabowskiauthor=R.+Volanteauthor=P.+J.+Reiderauthor=Y.+Katoauthor=S.+Okadaauthor=T.+Nemotoauthor=H.+Satoauthor=A.+Akaoauthor=T.+Mase&title=Practical+asymmetric+synthesis+of+a+selective+endothelin+A+receptor+%28ETA%29+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol016601s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol016601s%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DZ.%2BJ.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DFrey%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DTillyer%26aufirst%3DR.%26aulast%3DGrabowski%26aufirst%3DE.%2BJ.%26aulast%3DVolante%26aufirst%3DR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DNemoto%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DAkao%26aufirst%3DA.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DPractical%2520asymmetric%2520synthesis%2520of%2520a%2520selective%2520endothelin%2520A%2520receptor%2520%2528ETA%2529%2520antagonist%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D3357%26epage%3D3360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Kim, S.-H.; Trovato, R.; Markovitz, B.; Vanecko, J.; Shenderovich, M.; Robinson, R.; McKinnon, R.; Alberts, G.; Austin, H.; Cimbora, D.; Baichwal, V.; Papac, D.; Wettstein, D.; Bajji, A.; Yager, K. M.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kim%2C+S.-H.%3B+Trovato%2C+R.%3B+Markovitz%2C+B.%3B+Vanecko%2C+J.%3B+Shenderovich%2C+M.%3B+Robinson%2C+R.%3B+McKinnon%2C+R.%3B+Alberts%2C+G.%3B+Austin%2C+H.%3B+Cimbora%2C+D.%3B+Baichwal%2C+V.%3B+Papac%2C+D.%3B+Wettstein%2C+D.%3B+Bajji%2C+A.%3B+Yager%2C+K.+M.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.-H." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Regina, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavecchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Befani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostinelli, E.</span><span> </span><span class="NLM_article-title">New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">922</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=922-931&author=G.+L.+Reginaauthor=R.+Silvestriauthor=M.+Articoauthor=A.+Lavecchiaauthor=E.+Novellinoauthor=O.+Befaniauthor=P.+Turiniauthor=E.+Agostinelli&title=New+pyrrole+inhibitors+of+monoamine+oxidase%3A+synthesis%2C+biological+evaluation%2C+and+structural+determinants+of+MAO-A+and+MAO-B+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRegina%26aufirst%3DG.%2BL.%26aulast%3DSilvestri%26aufirst%3DR.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DLavecchia%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DAgostinelli%26aufirst%3DE.%26atitle%3DNew%2520pyrrole%2520inhibitors%2520of%2520monoamine%2520oxidase%253A%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520structural%2520determinants%2520of%2520MAO-A%2520and%2520MAO-B%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D922%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit55a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Watson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span> </span><span class="NLM_article-title">A diastereoselective synthesis of 2,4-disubstituted piperidines: scaffolds for drug discovery</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3679</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol006589o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVaktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3679&author=P.+S.+Watsonauthor=B.+Jiangauthor=B.+Scott&title=A+diastereoselective+synthesis+of+2%2C4-disubstituted+piperidines%3A+scaffolds+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55aR"><div class="casContent"><span class="casTitleNuber">54a</span><div class="casTitle"><span class="NLM_cas:atitle">A Diastereoselective Synthesis of 2,4-Disubstituted Piperidines: Scaffolds for Drug Discovery</span></div><div class="casAuthors">Watson, Paul S.; Jiang, Bin; Scott, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3679-3681</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The piperidines I [R = allyl, CHMe2, CH2Ph; R1 = Ph, CO2Et, 4-CbzNHC6H4] were prepd. from 4-methoxypyridine and were reduced stereoselectively.  Li-NH3 redn., followed by deblocking gave trans-disubstituted piperidines II [R2 = Ph, CH2OH], whereas deblocking, followed by redn. gave cis-II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ZCVtcb80zLVg90H21EOLACvtfcHk0ljPdK9Ws5_H_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVaktrk%253D&md5=53f3c6af3a76c2a5aa14ddc5f65e35b2</span></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1021%2Fol006589o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006589o%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DP.%2BS.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DB.%26atitle%3DA%2520diastereoselective%2520synthesis%2520of%25202%252C4-disubstituted%2520piperidines%253A%2520scaffolds%2520for%2520drug%2520discovery%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D3679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Weintraub, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabol, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borcherding, D. R.</span><span> </span><span class="NLM_article-title">Recent advances in the synthesis of piperidones and piperidines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2FS0040-4020%2803%2900295-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFCjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=2953&author=P.+M.+Weintraubauthor=J.+S.+Sabolauthor=J.+M.+Kaneauthor=D.+R.+Borcherding&title=Recent+advances+in+the+synthesis+of+piperidones+and+piperidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55bR"><div class="casContent"><span class="casTitleNuber">54b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the synthesis of piperidones and piperidines</span></div><div class="casAuthors">Weintraub, Philip M.; Sabol, Jeffrey S.; Kane, John M.; Borcherding, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2953-2989</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeTP7idpcAM7Vg90H21EOLACvtfcHk0lgjklBdz2q8cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFCjsL8%253D&md5=bbf687c328825595af2a3ca779916398</span></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2803%2900295-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252803%252900295-3%26sid%3Dliteratum%253Aachs%26aulast%3DWeintraub%26aufirst%3DP.%2BM.%26aulast%3DSabol%26aufirst%3DJ.%2BS.%26aulast%3DKane%26aufirst%3DJ.%2BM.%26aulast%3DBorcherding%26aufirst%3DD.%2BR.%26atitle%3DRecent%2520advances%2520in%2520the%2520synthesis%2520of%2520piperidones%2520and%2520piperidines%26jtitle%3DTetrahedron%26date%3D2003%26volume%3D59%26spage%3D2953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Raub, T. J.</span><span> </span><span class="NLM_article-title">P-Glycoprotein recognition of substrates and circumvention through rational drug design</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp0500871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=3-25&author=T.+J.+Raub&title=P-Glycoprotein+recognition+of+substrates+and+circumvention+through+rational+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design</span></div><div class="casAuthors">Raub, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is now well recognized that membrane efflux transporters, esp. P-glycoprotein (P-gp; ABCB1), play a role in detg. the absorption, distribution, metab., excretion, and toxicol. behaviors of some drugs and mols. in development.  An investment in screening structure-activity relation (SAR) is warranted in early discovery when exposure and/or target activity in an in vivo efficacy model is not achieved and P-gp efflux is identified as a rate-limiting factor.  However, the amt. of investment in SAR must be placed into perspective by assessing the risks assocd. with the intended therapeutic target, the potency and margin of safety of the compd., the intended patient population(s), and the market competition.  The task of rationally designing a chem. strategy for circumventing a limiting P-gp interaction can be daunting.  The necessity of retaining biol. potency and metabolic stability places restrictions on what can be done, and the factors for P-gp recognition of substrates are complicated and poorly understood.  The parameters within the assays that affect overall pump efficiency or net efflux, such as passive diffusion, membrane partitioning, and mol. interaction between pump and substrate, should be understood when interpreting data sets assocd. with chem. around a scaffold.  No single, functional group alone is often the cause, but one group can accentuate the recognition points existing within a scaffold.  This can be likened to a rheostat, rather than an on/off switch, where addn. or removal of a key group can increase or decrease the pumping efficiency.  The most practical approach to de-emphasize the limiting effects of P-gp on a particular scaffold is to increase passive diffusion.  Efflux pumping efficiency may be overcome when passive diffusion is fast enough.  Eliminating, or substituting with fewer, groups that solvate in water, or decreasing their hydrogen bonding capacity, and adding halogen groups can increase passive diffusion.  Reducing mol. size, replacing electroneg. atoms, blocking or masking H-bond donors with N-alkylation or bulky flanking groups, introducing constrained conformation, or by promoting intramol. hydrogen bonds are all examples of steps to take.  This review discusses our understanding of how P-gp recognizes and pumps compds. as substrates and describes cases where structural changes were made in a chem. scaffold to circumvent the effects of P-gp interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRbEgPosNnxrVg90H21EOLACvtfcHk0lgjklBdz2q8cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP&md5=cc89be920dfa0e32edb994be94626aa5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fmp0500871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp0500871%26sid%3Dliteratum%253Aachs%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DP-Glycoprotein%2520recognition%2520of%2520substrates%2520and%2520circumvention%2520through%2520rational%2520drug%2520design%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2006%26volume%3D3%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Delorme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducharme, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubé, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lépine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAuliffe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarlane, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffithh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yergey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, Y.</span><span> </span><span class="NLM_article-title">Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure–activity relationship study directed toward the improvement of metabolic stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3951</span><span class="NLM_x">–</span> <span class="NLM_lpage">3970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960301c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=3951-3970&author=D.+Delormeauthor=Y.+Ducharmeauthor=C.+Brideauauthor=C.-C.+Chanauthor=N.+Chauretauthor=S.+Desmaraisauthor=D.+Dub%C3%A9author=J.-P.+Falgueyretauthor=R.+Fortinauthor=J.+Guayauthor=P.+Hamelauthor=T.+R.+Jonesauthor=C.+L%C3%A9pineauthor=C.+Liauthor=M.+McAuliffeauthor=C.+S.+McFarlaneauthor=D.+A.+Nicoll-Griffithhauthor=D.+Riendeauauthor=J.+A.+Yergeyauthor=Y.+Girard&title=Dioxabicyclooctanyl+naphthalenenitriles+as+nonredox+5-lipoxygenase+inhibitors%3A+structure%E2%80%93activity+relationship+study+directed+toward+the+improvement+of+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm960301c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960301c%26sid%3Dliteratum%253Aachs%26aulast%3DDelorme%26aufirst%3DD.%26aulast%3DDucharme%26aufirst%3DY.%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DC.-C.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDub%25C3%25A9%26aufirst%3DD.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DFortin%26aufirst%3DR.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DL%25C3%25A9pine%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMcAuliffe%26aufirst%3DM.%26aulast%3DMcFarlane%26aufirst%3DC.%2BS.%26aulast%3DNicoll-Griffithh%26aufirst%3DD.%2BA.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DYergey%26aufirst%3DJ.%2BA.%26aulast%3DGirard%26aufirst%3DY.%26atitle%3DDioxabicyclooctanyl%2520naphthalenenitriles%2520as%2520nonredox%25205-lipoxygenase%2520inhibitors%253A%2520structure%25E2%2580%2593activity%2520relationship%2520study%2520directed%2520toward%2520the%2520improvement%2520of%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D3951%26epage%3D3970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit58a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodeoka, M.</span><span> </span><span class="NLM_article-title">Stereocontrolled and convergent entry to CF<sub>2</sub>-sialosides: synthesis of CF<sub>2</sub>-linked ganglioside GM4</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">15420</span><span class="NLM_x">–</span> <span class="NLM_lpage">15421</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja075738w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=15420-15421&author=G.+Hiraiauthor=T.+Watanabeauthor=K.+Yamaguchiauthor=T.+Miyagiauthor=M.+Sodeoka&title=Stereocontrolled+and+convergent+entry+to+CF2-sialosides%3A+synthesis+of+CF2-linked+ganglioside+GM4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58a&amp;dbid=16384&amp;doi=10.1021%2Fja075738w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja075738w%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DG.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DSodeoka%26aufirst%3DM.%26atitle%3DStereocontrolled%2520and%2520convergent%2520entry%2520to%2520CF2-sialosides%253A%2520synthesis%2520of%2520CF2-linked%2520ganglioside%2520GM4%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D15420%26epage%3D15421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit58b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Prakash, G. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zibinsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oertell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shock, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, G. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of fluorinated deoxynucleotide analogs based on bis-(difluoromethylene)triphosphoric acid</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">15693</span><span class="NLM_x">–</span> <span class="NLM_lpage">15698</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=15693-15698&author=G.+K.+S.+Prakashauthor=M.+Zibinskyauthor=T.+G.+Uptonauthor=B.+A.+Kashemirovauthor=C.+E.+McKennaauthor=K.+Oertellauthor=M.+F.+Goodmanauthor=V.+Batraauthor=L.+C.+Pedersenauthor=W.+A.+Beardauthor=D.+D.+Shockauthor=S.+H.+Wilsonauthor=G.+A.+Olah&title=Synthesis+and+biological+evaluation+of+fluorinated+deoxynucleotide+analogs+based+on+bis-%28difluoromethylene%29triphosphoric+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrakash%26aufirst%3DG.%2BK.%2BS.%26aulast%3DZibinsky%26aufirst%3DM.%26aulast%3DUpton%26aufirst%3DT.%2BG.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26aulast%3DOertell%26aufirst%3DK.%26aulast%3DGoodman%26aufirst%3DM.%2BF.%26aulast%3DBatra%26aufirst%3DV.%26aulast%3DPedersen%26aufirst%3DL.%2BC.%26aulast%3DBeard%26aufirst%3DW.%2BA.%26aulast%3DShock%26aufirst%3DD.%2BD.%26aulast%3DWilson%26aufirst%3DS.%2BH.%26aulast%3DOlah%26aufirst%3DG.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520fluorinated%2520deoxynucleotide%2520analogs%2520based%2520on%2520bis-%2528difluoromethylene%2529triphosphoric%2520acid%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D15693%26epage%3D15698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4953</span><span class="NLM_x">–</span> <span class="NLM_lpage">4960</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060297x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4953-4960&author=R.+M.+Immorminoauthor=Y.+Kangauthor=G.+Chiosisauthor=D.+T.+Gewirth&title=Structural+and+quantum+chemical+studies+of+8-aryl-sulfanyl+adenine+class+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm060297x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060297x%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructural%2520and%2520quantum%2520chemical%2520studies%2520of%25208-aryl-sulfanyl%2520adenine%2520class%2520Hsp90%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4953%26epage%3D4960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Brazidec, J. -Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">7′-Substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5352</span><span class="NLM_x">–</span> <span class="NLM_lpage">5362</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051146h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5352-5362&author=L.+Zhangauthor=J.+Fanauthor=K.+Vuauthor=K.+Hongauthor=J.+-Y.+Le+Brazidecauthor=J.+Shiauthor=M.+Biamonteauthor=D.+J.+Buschauthor=R.+E.+Loughauthor=R.+Greckoauthor=Y.+Ranauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=R.+Mansfieldauthor=G.+A.+Timonyauthor=E.+H.+Ulmauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehm&title=7%E2%80%B2-Substituted+benzothiazolothio-+and+pyridinothiazolothio-purines+as+potent+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm051146h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051146h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DVu%26aufirst%3DK.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DLe%2BBrazidec%26aufirst%3DJ.%2B-Y.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DBiamonte%26aufirst%3DM.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DUlm%26aufirst%3DE.%2BH.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3D7%25E2%2580%25B2-Substituted%2520benzothiazolothio-%2520and%2520pyridinothiazolothio-purines%2520as%2520potent%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5352%26epage%3D5362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0ljBmpn2_GBqLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Lima, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a useful strategy for molecular modification and drug design</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F0929867053363540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=15638729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=23-49&author=L.+M.+Limaauthor=E.+J.+Barreiro&title=Bioisosterism%3A+a+useful+strategy+for+molecular+modification+and+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A useful strategy for molecular modification and drug design</span></div><div class="casAuthors">Lima, Lidia Moreira; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-49</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review aims to demonstrate the role of bioisosterism in rational drug design as well as in the mol. modification and optimization process aiming to improve pharmacodynamic and pharmacokinetic properties of lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe7625guUbh7Vg90H21EOLACvtfcHk0ljBmpn2_GBqLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOrug%253D%253D&md5=4836e1d51143b240e357548b39f04251</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F0929867053363540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867053363540%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DL.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520useful%2520strategy%2520for%2520molecular%2520modification%2520and%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D23%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Tasker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jae, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Geldern, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calzadila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">WuWong, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opgenorth, T. J.</span><span> </span><span class="NLM_article-title">Potent and selective non-benzodioxole-containing endothelin-A receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960077r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=322-330&author=A.+S.+Taskerauthor=B.+K.+Sorensenauthor=H.+S.+Jaeauthor=M.+Winnauthor=T.+W.+von+Geldernauthor=D.+B.+Dixonauthor=W.+J.+Chiouauthor=B.+D.+Daytonauthor=S.+Calzadilaauthor=L.+Hernandezauthor=K.+C.+Marshauthor=J.+R.+WuWongauthor=T.+J.+Opgenorth&title=Potent+and+selective+non-benzodioxole-containing+endothelin-A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm960077r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960077r%26sid%3Dliteratum%253Aachs%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DSorensen%26aufirst%3DB.%2BK.%26aulast%3DJae%26aufirst%3DH.%2BS.%26aulast%3DWinn%26aufirst%3DM.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26aulast%3DDixon%26aufirst%3DD.%2BB.%26aulast%3DChiou%26aufirst%3DW.%2BJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DCalzadila%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DWuWong%26aufirst%3DJ.%2BR.%26aulast%3DOpgenorth%26aufirst%3DT.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520non-benzodioxole-containing%2520endothelin-A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D322%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Murray, M.</span><span> </span><span class="NLM_article-title">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F1389200003339270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=11467081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=67-84&author=M.+Murray&title=Mechanisms+of+inhibitory+and+regulatory+effects+of+methylenedioxyphenyl+compounds+on+cytochrome+P450-dependent+drug+oxidation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span></div><div class="casAuthors">Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-84</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 110 refs.  Cytochrome P 450 (CYP) enzymes catalyze the oxidative conversion of drugs and other lipophilic compds. to hydrophilic metabolites.  Thus, CYPs play a dominant role in the elimination of drugs from the body.  Inhibitory interactions occur when drugs compete for oxidn. by specific CYPs, whereas certain drugs increase the capacity for oxidative biotransformation by inducing the synthesis of new CYPs.  Methylenedioxyphenyl (MDP) compds. have been widely employed as com. important pesticide synergists and a no. of derivs. are found in oils and spices.  MDP compds. are of considerable toxicol. significance because of their capacity to inhibit and induce CYP enzymes in mammals; some derivs. produce neurotoxic and hepatotoxic effects.  Although there are relatively few therapeutic agents of present clin. importance that possess the MDP structural feature, the synthesis and preclin. evaluation of such agents appears to be increasing.  In the context of the existing literature surrounding MDP compds. it is noteworthy that these potential drugs also elicit significant modulatory effects on CYP activities in rat and human liver.  These developments indicate the importance of understanding the chem. mechanisms by which MDPs interact with CYPs.  Thus, the presence of the MDP structure may undermine the potential clin. value of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYAjGf6nf5ZbVg90H21EOLACvtfcHk0ljBmpn2_GBqLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D&md5=dcafc824c8bcd0080d256d6dd8c50ae7</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.2174%2F1389200003339270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200003339270%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520inhibitory%2520and%2520regulatory%2520effects%2520of%2520methylenedioxyphenyl%2520compounds%2520on%2520cytochrome%2520P450-dependent%2520drug%2520oxidation%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2000%26volume%3D1%26spage%3D67%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Trachsel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadorn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumberger, F.</span><span> </span><span class="NLM_article-title">Synthesis of fluoro analogues of 3,4-(methylenedioxy)amphetamine (MDA) and its derivatives</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=326-336&author=D.+Trachselauthor=M.+Hadornauthor=F.+Baumberger&title=Synthesis+of+fluoro+analogues+of+3%2C4-%28methylenedioxy%29amphetamine+%28MDA%29+and+its+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrachsel%26aufirst%3DD.%26aulast%3DHadorn%26aufirst%3DM.%26aulast%3DBaumberger%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520fluoro%2520analogues%2520of%25203%252C4-%2528methylenedioxy%2529amphetamine%2520%2528MDA%2529%2520and%2520its%2520derivatives%26jtitle%3DChem.%2520Biodiversity%26date%3D2006%26volume%3D3%26spage%3D326%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Davies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span> </span><span class="NLM_article-title">Physiological parameters in laboratory animals and humans</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1023%2FA%3A1018943613122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=8378254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=1093-1095&author=B.+Daviesauthor=T.+Morris&title=Physiological+parameters+in+laboratory+animals+and+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological parameters in laboratory animals and humans</span></div><div class="casAuthors">Davies B; Morris T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-5</span>
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDDwka3A6hEYYPsCkJIw00fW6udTcc2ebi12N-537P9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D&md5=094cdd17306b58cc17c8cf4fd5db9927</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018943613122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018943613122%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%26atitle%3DPhysiological%2520parameters%2520in%2520laboratory%2520animals%2520and%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D1093%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit67a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzarano, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span> </span><span class="NLM_article-title">Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. I. Investigation of potential experimental and mechanistic explanations</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=353-366&author=K.+W.+Wardauthor=L.+M.+Azzaranoauthor=C.+A.+Evansauthor=B.+R.+Smith&title=Apparent+absolute+oral+bioavailability+in+excess+of+100%25+for+a+vitronectin+receptor+antagonist+%28SB-265123%29+in+rat.+I.+Investigation+of+potential+experimental+and+mechanistic+explanations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DAzzarano%26aufirst%3DL.%2BM.%26aulast%3DEvans%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26atitle%3DApparent%2520absolute%2520oral%2520bioavailability%2520in%2520excess%2520of%2520100%2525%2520for%2520a%2520vitronectin%2520receptor%2520antagonist%2520%2528SB-265123%2529%2520in%2520rat.%2520I.%2520Investigation%2520of%2520potential%2520experimental%2520and%2520mechanistic%2520explanations%26jtitle%3DXenobiotica%26date%3D2004%26volume%3D34%26spage%3D353%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit67b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzarano, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span> </span><span class="NLM_article-title">Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Investigation of potential experimental and mechanistic explanations</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=367-377&author=K.+W.+Wardauthor=L.+M.+Azzaranoauthor=C.+A.+Evansauthor=B.+R.+Smith&title=Apparent+absolute+oral+bioavailability+in+excess+of+100%25+for+a+vitronectin+receptor+antagonist+%28SB-265123%29+in+rat.+II.+Investigation+of+potential+experimental+and+mechanistic+explanations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DAzzarano%26aufirst%3DL.%2BM.%26aulast%3DEvans%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26atitle%3DApparent%2520absolute%2520oral%2520bioavailability%2520in%2520excess%2520of%2520100%2525%2520for%2520a%2520vitronectin%2520receptor%2520antagonist%2520%2528SB-265123%2529%2520in%2520rat.%2520II.%2520Investigation%2520of%2520potential%2520experimental%2520and%2520mechanistic%2520explanations%26jtitle%3DXenobiotica%26date%3D2004%26volume%3D34%26spage%3D367%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Martinez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span> </span><span class="NLM_article-title">A mechanistic approach to understanding the factors affecting drug absorption; a review of fundamentals</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1177%2F00970002042006005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=12043951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD38Xks1OgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=620-643&author=M.+L.+Martinezauthor=G.+L.+Amidon&title=A+mechanistic+approach+to+understanding+the+factors+affecting+drug+absorption%3B+a+review+of+fundamentals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals</span></div><div class="casAuthors">Martinez, Marilyn N.; Amidon, Gordon L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-643</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  This article provides an overview of the patient-specific and drug-specific variables that can affect drug absorption following oral product administration.  The oral absorption of any chem. entity reflects a complex spectrum of events.  Factors influencing product bioavailability include drug soly., permeability, and the rate of in vivo dissoln.  In this regard, the Biopharmaceutics Classification System has proven to be an important tool for predicting compds. likely to be assocd. with bioavailability problems.  It also helps in identifying those factors that may alter the rate and extent of drug absorption.  Product bioavailability can also be markedly influenced by patient attributes such as the integrity of the gastrointestinal tract, physiol. status, site of drug absorption, membrane transporters, presystemic drug metab. (intrinsic variables), and extrinsic variables such as the effect of food or concomitant medication.  Through an awareness of a drug's physicochem. properties and the physiol. processes affecting drug absorption, the skilled pharmaceutical scientist can develop formulations that will maximize product availability.  By appreciating the potential impact of patient physiol. status, phenotype, age, gender, and lifestyle, dosing regimens can be tailored to better meet the needs of the individual patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7090GVIXnsrVg90H21EOLACvtfcHk0li156MbUrNOrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xks1OgsLc%253D&md5=65abdd33877aa4cd9295c594a338584e</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1177%2F00970002042006005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F00970002042006005%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DM.%2BL.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26atitle%3DA%2520mechanistic%2520approach%2520to%2520understanding%2520the%2520factors%2520affecting%2520drug%2520absorption%253B%2520a%2520review%2520of%2520fundamentals%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D42%26spage%3D620%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsey, R.</span><span> </span><span class="NLM_article-title">The stress response: implications for the clinical development of hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F1568009033481787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=14529386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2isrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=349-358&author=L.+Whitesellauthor=R.+Bagatellauthor=R.+Falsey&title=The+stress+response%3A+implications+for+the+clinical+development+of+hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The stress response: Implications for the clinical development of Hsp90 inhibitors</span></div><div class="casAuthors">Whitesell, Luke; Bagatell, Rochelle; Falsey, Ryan</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-358</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In their role as mol. chaperones, heat shock proteins serve as central integrators of protein homeostasis within cells.  As part of this function, they guide the folding, assembly, intracellular disposition and proteolytic turnover of many key regulators of cell growth, differentiation and survival.  Not surprisingly then, heat shock proteins are over expressed in many types of cancer, and induction of the stress response may actually be required for cells to tolerate the genetic disarray characteristic of malignant transformation.  Regulation of heat shock protein levels via the stress response is complex, but recent data indicate that the mol. chaperone Hsp90 plays a key role.  Specifically, Hsp90 inhibitors alter the multi-chaperone complexes assocd. with Heat Shock Factor 1 (HSF1), the dominant transcription factor controlling induction of the stress response, and stimulate HSF1-activated heat shock gene expression.  Induction of this heat shock response has now emerged as an important consideration in the further clin. development of Hsp90 inhibitors for several reasons.  First, tumors in which the stress response is compromised appear particularly sensitive to Hsp90 inhibition.  Second, induction of the stress response by Hsp90 inhibitors provides a sensitive pharmacodynamic endpoint with which to monitor drug action in individual patients.  Third, Hsp90 inhibitors display important therapeutic interactions with both conventional DNA-targeted chemotherapeutics and newer molecularly targeted agents.  These interactions are, at least in part, due to modulation of the stress response by these drugs.  Lastly, stress response induction by Hsp90 inhibitors may have therapeutic benefits in non-neoplastic disorders such as heart disease, stroke and neurodegenerative diseases.  These benefits are just beginning to be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplWj51nToxhrVg90H21EOLACvtfcHk0li156MbUrNOrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2isrc%253D&md5=f89ec1c0f23a2bf9369d22fe59e63cc0</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.2174%2F1568009033481787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481787%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DFalsey%26aufirst%3DR.%26atitle%3DThe%2520stress%2520response%253A%2520implications%2520for%2520the%2520clinical%2520development%2520of%2520hsp90%2520inhibitors%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D349%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paine-Murrieta, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulcini, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjamin, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesell, L.</span><span> </span><span class="NLM_article-title">Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3312</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=10955818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVOmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=3312-3318&author=R.+Bagatellauthor=G.+D.+Paine-Murrietaauthor=C.+W.+Taylorauthor=E.+J.+Pulciniauthor=S.+Akinagaauthor=I.+J.+Benjaminauthor=L.+Whitesell&title=Induction+of+a+heat+shock+factor+1-dependent+stress+response+alters+the+cytotoxic+activity+of+hsp90-binding+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of Hsp90-binding agents</span></div><div class="casAuthors">Bagatell, Rochelle; Paine-Murrieta, Gillian D.; Taylor, Charles W.; Pulcini, Elizabeth J.; Akinaga, Shiro; Benjamin, Ivor J.; Whitesell, Luke</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3312-3318</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In addn. to its classic role in the cellular stress response, heat shock protein 90 (Hsp90) plays a crit. but less well appreciated role in regulating signal transduction pathways that control cell growth and survival under basal, nonstress conditions.  Over the past 5 yr, the antitumor antibiotics geldanamycin and radicicol have become recognized as selective Hsp90-binding agents (HBA) with a novel ability to alter the activity of many of the receptors, kinases, and transcription factors involved in these cancer-assocd. pathways.  As a consequence of their interaction with Hsp90, however, these agents also induce a marked cellular heat shock response.  To study the mechanism of this response and assess its relevance to the anticancer action of the HBA, we verified that the compds. could activate a reporter construct contg. consensus binding sites for heat shock factor 1 (HSF1), the major transcriptional regulator of the vertebrate heat shock response.  The authors then used transformed fibroblasts derived from HSF1 knock-out mice to show that unlike conventional chemotherapeutics, HBA increased the synthesis and cellular levels of heat shock proteins in an HSF1-dependent manner.  Compared with transformed fibroblasts derived from wild-type mice, HSF1 knock-out cells were significantly more sensitive to the cytotoxic effects of HBA but not to doxorubicin or cisplatin.  Consistent with these in vitro data, the authors found that systemic administration of an HBA led to marked increases in the level of Hsp72 in both normal mouse tissues and human tumor xenografts.  The authors conclude that HBA are useful probes for studying mol. mechanisms regulating the heat shock response both in cells and in whole animals.  Moreover, induction of the heat shock response by HBA will be an important consideration in the clin. application of these drugs, both in terms of modulating their cytotoxic activity as well as monitoring their biol. activity in individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCXM1LsRGAfLVg90H21EOLACvtfcHk0li156MbUrNOrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVOmtL0%253D&md5=3c6f4e392424161b38ddc010ea97afb1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DPaine-Murrieta%26aufirst%3DG.%2BD.%26aulast%3DTaylor%26aufirst%3DC.%2BW.%26aulast%3DPulcini%26aufirst%3DE.%2BJ.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DBenjamin%26aufirst%3DI.%2BJ.%26aulast%3DWhitesell%26aufirst%3DL.%26atitle%3DInduction%2520of%2520a%2520heat%2520shock%2520factor%25201-dependent%2520stress%2520response%2520alters%2520the%2520cytotoxic%2520activity%2520of%2520hsp90-binding%2520agents%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D3312%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Samlowski, W. E.; Papadopoulos, K.; Olszanski, A. J.; Cimbora, D.; Baichwal, V.; Shawbell, S.; Evans, B.; Balch, A.; Mather, G.; Beelen, A.</span><span> </span><span class="NLM_article-title">Phase 1 Study of the Hsp90 Inhibitor MPC-3100 in Subjects with Refractory or Recurrent Cancer</span>. Presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, San Francisco, CA, November 12–16, 2011. Myrexis Inc. Web site: <a href="http://www.myriadpharma.com/images/stories/product-pipeline/mpc-3100/mpc-3100-aacr-eortc-nci-2011-a96.pdf" class="extLink">http://www.myriadpharma.com/images/stories/product-pipeline/mpc-3100/mpc-3100-aacr-eortc-nci-2011-a96.pdf</a> (accessed July 02,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=W.+E.+Samlowski&author=K.+Papadopoulos&author=A.+J.+Olszanski&author=D.+Cimbora&author=V.+Baichwal&author=S.+Shawbell&author=B.+Evans&author=A.+Balch&author=G.+Mather&author=A.+Beelen&title=Phase+1+Study+of+the+Hsp90+Inhibitor+MPC-3100+in+Subjects+with+Refractory+or+Recurrent+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSamlowski%26aufirst%3DW.%2BE.%26atitle%3DPhase%25201%2520Study%2520of%2520the%2520Hsp90%2520Inhibitor%2520MPC-3100%2520in%2520Subjects%2520with%2520Refractory%2520or%2520Recurrent%2520Cancer%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1177%2F1087057104265995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=15296636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=375-381&author=J.+Kimauthor=S.+Feltsauthor=H.+Heauthor=H.+Huezoauthor=N.+Rosenauthor=G.+Chiosis&title=Development+of+a+fluorescence+polarization+assay+for+the+molecular+chaperone+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span></div><div class="casAuthors">Kim, Joungnam; Felts, Sara; Llauger, Laura; He, Huazhong; Huezo, Henri; Rosen, Neal; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone with essential functions in maintaining transformation, and there is increasing interest in developing Hsp90 inhibitors as cancer therapeutics.  In this study, the authors describe the development and optimization of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization.  The assay is based on the competition of fluorescently (BODIPY) labeled geldanamycin (GM) for binding to purified recombinant Hsp90α (GM is a natural product that binds to the ATP/ADP pocket in the amino terminal of Hsp90).  The authors show that GM-BODIPY binds Hsp90α with high affinity.  Even at low Hsp90α concns. (30 nM), the measured polarization value is close to the max. assay range of 160 mP, making measurements very sensitive.  Its performance, as judged by signal-to-noise ratios (> 10) and Z and Z' values (> 0.5), suggests that this is a robust and reliable assay.  GM, PU24FCl, ADP, and ATP, all known to bind to the Hsp90 pocket, compete with GM-BODIPY for binding to Hsp90α with EC50s in agreement with reported values.  These data demonstrate that the Hsp90-FP-based assay can be used for high-throughput screening in aiding the identification of novel Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTTKuW5DgFIbVg90H21EOLACvtfcHk0li1dDhIDU1lKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D&md5=e6e13d80237b2b5c65a78d20d2f3c4bc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1177%2F1087057104265995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104265995%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence%2520polarization%2520assay%2520for%2520the%2520molecular%2520chaperone%2520Hsp90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2004%26volume%3D9%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosser, M. F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarden, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Sensitivity of mature ErbB2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">3702</span><span class="NLM_x">–</span> <span class="NLM_lpage">3708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=3702-3708&author=W.+Xuauthor=E.+Mimnaughauthor=M.+F.+N.+Rosserauthor=C.+Nicchittaauthor=M.+Marcuauthor=Y.+Yardenauthor=L.+Neckers&title=Sensitivity+of+mature+ErbB2+to+geldanamycin+is+conferred+by+its+kinase+domain+and+is+mediated+by+the+chaperone+protein+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMimnaugh%26aufirst%3DE.%26aulast%3DRosser%26aufirst%3DM.%2BF.%2BN.%26aulast%3DNicchitta%26aufirst%3DC.%26aulast%3DMarcu%26aufirst%3DM.%26aulast%3DYarden%26aufirst%3DY.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DSensitivity%2520of%2520mature%2520ErbB2%2520to%2520geldanamycin%2520is%2520conferred%2520by%2520its%2520kinase%2520domain%2520and%2520is%2520mediated%2520by%2520the%2520chaperone%2520protein%2520Hsp90%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D3702%26epage%3D3708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Tikhomirov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G.</span><span> </span><span class="NLM_article-title">Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=39-43&author=O.+Tikhomirovauthor=G.+Carpenter&title=Identification+of+ErbB-2+kinase+domain+motifs+required+for+geldanamycin-induced+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTikhomirov%26aufirst%3DO.%26aulast%3DCarpenter%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520ErbB-2%2520kinase%2520domain%2520motifs%2520required%2520for%2520geldanamycin-induced%2520degradation%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39a','cit39b'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44a','cit44b'],'ref45':['cit45'],'ref46':['cit46a','cit46b','cit46c'],'ref47':['cit47'],'ref48':['cit48a','cit48b','cit48c'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55a','cit55b'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58a','cit58b'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67a','cit67b'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Li Li, Lei Wang, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiao-Li Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1798-1822. <a href="https://doi.org/10.1021/acs.jmedchem.9b00940" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00940</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00940%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeat%252BShock%252BProtein%252B90%252BInhibitors%25253A%252BAn%252BUpdate%252Bon%252BAchievements%25252C%252BChallenges%25252C%252Band%252BFuture%252BDirections%26aulast%3DLi%26aufirst%3DLi%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D13062019%26date%3D12112019%26date%3D30102019%26volume%3D63%26issue%3D5%26spage%3D1798%26epage%3D1822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pablo Garnica, Ignacio Encío, Daniel Plano, Juan A. Palop, <span class="NLM_string-name hlFld-ContribAuthor">Carmen Sanmartín</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Acylselenourea–Diselenide Structures: New Potent and Selective Antitumoral Agents as Autophagy Activators. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (4)
                                     , 306-311. <a href="https://doi.org/10.1021/acsmedchemlett.7b00482" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00482%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCombined%252BAcylselenourea%2525E2%252580%252593Diselenide%252BStructures%25253A%252BNew%252BPotent%252Band%252BSelective%252BAntitumoral%252BAgents%252Bas%252BAutophagy%252BActivators%26aulast%3DGarnica%26aufirst%3DPablo%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D22112017%26date%3D13032018%26date%3D19032018%26date%3D13032018%26volume%3D9%26issue%3D4%26spage%3D306%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Hui-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Hui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Min  Jia</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, and <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10498-10519. <a href="https://doi.org/10.1021/acs.jmedchem.6b00912" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00912%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BTetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidines%252Bas%252BPotent%252BInhibitors%252Bof%252BChaperone%252BHeat%252BShock%252BProtein%252B90%26aulast%3DJiang%26aufirst%3DFen%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D22112016%26date%3D08122016%26date%3D09112016%26volume%3D59%26issue%3D23%26spage%3D10498%26epage%3D10519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsuyuki  Yoshii</span>, <span class="hlFld-ContribAuthor ">Keigo  Mizusawa</span>, <span class="hlFld-ContribAuthor ">Yousuke  Takaoka</span>, and <span class="hlFld-ContribAuthor ">Itaru  Hamachi</span>  . </span><span class="cited-content_cbyCitation_article-title">Intracellular Protein-Responsive Supramolecules: Protein Sensing and In-Cell Construction of Inhibitor Assay System. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (47)
                                     , 16635-16642. <a href="https://doi.org/10.1021/ja508955y" title="DOI URL">https://doi.org/10.1021/ja508955y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja508955y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja508955y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DIntracellular%252BProtein-Responsive%252BSupramolecules%25253A%252BProtein%252BSensing%252Band%252BIn-Cell%252BConstruction%252Bof%252BInhibitor%252BAssay%252BSystem%26aulast%3DYoshii%26aufirst%3DTatsuyuki%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07092014%26date%3D11112014%26date%3D26112014%26date%3D31102014%26volume%3D136%26issue%3D47%26spage%3D16635%26epage%3D16642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rohit  Bhat</span>, <span class="hlFld-ContribAuthor ">Sreedhar R.  Tummalapalli</span>, and <span class="hlFld-ContribAuthor ">David P.  Rotella</span>  . </span><span class="cited-content_cbyCitation_article-title">Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (21)
                                     , 8718-8728. <a href="https://doi.org/10.1021/jm500823a" title="DOI URL">https://doi.org/10.1021/jm500823a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500823a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500823a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252Bthe%252BDiscovery%252Band%252BDevelopment%252Bof%252BHeat%252BShock%252BProtein%252B90%252B%252528Hsp90%252529%252BInhibitors%26aulast%3DBhat%26aufirst%3DRohit%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D30052014%26date%3D29082014%26date%3D13112014%26date%3D20082014%26volume%3D57%26issue%3D21%26spage%3D8718%26epage%3D8728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Russell R. A.  Kitson</span> and <span class="hlFld-ContribAuthor ">Christopher J.  Moody</span>  . </span><span class="cited-content_cbyCitation_article-title">Learning from Nature: Advances in Geldanamycin- and Radicicol-Based Inhibitors of Hsp90. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (11)
                                     , 5117-5141. <a href="https://doi.org/10.1021/jo4002849" title="DOI URL">https://doi.org/10.1021/jo4002849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo4002849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo4002849%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLearning%252Bfrom%252BNature%25253A%252BAdvances%252Bin%252BGeldanamycin-%252Band%252BRadicicol-Based%252BInhibitors%252Bof%252BHsp90%26aulast%3DKitson%26aufirst%3DRussell%2BR.%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06022013%26date%3D26032013%26date%3D07062013%26date%3D15032013%26volume%3D78%26issue%3D11%26spage%3D5117%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thierry  Milcent</span>, <span class="hlFld-ContribAuthor ">Benoit  Crousse</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of
              N
              ‐
              
                CF
                2
                H
              
              ,
              N
              ‐
              
                CF
                3
              
              , and
              N
              ‐
              
                CH
                2
                CF
                3
              
              Motifs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 723-761. <a href="https://doi.org/10.1002/9783527824342.ch24" title="DOI URL">https://doi.org/10.1002/9783527824342.ch24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527824342.ch24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527824342.ch24%26sid%3Dliteratum%253Aachs%26atitle%3DConstruction%252Bof%252BN%252B%2525E2%252580%252590%252BCF%252B2%252BH%252B%25252C%252BN%252B%2525E2%252580%252590%252BCF%252B3%252B%25252C%252Band%252BN%252B%2525E2%252580%252590%252BCH%252B2%252BCF%252B3%252BMotifs%26aulast%3DMilcent%26aufirst%3DThierry%26date%3D2020%26date%3D2020%26spage%3D723%26epage%3D761%26pub%3DWiley%26atitle%3DEmerging%252BFluorinated%252BMotifs%26aulast%3DCahard%26aufirst%3DDominique%26date%3D2020%26date%3D2020%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurence  Dubrez</span>, <span class="hlFld-ContribAuthor ">Sébastien  Causse</span>, <span class="hlFld-ContribAuthor ">Natalia  Borges Bonan</span>, <span class="hlFld-ContribAuthor ">Baptiste  Dumétier</span>, <span class="hlFld-ContribAuthor ">Carmen  Garrido</span>. </span><span class="cited-content_cbyCitation_article-title">Heat-shock proteins: chaperoning DNA repair. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2020,</strong> <em>39 </em>
                                    (3)
                                     , 516-529. <a href="https://doi.org/10.1038/s41388-019-1016-y" title="DOI URL">https://doi.org/10.1038/s41388-019-1016-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-019-1016-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-019-1016-y%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DHeat-shock%252Bproteins%25253A%252Bchaperoning%252BDNA%252Brepair%26aulast%3DDubrez%26aufirst%3DLaurence%26date%3D2020%26date%3D2019%26volume%3D39%26issue%3D3%26spage%3D516%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neil  Beeharry</span>, <span class="hlFld-ContribAuthor ">Sean  Landrette</span>, <span class="hlFld-ContribAuthor ">Sophia  Gayle</span>, <span class="hlFld-ContribAuthor ">Marylens  Hernandez</span>, <span class="hlFld-ContribAuthor ">Jeff E.  Grotzke</span>, <span class="hlFld-ContribAuthor ">Peter R.  Young</span>, <span class="hlFld-ContribAuthor ">Paul  Beckett</span>, <span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Bing Z.  Carter</span>, <span class="hlFld-ContribAuthor ">Michael  Andreeff</span>, <span class="hlFld-ContribAuthor ">Stephanie  Halene</span>, <span class="hlFld-ContribAuthor ">Tian  Xu</span>, <span class="hlFld-ContribAuthor ">Jonathan  Rothberg</span>, <span class="hlFld-ContribAuthor ">Henri  Lichenstein</span>. </span><span class="cited-content_cbyCitation_article-title">LAM-003, a new drug for treatment of tyrosine kinase inhibitor–resistant FLT3-ITD–positive AML. </span><span class="cited-content_cbyCitation_journal-name">Blood Advances</span><span> <strong>2019,</strong> <em>3 </em>
                                    (22)
                                     , 3661-3673. <a href="https://doi.org/10.1182/bloodadvances.2019001068" title="DOI URL">https://doi.org/10.1182/bloodadvances.2019001068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/bloodadvances.2019001068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fbloodadvances.2019001068%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%2520Advances%26atitle%3DLAM-003%25252C%252Ba%252Bnew%252Bdrug%252Bfor%252Btreatment%252Bof%252Btyrosine%252Bkinase%252Binhibitor%2525E2%252580%252593resistant%252BFLT3-ITD%2525E2%252580%252593positive%252BAML%26aulast%3DBeeharry%26aufirst%3DNeil%26date%3D2019%26date%3D2019%26volume%3D3%26issue%3D22%26spage%3D3661%26epage%3D3673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yin  Luo</span>, <span class="hlFld-ContribAuthor ">Yang  Zhou</span>, <span class="hlFld-ContribAuthor ">Yanhua  Song</span>, <span class="hlFld-ContribAuthor ">Guo  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-Xiang  Wang</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Wei-Wei  Fan</span>, <span class="hlFld-ContribAuthor ">Yu-Shun  Yang</span>, <span class="hlFld-ContribAuthor ">Tao  Cheng</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of substituted cinnamic acyl sulfonamide derivatives as tubulin polymerization inhibitors with anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (23-24)
                                     , 3634-3638. <a href="https://doi.org/10.1016/j.bmcl.2018.10.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.10.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.10.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252Bsubstituted%252Bcinnamic%252Bacyl%252Bsulfonamide%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%252Bwith%252Banticancer%252Bactivity%26aulast%3DLuo%26aufirst%3DYin%26date%3D2018%26volume%3D28%26issue%3D23-24%26spage%3D3634%26epage%3D3638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa  Giulino-Roth</span>, <span class="hlFld-ContribAuthor ">Herman J.  van Besien</span>, <span class="hlFld-ContribAuthor ">Tanner  Dalton</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Totonchy</span>, <span class="hlFld-ContribAuthor ">Anna  Rodina</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Alexander  Bolaender</span>, <span class="hlFld-ContribAuthor ">Hediye  Erdjument-Bromage</span>, <span class="hlFld-ContribAuthor ">Jouliana  Sadek</span>, <span class="hlFld-ContribAuthor ">Amy  Chadburn</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Barth</span>, <span class="hlFld-ContribAuthor ">Filemon S.  Dela Cruz</span>, <span class="hlFld-ContribAuthor ">Allison  Rainey</span>, <span class="hlFld-ContribAuthor ">Andrew L.  Kung</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>, <span class="hlFld-ContribAuthor ">Ethel  Cesarman</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (9)
                                     , 1779-1790. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0848" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0848%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DInhibition%252Bof%252BHsp90%252BSuppresses%252BPI3K%25252FAKT%25252FmTOR%252BSignaling%252Band%252BHas%252BAntitumor%252BActivity%252Bin%252BBurkitt%252BLymphoma%26aulast%3DGiulino-Roth%26aufirst%3DLisa%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D9%26spage%3D1779%26epage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A Elisa  Pasqua</span>, <span class="hlFld-ContribAuthor ">B.  Wilding</span>, <span class="hlFld-ContribAuthor ">M.D.  Cheeseman</span>, <span class="hlFld-ContribAuthor ">K.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 202-280. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12395-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12395-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12395-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12395-9%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BProtein%252BSynthesis%25252C%252BFolding%25252C%252Band%252BDegradation%252BPathways%252Bin%252BCancer%26aulast%3DPasqua%26aufirst%3DA%2BElisa%26date%3D2017%26spage%3D202%26epage%3D280%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Hui-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Hui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Jiang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization and biological evaluation of celastrol derivatives as Hsp90–Cdc37 interaction disruptors with improved druglike properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (21)
                                     , 5431-5439. <a href="https://doi.org/10.1016/j.bmc.2016.08.070" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.08.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.08.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.08.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Band%252Bbiological%252Bevaluation%252Bof%252Bcelastrol%252Bderivatives%252Bas%252BHsp90%2525E2%252580%252593Cdc37%252Binteraction%252Bdisruptors%252Bwith%252Bimproved%252Bdruglike%252Bproperties%26aulast%3DJiang%26aufirst%3DFen%26date%3D2016%26volume%3D24%26issue%3D21%26spage%3D5431%26epage%3D5439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Verónica  Alcolea</span>, <span class="hlFld-ContribAuthor ">Daniel  Plano</span>, <span class="hlFld-ContribAuthor ">Ignacio  Encío</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Palop</span>, <span class="hlFld-ContribAuthor ">Arun K.  Sharma</span>, <span class="hlFld-ContribAuthor ">Carmen  Sanmartín</span>. </span><span class="cited-content_cbyCitation_article-title">Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>123 </em>, 407-418. <a href="https://doi.org/10.1016/j.ejmech.2016.07.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.07.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.07.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.07.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChalcogen%252Bcontaining%252Bheterocyclic%252Bscaffolds%25253A%252BNew%252Bhybrids%252Bwith%252Bantitumoral%252Bactivity%26aulast%3DAlcolea%26aufirst%3DVer%25C3%25B3nica%26date%3D2016%26volume%3D123%26spage%3D407%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>, <span class="hlFld-ContribAuthor ">Qi-chao  Bao</span>, <span class="hlFld-ContribAuthor ">Jian-Min  Jia</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiao-Ke  Guo</span>, <span class="hlFld-ContribAuthor ">Ming-ye  Zhang</span>, <span class="hlFld-ContribAuthor ">Jin-lian  Wei</span>, <span class="hlFld-ContribAuthor ">Meng-chen  Lu</span>, <span class="hlFld-ContribAuthor ">Li-li  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao-Jin  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Hao-Peng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">CPUY201112, a novel synthetic small-molecule compound and inhibitor of heat shock protein Hsp90, induces p53-mediated apoptosis in MCF-7 cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep19004" title="DOI URL">https://doi.org/10.1038/srep19004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep19004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep19004%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCPUY201112%25252C%252Ba%252Bnovel%252Bsynthetic%252Bsmall-molecule%252Bcompound%252Band%252Binhibitor%252Bof%252Bheat%252Bshock%252Bprotein%252BHsp90%25252C%252Binduces%252Bp53-mediated%252Bapoptosis%252Bin%252BMCF-7%252Bcells%26aulast%3DXu%26aufirst%3DXiao-Li%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manoj  Pandey</span>, <span class="hlFld-ContribAuthor ">Sahdeo  Prasad</span>, <span class="hlFld-ContribAuthor ">Amit  Tyagi</span>, <span class="hlFld-ContribAuthor ">Lokesh  Deb</span>, <span class="hlFld-ContribAuthor ">Jiamin  Huang</span>, <span class="hlFld-ContribAuthor ">Deepkamal  Karelia</span>, <span class="hlFld-ContribAuthor ">Shantu  Amin</span>, <span class="hlFld-ContribAuthor ">Bharat  Aggarwal</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Cell Survival Proteins for Cancer Cell Death. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2016,</strong> <em>9 </em>
                                    (1)
                                     , 11. <a href="https://doi.org/10.3390/ph9010011" title="DOI URL">https://doi.org/10.3390/ph9010011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph9010011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph9010011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DTargeting%252BCell%252BSurvival%252BProteins%252Bfor%252BCancer%252BCell%252BDeath%26aulast%3DPandey%26aufirst%3DManoj%26date%3D2016%26date%3D2016%26volume%3D9%26issue%3D1%26spage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Se-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Rajendra  Tangallapally</span>, <span class="hlFld-ContribAuthor ">In Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Richard  Trovato</span>, <span class="hlFld-ContribAuthor ">Daniel  Parker</span>, <span class="hlFld-ContribAuthor ">J. Scott  Patton</span>, <span class="hlFld-ContribAuthor ">Leslie  Reeves</span>, <span class="hlFld-ContribAuthor ">Chad  Bradford</span>, <span class="hlFld-ContribAuthor ">Daniel  Wettstein</span>, <span class="hlFld-ContribAuthor ">Vijay  Baichwal</span>, <span class="hlFld-ContribAuthor ">Damon  Papac</span>, <span class="hlFld-ContribAuthor ">Ashok  Bajji</span>, <span class="hlFld-ContribAuthor ">Robert  Carlson</span>, <span class="hlFld-ContribAuthor ">Kraig M.  Yager</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an l-alanine ester prodrug of the Hsp90 inhibitor, MPC-3100. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (22)
                                     , 5254-5257. <a href="https://doi.org/10.1016/j.bmcl.2015.09.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ban%252Bl-alanine%252Bester%252Bprodrug%252Bof%252Bthe%252BHsp90%252Binhibitor%25252C%252BMPC-3100%26aulast%3DKim%26aufirst%3DSe-Ho%26date%3D2015%26volume%3D25%26issue%3D22%26spage%3D5254%26epage%3D5257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rémi  Tirfoin</span>, <span class="hlFld-ContribAuthor ">Joseph A. B.  Abdalla</span>, <span class="hlFld-ContribAuthor ">Simon  Aldridge</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional Indenyl-Derived Receptors for Fluoride Chelation and Detection. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2015,</strong> <em>21 </em>
                                    (33)
                                     , 11813-11824. <a href="https://doi.org/10.1002/chem.201501547" title="DOI URL">https://doi.org/10.1002/chem.201501547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201501547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201501547%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DBifunctional%252BIndenyl-Derived%252BReceptors%252Bfor%252BFluoride%252BChelation%252Band%252BDetection%26aulast%3DTirfoin%26aufirst%3DR%25C3%25A9mi%26date%3D2015%26date%3D2015%26volume%3D21%26issue%3D33%26spage%3D11813%26epage%3D11824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierfausto  Seneci</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Protein Quality Control (PQC) Machinery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 25-71. <a href="https://doi.org/10.1016/B978-0-12-801944-3.00002-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-801944-3.00002-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-801944-3.00002-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-801944-3.00002-3%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252Bthe%252BProtein%252BQuality%252BControl%252B%252528PQC%252529%252BMachinery%26aulast%3DSeneci%26aufirst%3DPierfausto%26date%3D2015%26spage%3D25%26epage%3D71%26pub%3DElsevier%26atitle%3DChemical%252BModulators%252Bof%252BProtein%252BMisfolding%252Band%252BNeurodegenerative%252BDisease%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ren</span>, <span class="hlFld-ContribAuthor ">Min  Yang</span>, <span class="hlFld-ContribAuthor ">Hongchun  Liu</span>, <span class="hlFld-ContribAuthor ">Danyan  Cao</span>, <span class="hlFld-ContribAuthor ">Danqi  Chen</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Le  Tang</span>, <span class="hlFld-ContribAuthor ">Jianhua  He</span>, <span class="hlFld-ContribAuthor ">Yue-Lei  Chen</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>, <span class="hlFld-ContribAuthor ">Jingkang  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-substituted 8-aminoimidazo[1,2-a]pyrazines by Groebke–Blackburn–Bienaymé reaction and their Hsp90 inhibitory activity. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (5)
                                     , 1531-1535. <a href="https://doi.org/10.1039/C4OB01865F" title="DOI URL">https://doi.org/10.1039/C4OB01865F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB01865F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB01865F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMulti-substituted%252B8-aminoimidazo%25255B1%25252C2-a%25255Dpyrazines%252Bby%252BGroebke%2525E2%252580%252593Blackburn%2525E2%252580%252593Bienaym%2525C3%2525A9%252Breaction%252Band%252Btheir%252BHsp90%252Binhibitory%252Bactivity%26aulast%3DRen%26aufirst%3DJing%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D5%26spage%3D1531%26epage%3D1535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raffaella  Amici</span>, <span class="hlFld-ContribAuthor ">Chiara  Bigogno</span>, <span class="hlFld-ContribAuthor ">Roberto  Boggio</span>, <span class="hlFld-ContribAuthor ">Andrea  Colombo</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Courtney</span>, <span class="hlFld-ContribAuthor ">Roberto  Dal Zuffo</span>, <span class="hlFld-ContribAuthor ">Giulio  Dondio</span>, <span class="hlFld-ContribAuthor ">Fulvia  Fusar</span>, <span class="hlFld-ContribAuthor ">Stefania  Gagliardi</span>, <span class="hlFld-ContribAuthor ">Saverio  Minucci</span>, <span class="hlFld-ContribAuthor ">Marco  Molteni</span>, <span class="hlFld-ContribAuthor ">Christian A. G. N.  Montalbetti</span>, <span class="hlFld-ContribAuthor ">Annalisa  Mortoni</span>, <span class="hlFld-ContribAuthor ">Mario  Varasi</span>, <span class="hlFld-ContribAuthor ">Stefania  Vultaggio</span>, <span class="hlFld-ContribAuthor ">Ciro  Mercurio</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral Resolution and Pharmacological Characterization of the Enantiomers of the Hsp90 Inhibitor 2-Amino-7-[4-fluoro-2-(3-pyridyl)phenyl]-4-methyl-7,8-dihydro-6
              H
              -quinazolin-5-one Oxime. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (7)
                                     , 1574-1585. <a href="https://doi.org/10.1002/cmdc.201400037" title="DOI URL">https://doi.org/10.1002/cmdc.201400037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201400037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201400037%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DChiral%252BResolution%252Band%252BPharmacological%252BCharacterization%252Bof%252Bthe%252BEnantiomers%252Bof%252Bthe%252BHsp90%252BInhibitor%252B2-Amino-7-%25255B4-fluoro-2-%2525283-pyridyl%252529phenyl%25255D-4-methyl-7%25252C8-dihydro-6%252BH%252B-quinazolin-5-one%252BOxime%26aulast%3DAmici%26aufirst%3DRaffaella%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D1574%26epage%3D1585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Hardik J  Patel</span>, <span class="hlFld-ContribAuthor ">Alexander  Bolaender</span>, <span class="hlFld-ContribAuthor ">Maulik R  Patel</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Protein chaperones: a composition of matter review (2008 – 2013). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (5)
                                     , 501-518. <a href="https://doi.org/10.1517/13543776.2014.887681" title="DOI URL">https://doi.org/10.1517/13543776.2014.887681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.887681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.887681%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DProtein%252Bchaperones%25253A%252Ba%252Bcomposition%252Bof%252Bmatter%252Breview%252B%2525282008%252B%2525E2%252580%252593%252B2013%252529%26aulast%3DTaldone%26aufirst%3DTony%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D5%26spage%3D501%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Komal  Jhaveri</span>, <span class="hlFld-ContribAuthor ">Stefan O  Ochiana</span>, <span class="hlFld-ContribAuthor ">Mark PS  Dunphy</span>, <span class="hlFld-ContribAuthor ">John F  Gerecitano</span>, <span class="hlFld-ContribAuthor ">Adriana D  Corben</span>, <span class="hlFld-ContribAuthor ">Radu I  Peter</span>, <span class="hlFld-ContribAuthor ">Yelena Y  Janjigian</span>, <span class="hlFld-ContribAuthor ">Erica M  Gomes-DaGama</span>, <span class="hlFld-ContribAuthor ">John  Koren</span>, <span class="hlFld-ContribAuthor ">Shanu  Modi</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (5)
                                     , 611-628. <a href="https://doi.org/10.1517/13543784.2014.902442" title="DOI URL">https://doi.org/10.1517/13543784.2014.902442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2014.902442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2014.902442%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DHeat%252Bshock%252Bprotein%252B90%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Bcancer%25253A%252Bcurrent%252Bstatus%252Band%252Bfuture%252Bdirections%26aulast%3DJhaveri%26aufirst%3DKomal%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D5%26spage%3D611%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dácil  Hernández</span>, <span class="hlFld-ContribAuthor ">Alicia  Boto</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleoside Analogues: Synthesis and Biological Properties of Azanucleoside Derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (11)
                                     , 2201-2220. <a href="https://doi.org/10.1002/ejoc.201301731" title="DOI URL">https://doi.org/10.1002/ejoc.201301731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201301731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201301731%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DNucleoside%252BAnalogues%25253A%252BSynthesis%252Band%252BBiological%252BProperties%252Bof%252BAzanucleoside%252BDerivatives%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DD%25C3%25A1cil%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D11%26spage%3D2201%26epage%3D2220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>, <span class="hlFld-ContribAuthor ">Hao-Peng  Sun</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Jian-Min  Jia</span>, <span class="hlFld-ContribAuthor ">Xiao-Ke  Guo</span>, <span class="hlFld-ContribAuthor ">Yang  Pan</span>, <span class="hlFld-ContribAuthor ">Hao-Ze  Huang</span>, <span class="hlFld-ContribAuthor ">Xiao-Jin  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Bioevaluation of Novel Pyrazolopyrimidine Analogs as Competitive Hsp90 Inhibitors Through Shape-Based Similarity Screening. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2014,</strong> <em>33 </em>
                                    (4)
                                     , 293-306. <a href="https://doi.org/10.1002/minf.201300150" title="DOI URL">https://doi.org/10.1002/minf.201300150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201300150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201300150%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DDiscovery%252Band%252BBioevaluation%252Bof%252BNovel%252BPyrazolopyrimidine%252BAnalogs%252Bas%252BCompetitive%252BHsp90%252BInhibitors%252BThrough%252BShape-Based%252BSimilarity%252BScreening%26aulast%3DXu%26aufirst%3DXiao-Li%26date%3D2014%26date%3D2014%26volume%3D33%26issue%3D4%26spage%3D293%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong-Zhen  Huang</span>, <span class="hlFld-ContribAuthor ">Jun-Hui  Yang</span>, <span class="hlFld-ContribAuthor ">Bai-Wei  Ma</span>, <span class="hlFld-ContribAuthor ">Gui-Rong  Qu</span>, <span class="hlFld-ContribAuthor ">Hai-Ming  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 9-oxiranyl-9H-purine derivatives in β-cyclodextrin cavity. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (6)
                                     , 1203-1206. <a href="https://doi.org/10.1016/j.tetlet.2013.12.117" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.12.117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.12.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.12.117%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252B9-oxiranyl-9H-purine%252Bderivatives%252Bin%252B%2525CE%2525B2-cyclodextrin%252Bcavity%26aulast%3DZhang%26aufirst%3DQian%26date%3D2014%26volume%3D55%26issue%3D6%26spage%3D1203%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan O.  Ochiana</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Drugs Against Hsp90 for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 151-183. <a href="https://doi.org/10.1007/978-1-4939-1130-1_7" title="DOI URL">https://doi.org/10.1007/978-1-4939-1130-1_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-1130-1_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-1130-1_7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BDrugs%252BAgainst%252BHsp90%252Bfor%252BCancer%252BTherapy%26aulast%3DOchiana%26aufirst%3DStefan%2BO.%26date%3D2014%26date%3D2014%26spage%3D151%26epage%3D183%26pub%3DSpringer%2520New%2520York%26atitle%3DThe%252BMolecular%252BChaperones%252BInteraction%252BNetworks%252Bin%252BProtein%252BFolding%252Band%252BDegradation%26aulast%3DHoury%26aufirst%3DWalid%2BA.%26date%3D2014%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swee  Sharp</span>, <span class="hlFld-ContribAuthor ">Keith  Jones</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting Cancer Dependence on Molecular Chaperones. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 239-274. <a href="https://doi.org/10.1016/B978-0-12-396521-9.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-396521-9.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396521-9.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396521-9.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DExploiting%252BCancer%252BDependence%252Bon%252BMolecular%252BChaperones%26aulast%3DSharp%26aufirst%3DSwee%26date%3D2014%26spage%3D239%26epage%3D274%26pub%3DElsevier%26atitle%3DCancer%252BDrug%252BDesign%252Band%252BDiscovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Liang  Feng</span>, <span class="hlFld-ContribAuthor ">Nengzhong  Wang</span>, <span class="hlFld-ContribAuthor ">Xuge  Liu</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Yuehai  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Practical synthesis of C1–8 fragment of autolytimycin via a chelation-controlled diastereoselective addition of diisopropenylzinc to α-methoxy aldehyde. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (45)
                                     , 9463-9468. <a href="https://doi.org/10.1016/j.tet.2013.08.067" title="DOI URL">https://doi.org/10.1016/j.tet.2013.08.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.08.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.08.067%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DPractical%252Bsynthesis%252Bof%252BC1%2525E2%252580%2525938%252Bfragment%252Bof%252Bautolytimycin%252Bvia%252Ba%252Bchelation-controlled%252Bdiastereoselective%252Baddition%252Bof%252Bdiisopropenylzinc%252Bto%252B%2525CE%2525B1-methoxy%252Baldehyde%26aulast%3DYang%26aufirst%3DFan%26date%3D2013%26volume%3D69%26issue%3D45%26spage%3D9463%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">TaeHun  Kim</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (8)
                                     , 919-943. <a href="https://doi.org/10.1517/13543776.2013.780597" title="DOI URL">https://doi.org/10.1517/13543776.2013.780597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.780597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.780597%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252Bheat%252Bshock%252Bprotein%252B90%252Binhibitors%252Bas%252Banticancer%252Bagents%25253A%252Ba%252Breview%252Bof%252Bpatented%252Bpotent%252Bgeldanamycin%252Bderivatives%26aulast%3DKim%26aufirst%3DTaeHun%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D8%26spage%3D919%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Natural product and natural-product-derived Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selected purine-based and purine-like Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selected examples of structurally diverse non-purine Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>24a</b>–<b>g</b>, Pd<sub>2</sub>dba<sub>3</sub>, xantphos, K<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 15–45%; (b) <b>25b</b>, Barton’s base, 80 °C, DMF, 20–51%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>25a</b> or <b>25c</b>–<b>i</b>, Barton’s base, 80 °C, DMF, 20–51%; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, >90%; (c) EDCI, HOBt, DMF, R<sub>2</sub>CO<sub>2</sub>H (R<sub>2</sub> = H, CH<sub>3</sub>, propyl, cyclopropyl, cyclopentyl, CH<sub>2</sub>OH, (<i>S</i> or <i>R</i>)-CH(OH)CH<sub>3</sub>, C(CH<sub>3</sub>)<sub>2</sub>OH, acetyl, CH<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub>); (d) EDCI, HOBt, DMF–THF, rt, R<sub>2</sub>CO<sub>2</sub>H (R<sub>2</sub> = (<i>S</i>)-CH(CH<sub>3</sub>)NHBoc, (<i>S</i>)-CH(<i>i</i>Bu)NHBoc, C(CH<sub>3</sub>)<sub>2</sub>NHBoc or <i>N</i>-Boc-<span class="smallcaps smallerCapital">l</span>-proline), then 4 M HCl or TFA.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc<sub>2</sub>O, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) HCO<sub>2</sub>Me, NaOH, MeOH; (c) acetone, <i>i</i>-Bu-CHO, or <i>c</i>-Hex-CHO, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub> (or NaCNBH<sub>3,</sub> AcOH, MeOH–THF); (d) CF<sub>3</sub>CH<sub>2</sub>I, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux or CF<sub>3</sub>CH<sub>2</sub>OMs, NEt<sub>3</sub>, THF; (e) propargyl bromide, Hünig’s base, THF; (f) MsCl, or TsCl, NEt<sub>3</sub> (or DMAP), CH<sub>2</sub>Cl<sub>2</sub>, rt, 30–95%; (g) SCN-Me or SCN-<i>t</i>-Bu, CH<sub>2</sub>Cl<sub>2</sub>, rt, 80–85%; (h) NaN<sub>3</sub>, HgCl<sub>2</sub>, NEt<sub>3</sub>, DMF, 41–50%.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>52</b>, Pd<sub>2</sub>dba<sub>3</sub> (5–10 mol %), xantphos (10–20 mol %), Hünig’s base, dioxane, 100 °C, 10 h, >80%; (b) NBS, HBF<sub>4</sub>·Et<sub>2</sub>O, AcCN, −15 to 5 °C, >70%; (c) DDQ, 1,4-dioxane, 100 °C, ∼90%.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>25a</b> or <b>25b</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h, ∼80%; (b) Br<sub>2</sub>, NaOAc–AcOH (pH 4.6), MeOH/THF, rt, 2 h, ∼67%; (c) <b>43a</b>–<b>c</b>, <b>45</b>, <b>46</b>, <b>48</b>, <b>49</b>, or <b>51</b>, NaOEt, THF/EtOH (10/1, v/v), 60 °C, 3–10 h, 35–80%.</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>43a</b>–<b>c</b>, <b>45</b>, <b>51</b>, NaOEt, THF/EtOH (10/1, v/v), 60 °C, 3–10 h, 35–80%; (b) TFA or 4 M HCl in dioxane, CH<sub>2</sub>Cl<sub>2</sub>, rt, >90%.</p></p></figure><figure data-id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EDCI, HOBt, DMF–THF, R<sub>2</sub>CO<sub>2</sub>H (R<sub>2</sub> = H, CH<sub>2</sub>OH, (<i>S</i> or <i>R</i>)-CH(OH)CH<sub>3</sub>), rt, 10 h, 55–93%.</p></p></figure><figure data-id="sch10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 10. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 120 °C, 16 h, 94%; (b) NBS, AcOH, rt, 73%; (c) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, >90%; (d) EDCI, HOBt, DMF, R<sub>2</sub>CO<sub>2</sub>H (R<sub>2</sub> = H, CH<sub>2</sub>OH, (<i>S</i> or <i>R</i>)-CH(OH)CH<sub>3</sub>), rt, 10 h, 55–93%.</p></p></figure><figure data-id="sch11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Putative binding mode of <b>28g</b> in the ATP-binding site of Hsp90 as determined by molecular modeling with Hsp90 crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYI">1UYI</a>). Protein, ligand, and structured water molecules are rendered with Accelrys DS Visualizer 3.1. Atoms are colored by element: oxygen, red; nitrogen, blue; sulfur, green; ligand carbon, white; protein carbon, gold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>28g</b> on Hsp90 client protein (Her2, Hsp70, and Akt) expression in NCI-N87, HCT116, and DU-145 cell lines by Western blot analyses. Cells were exposed to varying concentrations of <b>28g</b> for 24 h, and then cell lysates were probed with Her2-, Hsp70-, and Akt-specific antibodies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/medium/jm-2012-004619_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) In vivo efficacy data for <b>28g</b> (50, 75, 125, or 200 mg/kg, q.d., po 22 days) in the NCI-N87, Her2<sup>+</sup> human gastric cancer xenograft model. (b) Change in HSP70 expression level in NCI-N87 tumor-bearing mice. Mice with NCI-N87 tumors (median volume, ∼425 mm<sup>3</sup>) were given a single oral dose of <b>28g</b> (200 mg/kg). Blood, tumor, and liver samples (<i>n</i> = 6) were collected at 0.25, 0.5, 1, 2, 4, 8, 12, 36, and 48 h after dose for determination of compound concentrations in plasma and Hsp70 RNA levels in tumor and liver.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm3004619/production/images/large/jm-2012-004619_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3004619&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i79">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 73 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Walter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Molecular chaperones—cellular machines for protein folding</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=1098-1113&author=S.+Walterauthor=J.+Buchner&title=Molecular+chaperones%E2%80%94cellular+machines+for+protein+folding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DMolecular%2520chaperones%25E2%2580%2594cellular%2520machines%2520for%2520protein%2520folding%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D1098%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Calderwood, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaleque, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciocca, D. R.</span><span> </span><span class="NLM_article-title">Heat shock proteins in cancer: chaperones of tumorigenesis</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2Fj.tibs.2006.01.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=16483782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1ymsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=164-172&author=S.+K.+Calderwoodauthor=M.+A.+Khalequeauthor=D.+B.+Sawyerauthor=D.+R.+Ciocca&title=Heat+shock+proteins+in+cancer%3A+chaperones+of+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins in cancer: chaperones of tumorigenesis</span></div><div class="casAuthors">Calderwood, Stuart K.; Khaleque, Md Abdul; Sawyer, Douglas B.; Ciocca, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-172</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The heat shock proteins (HSPs) induced by cell stress are expressed at high levels in a wide range of tumors and are closely assocd. with a poor prognosis and resistance to therapy.  The increased transcription of HSPs in tumor cells is due to loss of p53 function and to higher expression of the proto-oncogenes HER2 and c-Myc, and is crucial to tumorigenesis.  The HSP family members play overlapping, essential roles in tumor growth both by promoting autonomous cell proliferation and by inhibiting death pathways.  The HSPs have thus become targets for rational anti-cancer drug design: HSP90 inhibitors are currently showing much promise in clin. trials, whereas the increased expression of HSPs in tumors is forming the basis of chaperone-based immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxhSfR-fO787Vg90H21EOLACvtfcHk0ljx06Vt_Is41g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1ymsL4%253D&md5=6780e2b46a19edac2e52edc0afafafff</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2006.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2006.01.006%26sid%3Dliteratum%253Aachs%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26aulast%3DKhaleque%26aufirst%3DM.%2BA.%26aulast%3DSawyer%26aufirst%3DD.%2BB.%26aulast%3DCiocca%26aufirst%3DD.%2BR.%26atitle%3DHeat%2520shock%2520proteins%2520in%2520cancer%253A%2520chaperones%2520of%2520tumorigenesis%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2006%26volume%3D31%26spage%3D164%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S. L.</span><span> </span><span class="NLM_article-title">HSP90 and the chaperoning of cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnrc1716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=16175177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=761-772&author=L.+Whitesellauthor=S.+L.+Lindquist&title=HSP90+and+the+chaperoning+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 and the chaperoning of cancer</span></div><div class="casAuthors">Whitesell, Luke; Lindquist, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">761-772</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Standing watch over the proteome, mol. chaperones are an ancient and evolutionarily conserved class of proteins that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth, differentiation and survival.  This essential guardian function is subverted during oncogenesis to allow malignant transformation and to facilitate rapid somatic evolution.  Pharmacol. 'bribing' the essential guard duty of the chaperone HSP90 (heat-shock protein of 90 kDa) seems to offer a unique anticancer strategy of considerable promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Vmb5bGXgDLVg90H21EOLACvtfcHk0ljx06Vt_Is41g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGjs7bF&md5=c418ec249a29c70047081cd241938931</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc1716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1716%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DLindquist%26aufirst%3DS.%2BL.%26atitle%3DHSP90%2520and%2520the%2520chaperoning%2520of%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D761%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ali, M. M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span> </span><span class="NLM_article-title">Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1017</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnature04716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=16625188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1agtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=1013-1017&author=M.+M.+U.+Aliauthor=S.+M.+Roeauthor=C.+K.+Vaughanauthor=P.+Meyerauthor=B.+Panaretouauthor=P.+W.+Piperauthor=C.+Prodromouauthor=L.+H.+Pearl&title=Crystal+structure+of+an+Hsp90-nucleotide-p23%2FSba1+closed+chaperone+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex</span></div><div class="casAuthors">Ali, Maruf M. U.; Roe, S. Mark; Vaughan, Cara K.; Meyer, Phillipe; Panaretou, Barry; Piper, Peter W.; Prodromou, Chrisostomos; Pearl, Laurence H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7087</span>),
    <span class="NLM_cas:pages">1013-1017</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hsp90 (heat shock protein of 90 kDa) is a ubiquitous mol. chaperone responsible for the assembly and regulation of many eukaryotic signaling systems and is an emerging target for rational chemotherapy of many cancers.  Although the structures of isolated domains of Hsp90 have been detd., the arrangement and ATP-dependent dynamics of these in the full Hsp90 dimer have been elusive and contentious.  Here we present the crystal structure of full-length yeast Hsp90 in complex with an ATP analog and the co-chaperone p23/Sba1.  The structure reveals the complex architecture of the closed' state of the Hsp90 chaperone, the extensive interactions between domains and between protein chains, the detailed conformational changes in the amino-terminal domain that accompany ATP binding, and the structural basis for stabilization of the closed state by p23/Sba1.  Contrary to expectations, the closed Hsp90 would not enclose its client proteins but provides a bipartite binding surface whose formation and disruption are coupled to the chaperone ATPase cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcaj34ODndPbVg90H21EOLACvtfcHk0liyPFgXV56y0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1agtLw%253D&md5=15ea0bcf7cbf297b3f4a7005c7798fb0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature04716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04716%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DM.%2BM.%2BU.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DVaughan%26aufirst%3DC.%2BK.%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DPanaretou%26aufirst%3DB.%26aulast%3DPiper%26aufirst%3DP.%2BW.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520an%2520Hsp90-nucleotide-p23%252FSba1%2520closed%2520chaperone%2520complex%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D1013%26epage%3D1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southworth, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, D. A.</span><span> </span><span class="NLM_article-title">Structural analysis of <i>E. coli</i> hsp90 reveals dramatic nucleotide-dependent conformational rearrangements</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=329-340&author=A.+K.+Shiauauthor=S.+F.+Harrisauthor=D.+R.+Southworthauthor=D.+A.+Agard&title=Structural+analysis+of+E.+coli+hsp90+reveals+dramatic+nucleotide-dependent+conformational+rearrangements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DSouthworth%26aufirst%3DD.%2BR.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26atitle%3DStructural%2520analysis%2520of%2520E.%2520coli%2520hsp90%2520reveals%2520dramatic%2520nucleotide-dependent%2520conformational%2520rearrangements%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D329%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Overview: translating Hsp90 biology into Hsp90 drugs</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F1568009033481868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=14529382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2isro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=297-300&author=P.+Workman&title=Overview%3A+translating+Hsp90+biology+into+Hsp90+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Overview: translating Hsp90 biology into Hsp90 drugs</span></div><div class="casAuthors">Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">297-300</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 mol. chaperone has emerged as one of the most exciting targets for cancer drug development.  Hsp90 is overexpressed in many malignancies, very likely as a result of the stress that is induced both by the hostile cancer microenvironment and also by the mutation and aberrant expression of oncoproteins.  A particularly attractive feature of Hsp90 as a cancer drug target is that it is required for the conformational stability and function of a wide range of oncogenic "client" proteins, including c-Raf-1, Cdk4, ErbB2, mutant p53, c-Met, Polo-1 and telomerase hTERT.  Inhibition of Hsp90 should therefore block multiple mission crit. oncogenic pathways in the cancer cell, leading to inhibition of all the hallmark traits of malignancy.  This combinatorial blockade of oncogenic targets should give rise to board spectrum antitumor activity across multiple cancer types.  The "drugability" of Hsp90 was confirmed by the discovery that the natural products geldanamycin and radicicol, which have anticancer activity, exert their biol. effects by inhibiting the essential ATPase activity assocd. with the N-terminal domain of the protein.  The first-in-class Hsp90 inhibitor has entered clin. trial and provided proof of concept that Hsp90 can be inhibited and clin. benefit seen at non-toxic doses.  Further development is underway and a related analog 17DMAG also shows promise in preclin. models.  In addn., novel Hsp90 inhibitors have been identified using methods such as high throughput screening and x-ray crystallog.  The opportunities and challenges involved in translating the fast moving biol. of Hsp90 into patient benefit is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplxhiU6T39gbVg90H21EOLACvtfcHk0liyPFgXV56y0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2isro%253D&md5=432b5cd2c5ce72ac7dfce9c5c8ae91fe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1568009033481868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481868%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DOverview%253A%2520translating%2520Hsp90%2520biology%2520into%2520Hsp90%2520drugs%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D297%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yufu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawata, H.</span><span> </span><span class="NLM_article-title">High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells</span> <span class="citation_source-journal">Leuk. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2F0145-2126%2892%2990008-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=1635378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADyaK38zktFOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1992&pages=597-605&author=Y.+Yufuauthor=J.+Nishimuraauthor=H.+Nawata&title=High+constitutive+expression+of+heat+shock+protein+90+alpha+in+human+acute+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells</span></div><div class="casAuthors">Yufu Y; Nishimura J; Nawata H</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">597-605</span>
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    </div><div class="casAbstract">The constitutive expression of the genes for four heat shock proteins (hsps) was studied in leukemia cell lines, cells obtained from patients with acute leukemia, and normal blood cells by means of Northern-blot analysis.  Western-blot analysis with hsp90 antibody showed that the leukemia cells contained larger amounts of hsp90 than the normal peripheral mononuclear cells.  The expression of the hsp90 alpha gene was enhanced in the leukemia cell lines and the acute leukemia cells from patients as compared with the normal blood cells.  In contrast, the expression of the hsp90 beta gene could hardly be recognized in either the acute leukemia cells or the normal blood cells.  An increased expression of hsp70 gene was observed in only one patient.  The expression of the hsp27 gene was enhanced in one-half the patients with common acute lymphoblastic leukemia.  Thus, exclusively the hsp90 alpha gene was expressed highly in the leukemia cells, indicating its association with cellular proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5VwdQU7f4_OxsqfvU0ziafW6udTcc2ebRHNhTmmK1fLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zktFOgtw%253D%253D&md5=1a8f482a0bf97db922baf3b698bacbef</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2F0145-2126%2892%2990008-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0145-2126%252892%252990008-U%26sid%3Dliteratum%253Aachs%26aulast%3DYufu%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DJ.%26aulast%3DNawata%26aufirst%3DH.%26atitle%3DHigh%2520constitutive%2520expression%2520of%2520heat%2520shock%2520protein%252090%2520alpha%2520in%2520human%2520acute%2520leukemia%2520cells%26jtitle%3DLeuk.%2520Res.%26date%3D1992%26volume%3D16%26spage%3D597%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ciocca, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuqua, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lock-Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, W. L.</span><span> </span><span class="NLM_article-title">Response of human breast cancer cells to heat shock chemotherapeutic drugs</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3648</span><span class="NLM_x">–</span> <span class="NLM_lpage">3654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=3648-3654&author=D.+R.+Cioccaauthor=S.+A.+Fuquaauthor=S.+Lock-Limauthor=D.+O.+Toftauthor=W.+J.+Welchauthor=W.+L.+McGuire&title=Response+of+human+breast+cancer+cells+to+heat+shock+chemotherapeutic+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCiocca%26aufirst%3DD.%2BR.%26aulast%3DFuqua%26aufirst%3DS.%2BA.%26aulast%3DLock-Lim%26aufirst%3DS.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DWelch%26aufirst%3DW.%2BJ.%26aulast%3DMcGuire%26aufirst%3DW.%2BL.%26atitle%3DResponse%2520of%2520human%2520breast%2520cancer%2520cells%2520to%2520heat%2520shock%2520chemotherapeutic%2520drugs%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D3648%26epage%3D3654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shifrin, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=1721-1728&author=L.+Whitesellauthor=S.+D.+Shifrinauthor=G.+Schwabauthor=L.+M.+Neckers&title=Benzoquinonoid+ansamycins+possess+selective+tumoricidal+activity+unrelated+to+src+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DShifrin%26aufirst%3DS.%2BD.%26aulast%3DSchwab%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DBenzoquinonoid%2520ansamycins%2520possess%2520selective%2520tumoricidal%2520activity%2520unrelated%2520to%2520src%2520kinase%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D1721%26epage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">8324</span><span class="NLM_x">–</span> <span class="NLM_lpage">8328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1073%2Fpnas.91.18.8324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=8078881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8324-8328&author=L.+Whitesellauthor=E.+G.+Mimnaughauthor=B.+De+Costaauthor=C.+E.+Myersauthor=L.+M.+Neckers&title=Inhibition+of+heat+shock+protein+HSP90-pp60v-src+heteroprotein+complex+formation+by+benzoquinone+ansamycins%3A+essential+role+for+stress+proteins+in+oncogenic+transformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span></div><div class="casAuthors">Whitesell, Luke; Mimnaugh, Edward G.; De Costa, Brian; Myers, Charles E.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8324-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The mol. mechanisms by which oncogenic tyrosine kinases induce cellular transformation are unclear.  Herbimycin A, geldanamycin, and certain other benzoquinone ansamycins display an unusual capacity to revert tyrosine kinase-induced oncogenic transformation.  As an approach to the study of v-src-mediated transformation, the authors examd. ansamycin action in transformed cells and found that drug-induced reversion could be achieved without direct inhibition of src phosphorylating activity.  To identify mechanisms other than kinase inhibition for drug-mediated reversion, the authors prepd. a solid phase-immobilized geldanamycin deriv. and affinity pptd. the mol. targets with which the drug interacted.  In a range of cell lines, immobilized geldanamycin bound elements of a major class of heat shock protein (HSP90) in a stable and pharmacol. specific manner.  Consistent with these binding data, the authors found that sol. geldanamycin and herbimycin A inhibited specifically the formation of a previously described src-HSP90 heteroprotein complex.  A related benzoquinone ansamycin that failed to revert transformed cells did not inhibit the formation of this complex.  These results demonstrate that HSP participation in multimol. complex formation is required for src-mediated transformation and can provide a target for drug modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTW8DJOglQLVg90H21EOLACvtfcHk0lhCU4qgqAjRRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D&md5=18f1cad01698df44adaa05ef3da9f850</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8324%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DDe%2BCosta%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%2520HSP90-pp60v-src%2520heteroprotein%2520complex%2520formation%2520by%2520benzoquinone%2520ansamycins%253A%2520essential%2520role%2520for%2520stress%2520proteins%2520in%2520oncogenic%2520transformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D8324%26epage%3D8328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0licu4J2lRyC4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sawyers, C.</span><span> </span><span class="NLM_article-title">Targeted cancer therapy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnature03095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=15549090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=294-297&author=C.+Sawyers&title=Targeted+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted cancer therapy</span></div><div class="casAuthors">Sawyers, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7015</span>),
    <span class="NLM_cas:pages">294-297</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Disruption of the normal regulation of cell-cycle progression and division lies at the heart of the events leading to cancer.  Complex networks of regulatory factors, the tumor microenvironment and stress signals, such as those resulting from damaged DNA, dictate whether cancer cells proliferate or die.  Recent progress in understanding the mol. changes that underlie cancer development offer the prospect of specifically targeting malfunctioning mols. and pathways to achieve more effective and rational cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAGMTW2TYsubVg90H21EOLACvtfcHk0licu4J2lRyC4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtL8%253D&md5=5bd377d2c9ddcffc136d5cf181facd02</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature03095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03095%26sid%3Dliteratum%253Aachs%26aulast%3DSawyers%26aufirst%3DC.%26atitle%3DTargeted%2520cancer%2520therapy%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D294%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ji, H.</span><span> </span><span class="NLM_article-title">Mechanistic insights into acquired drug resistance in epidermal growth factor receptor mutation-targeted lung cancer therapy</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2010&pages=1993&author=H.+Ji&title=Mechanistic+insights+into+acquired+drug+resistance+in+epidermal+growth+factor+receptor+mutation-targeted+lung+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%26atitle%3DMechanistic%2520insights%2520into%2520acquired%2520drug%2520resistance%2520in%2520epidermal%2520growth%2520factor%2520receptor%2520mutation-targeted%2520lung%2520cancer%2520therapy%26jtitle%3DCancer%2520Sci.%26date%3D2010%26volume%3D101%26spage%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sierra, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cepero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1186%2F1476-4598-9-75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20385023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADC%252BC3czhtVelsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=75&author=J.+R.+Sierraauthor=V.+Ceperoauthor=S.+Giordano&title=Molecular+mechanisms+of+acquired+resistance+to+tyrosine+kinase+targeted+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy</span></div><div class="casAuthors">Sierra J Rafael; Cepero Virna; Giordano Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In recent years, tyrosine kinases (TKs) have been recognized as central players and regulators of cancer cell proliferation, apoptosis, and angiogenesis, and are therefore considered suitable potential targets for anti-cancer therapies.  Several strategies for targeting TKs have been developed, the most successful being monoclonal antibodies and small molecule tyrosine kinase inhibitors.  However, increasing evidence of acquired resistance to these drugs has been documented, and extensive preclinical studies are ongoing to try to understand the molecular mechanisms by which cancer cells are able to bypass their inhibitory activity.This review intends to present the most recently identified molecular mechanisms that mediate acquired resistance to tyrosine kinase inhibitors, identified through the use of in vitro models or the analysis of patient samples.  The knowledge obtained from these studies will help to design better therapies that prevent and overcome resistance to treatment in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmF8Wk15sVr2xpATR2EQURfW6udTcc2eZ7d-SN_l3fK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czhtVelsQ%253D%253D&md5=89d75465d845f4bc04159d114fe57488</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-9-75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-9-75%26sid%3Dliteratum%253Aachs%26aulast%3DSierra%26aufirst%3DJ.%2BR.%26aulast%3DCepero%26aufirst%3DV.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DMolecular%2520mechanisms%2520of%2520acquired%2520resistance%2520to%2520tyrosine%2520kinase%2520targeted%2520therapy%26jtitle%3DMol.%2520Cancer%26date%3D2010%26volume%3D9%26spage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Goldie, J. H.</span><span> </span><span class="NLM_article-title">Drug resistance in cancer: a perspective</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1023%2FA%3A1013164609041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=11831649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVWlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=63-68&author=J.+H.+Goldie&title=Drug+resistance+in+cancer%3A+a+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance in cancer: A perspective</span></div><div class="casAuthors">Goldie, James H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">63-68</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review. Drug resistance remains the thorniest obstacle in developing improved systemic therapies for disseminated cancer.  The combination of genetic instability together with the great mol. heterogeneity that are displayed by malignant cells makes constructing effective, rational treatment programs difficult in the extreme.  However, new insights into the action of antitumor agents at the mol. level plus greater understanding of the relationship of drug-resistant states to the fundamental abnormalities that generate malignancy point the way to producing therapies that are more specific and therapeutically effective.  However, a nontrivial problem is the drug-development system itself which is currently poorly set up to yield patient-specific drug programs in a timely fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmR10o7PHtCLVg90H21EOLACvtfcHk0ljvptuuFv0wkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVWlur0%253D&md5=df96aee242d4ae829135d53ade71d856</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1023%2FA%3A1013164609041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1013164609041%26sid%3Dliteratum%253Aachs%26aulast%3DGoldie%26aufirst%3DJ.%2BH.%26atitle%3DDrug%2520resistance%2520in%2520cancer%253A%2520a%2520perspective%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2001%26volume%3D20%26spage%3D63%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Altered states: selectively drugging the Hsp90 cancer chaperone</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=47-51&author=P.+Workman&title=Altered+states%3A+selectively+drugging+the+Hsp90+cancer+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DAltered%2520states%253A%2520selectively%2520drugging%2520the%2520Hsp90%2520cancer%2520chaperone%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D47%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Weinstein, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joe, A.</span><span> </span><span class="NLM_article-title">Oncogene addiction</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3077</span><span class="NLM_x">–</span> <span class="NLM_lpage">3080</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3077-3080&author=I.+B.+Weinsteinauthor=A.+Joe&title=Oncogene+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinstein%26aufirst%3DI.%2BB.%26aulast%3DJoe%26aufirst%3DA.%26atitle%3DOncogene%2520addiction%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D3077%26epage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Garber, K.</span><span> </span><span class="NLM_article-title">Synthetic lethality: killing cancer with cancer</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1666</span><span class="NLM_x">–</span> <span class="NLM_lpage">1668</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1093%2Fjnci%2F94.22.1666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=12441317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADC%252BD38notFWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2002&pages=1666-1668&author=K.+Garber&title=Synthetic+lethality%3A+killing+cancer+with+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic lethality: killing cancer with cancer</span></div><div class="casAuthors">Garber Ken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1666-8</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcmhyNfLgktl1C8OJBvdfbfW6udTcc2eZUGD2-De0jRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38notFWitg%253D%253D&md5=5a85a414a3b9183584c9771c79052e98</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F94.22.1666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F94.22.1666%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DK.%26atitle%3DSynthetic%2520lethality%253A%2520killing%2520cancer%2520with%2520cancer%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2002%26volume%3D94%26spage%3D1666%26epage%3D1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0ljvptuuFv0wkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb600224w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=279-284&author=G.+Chiosisauthor=L.+Neckers&title=Tumor+selectivity+of+Hsp90+inhibitors%3A+the+explanation+remains+elusive"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcb600224w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb600224w%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTumor%2520selectivity%2520of%2520Hsp90%2520inhibitors%253A%2520the%2520explanation%2520remains%2520elusive%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2006%26volume%3D1%26spage%3D279%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Trepel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollapour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0lhbjHeYGDESoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 in neurodegenerative diseases</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1186%2F1750-1326-5-24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20525284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADC%252BC3cnkslCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=24&author=W.+Luoauthor=W.+Sunauthor=T.+Taldoneauthor=A.+Rodinaauthor=G.+Chiosis&title=Heat+shock+protein+90+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90 in neurodegenerative diseases</span></div><div class="casAuthors">Luo Wenjie; Sun Weilin; Taldone Tony; Rodina Anna; Chiosis Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neurodegeneration</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hsp90 is a molecular chaperone with important roles in regulating pathogenic transformation.  In addition to its well-characterized functions in malignancy, recent evidence from several laboratories suggests a role for Hsp90 in maintaining the functional stability of neuronal proteins of aberrant capacity, whether mutated or over-activated, allowing and sustaining the accumulation of toxic aggregates.  In addition, Hsp90 regulates the activity of the transcription factor heat shock factor-1 (HSF-1), the master regulator of the heat shock response, mechanism that cells use for protection when exposed to conditions of stress.  These biological functions therefore propose Hsp90 inhibition as a dual therapeutic modality in neurodegenerative diseases.  First, by suppressing aberrant neuronal activity, Hsp90 inhibitors may ameliorate protein aggregation and its associated toxicity.  Second, by activation of HSF-1 and the subsequent induction of heat shock proteins, such as Hsp70, Hsp90 inhibitors may redirect neuronal aggregate formation, and protect against protein toxicity.  This mini-review will summarize our current knowledge on Hsp90 in neurodegeneration and will focus on the potential beneficial application of Hsp90 inhibitors in neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYuS3z9s_ui5dYoSR9eyvsfW6udTcc2eZSau61TBM2mbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnkslCruw%253D%253D&md5=dd686137ecbf1860adf2d5607eb9b229</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1186%2F1750-1326-5-24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-1326-5-24%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DHeat%2520shock%2520protein%252090%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMol.%2520Neurodegener.%26date%3D2010%26volume%3D5%26spage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Neef, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, D. J.</span><span> </span><span class="NLM_article-title">Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=930-944&author=D.+W.+Neefauthor=A.+M.+Jaegerauthor=D.+J.+Thiele&title=Heat+shock+transcription+factor+1+as+a+therapeutic+target+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeef%26aufirst%3DD.%2BW.%26aulast%3DJaeger%26aufirst%3DA.%2BM.%26aulast%3DThiele%26aufirst%3DD.%2BJ.%26atitle%3DHeat%2520shock%2520transcription%2520factor%25201%2520as%2520a%2520therapeutic%2520target%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D930%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chaudhury, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S. J.</span><span> </span><span class="NLM_article-title">Hsp90 as a target for drug development</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1331</span><span class="NLM_x">–</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1331-1340&author=S.+Chaudhuryauthor=T.+R.+Welchauthor=B.+S.+J.+Blagg&title=Hsp90+as+a+target+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhury%26aufirst%3DS.%26aulast%3DWelch%26aufirst%3DT.%2BR.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DHsp90%2520as%2520a%2520target%2520for%2520drug%2520development%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D1331%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Jhaveri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+in+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D90%26spage%3D742%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">ATPase inhibitors of heat-shock protein 90, second season</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=342-353&author=Y.+L.+Janin&title=ATPase+inhibitors+of+heat-shock+protein+90%2C+second+season"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DATPase%2520inhibitors%2520of%2520heat-shock%2520protein%252090%252C%2520second%2520season%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depew, K. M.</span><span> </span><span class="NLM_article-title">Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2Fj.cbpa.2010.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20409745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=412-420&author=J.+R.+Porterauthor=C.+C.+Fritzauthor=K.+M.+Depew&title=Discovery+and+development+of+Hsp90+inhibitors%3A+a+promising+pathway+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy</span></div><div class="casAuthors">Porter, James R.; Fritz, Christian C.; Depew, Kristopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-420</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Hsp90 chaperone is a master regulator of the stability and activity of multiple oncoproteins such as Her2, Akt, Bcr-Abl, c-Kit, EGFR and mutant BRAF.  The promise of inhibition of such a master regulator for cancer therapy is the potential to cause combinatorial inhibition of multiple oncogenic signaling pathways simultaneously.  With the recent discovery of feedback loops that effectively negate the efficacy of selectively targeted anti-cancer agents, there is renewed interest in such a multi-pronged approach.  There are now 14 drug candidates that target Hsp90 undergoing clin. trials in multiple indications as single agents or combination therapy.  These compds. represent a diverse array of chem. matter stemming from natural product scaffolds to synthetic structure-based design.  Although the compds. fall into distinct classes with unique properties, each inhibitor binds in the N-terminal ATP pocket and accumulates in tumor tissue while being rapidly cleared from circulation and normal tissue.  The most advanced candidates are now in Phase 2 clin. trials and defining the therapeutic window, dosing schedule, and indication are the primary challenges for these potential first-in-class inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSHW-vNCZ49rVg90H21EOLACvtfcHk0lhF6q9Zus5tJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsbw%253D&md5=628b4d92e4ff4cd8d831e51674501001</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DFritz%26aufirst%3DC.%2BC.%26aulast%3DDepew%26aufirst%3DK.%2BM.%26atitle%3DDiscovery%2520and%2520development%2520of%2520Hsp90%2520inhibitors%253A%2520a%2520promising%2520pathway%2520for%2520cancer%2520therapy%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D412%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Water, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perret, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-C.</span><span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.-C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0lhF6q9Zus5tJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.-C.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarcon, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giaccone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepel, J. B.</span><span> </span><span class="NLM_article-title">Update on Hsp90 inhibitors in clinical trial</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1479</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F156802609789895728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=19860730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1479-1492&author=Y.+S.+Kimauthor=S.+V.+Alarconauthor=S.+Leeauthor=M.-J.+Leeauthor=G.+Giacconeauthor=L.+Neckersauthor=J.+B.+Trepel&title=Update+on+Hsp90+inhibitors+in+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Hsp90 inhibitors in clinical trial</span></div><div class="casAuthors">Kim, Y. S.; Alarcon, S. V.; Lee, S.; Lee, M.-J.; Giaccone, G.; Neckers, L.; Trepel, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1479-1492</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Twenty-five years ago the first small mol. inhibitors of Hsp90 were identified.  In the intervening years there has been dramatic progress in basic scientific understanding of the Hsp90 chaperone machinery and in the role of Hsp90 in malignancy.  The first-in-class Hsp90 inhibitor 17-AAG entered into Phase I clin. trials in 1999.  There are now 13 Hsp90 inhibitors in clin. trial, representing multiple drug classes, and hundreds of patients have been treated in adult oncol. and pediatric oncol. trials.  This review will provide an overview of the clin. trial results thus far.  In addn., pivotal issues in further development of Hsp90 inhibitors as anticancer drugs will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMNnAHRqUDCbVg90H21EOLACvtfcHk0lj96-VIoyWW8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakurc%253D&md5=7b375c5935176b38d0eeab68d3a0d0e8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F156802609789895728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789895728%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DAlarcon%26aufirst%3DS.%2BV.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.-J.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26atitle%3DUpdate%2520on%2520Hsp90%2520inhibitors%2520in%2520clinical%2520trial%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1479%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Amolins, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S. J.</span><span> </span><span class="NLM_article-title">Natural product inhibitors of Hsp90: potential leads for drug discovery</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=140-152&author=M.+W.+Amolinsauthor=B.+S.+J.+Blagg&title=Natural+product+inhibitors+of+Hsp90%3A+potential+leads+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmolins%26aufirst%3DM.%2BW.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DNatural%2520product%2520inhibitors%2520of%2520Hsp90%253A%2520potential%2520leads%2520for%2520drug%2520discovery%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D140%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Samuni, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyodo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuni, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span> </span><span class="NLM_article-title">Reactive oxygen species mediated hepatotoxicity induced by the Hsp90 inhibiting anti-cancer geldanamycin and its analogs</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1559</span><span class="NLM_x">–</span> <span class="NLM_lpage">1563</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2Fj.freeradbiomed.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=20211249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=1559-1563&author=Y.+Samuniauthor=H.+Ishiiauthor=F.+Hyodoauthor=U.+Samuniauthor=M.+C.+Krishnaauthor=S.+Goldsteinauthor=J.+B.+Mitchell&title=Reactive+oxygen+species+mediated+hepatotoxicity+induced+by+the+Hsp90+inhibiting+anti-cancer+geldanamycin+and+its+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs</span></div><div class="casAuthors">Samuni, Yuval; Ishii, Hisanari; Hyodo, Fuminori; Samuni, Uri; Krishna, Murali C.; Goldstein, Sara; Mitchell, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1559-1563</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Geldanamycin (GM), a benzoquinone ansamycin antibiotic, is a natural product inhibitor of Hsp90 with potent and broad anti-cancer properties.  Because of its adverse effects on liver, its less toxic derivs. 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) are currently being evaluated for the treatment of cancer.  Previously, it was demonstrated that the redox cycling of GM by NADPH-cytochrome P 450 reductase leads to the formation of the GM semiquinone and superoxide radicals, the latter being identified using spin-trapping.  We hypothesized that the different hepatotoxicity induced by GM, 17-AAG, and 17-DMAG reflects the redox active properties of the quinone moiety and possibly the extent of superoxide formation, which may stimulate cellular oxidative injury.  Our data demonstrate that superoxide can be efficiently trapped during the redn. of GM, 17-AAG, and 17-DMAG by NADPH-cytochrome P 450 reductase, and that superoxide formation rate followed the order 17-DMAG > 17-AAG > GM.  In the absence of superoxide scavengers, the rate of NADPH oxidn. followed the order 17-DMAG > GM > 17-AAG.  The half-wave one-electron redn. potentials (E1/2) of GM, 17-AAG, and 17-DMAG in DMSO were detd. to be -0.37, -0.13 and -0.015 V (vs. Ag/AgCl), resp.  If the same order of E1/2 follows in neutral aq. media, thermodn. considerations imply that 17-DMAG is more readily reduced by the P 450 reductase as well as by superoxide.  The order of the drug cytotoxicity toward rat primary hepatocytes, as detd. by their effect on cell viability and on intracellular oxidant level, was opposite to the order of E1/2 of the resp. quinone/semiquinone couples.  These results suggest that hepatotoxicity exhibited by the Hsp90 inhibitors belonging to benzoquinone ansamycins could be attributed to superoxide.  The apparent discrepancy between the order of toxicity and the orders of superoxide formation rate, which is correlated with E1/2, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpruuvDYz3MwbVg90H21EOLACvtfcHk0lj96-VIoyWW8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGru7Y%253D&md5=25d6f75c0c010667a4d9d9be51f67c21</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DSamuni%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DHyodo%26aufirst%3DF.%26aulast%3DSamuni%26aufirst%3DU.%26aulast%3DKrishna%26aufirst%3DM.%2BC.%26aulast%3DGoldstein%26aufirst%3DS.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DReactive%2520oxygen%2520species%2520mediated%2520hepatotoxicity%2520induced%2520by%2520the%2520Hsp90%2520inhibiting%2520anti-cancer%2520geldanamycin%2520and%2520its%2520analogs%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26spage%3D1559%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Cysyk, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steeg, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strong, J. M.</span><span> </span><span class="NLM_article-title">Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx050237e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=376-381&author=R.+L.+Cysykauthor=R.+J.+Parkerauthor=J.+J.+Barchiauthor=P.+S.+Steegauthor=N.+R.+Hartmanauthor=J.+M.+Strong&title=Reaction+of+geldanamycin+and+C17-substituted+analogues+with+glutathione%3A+product+identifications+and+pharmacological+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Ftx050237e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx050237e%26sid%3Dliteratum%253Aachs%26aulast%3DCysyk%26aufirst%3DR.%2BL.%26aulast%3DParker%26aufirst%3DR.%2BJ.%26aulast%3DBarchi%26aufirst%3DJ.%2BJ.%26aulast%3DSteeg%26aufirst%3DP.%2BS.%26aulast%3DHartman%26aufirst%3DN.%2BR.%26aulast%3DStrong%26aufirst%3DJ.%2BM.%26atitle%3DReaction%2520of%2520geldanamycin%2520and%2520C17-substituted%2520analogues%2520with%2520glutathione%253A%2520product%2520identifications%2520and%2520pharmacological%2520implications%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2006%26volume%3D19%26spage%3D376%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span> </span><span class="NLM_article-title">Development of radicicol analogues</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F1568009033481859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=14529387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=359-369&author=S.+Sogaauthor=Y.+Shiotsuauthor=S.+Akinagaauthor=S.+Sharma&title=Development+of+radicicol+analogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radicicol analogues</span></div><div class="casAuthors">Soga, Shiro; Shiotsu, Yukimasa; Akinaga, Shiro; Sharma, Sreenath V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-369</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Radicicol, a macrocyclic antibiotic produced by fungi, was originally isolated many years ago, and was described as tyrosine kinase inhibitor.  We also rediscovered radicicol as an inhibitor of signal transduction of oncogene products, such as K-ras and v-Src, using yeast and mammalian cell-based assays.  In a study of mechanisms of action, it was revealed that radicicol depletes the Hsp90 client signaling mols. in cells, and thus inhibit the signal transduction pathway.  In addn., direct binding of radicicol to the N-terminal ATP/ADP binding site of Hsp90 was shown, and thus radicicol has been recognized as a structurally unique antibiotic that binds and inhibits the mol. chaperone Hsp90.  Although radicicol itself has little or no activity in animals because of instability in animals, its oxime derivs. showed potent antitumor activities against human tumor xenograft models.  Hsp90 client proteins were depleted and apoptosis was induced in the tumor specimen treated with radicicol oxime derivs.  Taken together, these results suggest that the antitumor activity of radicicol oxime derivs. is mediated by binding to Hsp90 and destabilization of Hsp90 client proteins in the tumor.  Among Hsp90 clients, we focused on ErbB2 and Bcr-Abl as examples of important targets of Hsp90 inhibitors.  Radicicol oxime showed potent antitumor activity against ER neg./ErbB2 overexpressing breast cancer and Bcr-Abl expressing CML.  Putative mechanisms of action and future directions of radicicol oxime against these kinds of tumor are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uapkd0TYQrVg90H21EOLACvtfcHk0lhXO-GRxN4DIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2is74%253D&md5=59ef4ec5535cec06665a164be0b12305</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1568009033481859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481859%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520radicicol%2520analogues%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D359%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Winssinger, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barluenga, S.</span><span> </span><span class="NLM_article-title">Chemistry and biology of resorcylic acid lactones</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=22-36&author=N.+Winssingerauthor=S.+Barluenga&title=Chemistry+and+biology+of+resorcylic+acid+lactones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWinssinger%26aufirst%3DN.%26aulast%3DBarluenga%26aufirst%3DS.%26atitle%3DChemistry%2520and%2520biology%2520of%2520resorcylic%2520acid%2520lactones%26jtitle%3DChem.%2520Commun.%26date%3D2007%26spage%3D22%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Geng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danishefsky, S. J.</span><span> </span><span class="NLM_article-title">Synthetic development of radicicol and cycloproparadicicol: highly promising anticancer agents targeting Hsp90</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=1325-1333&author=X.+Gengauthor=Z.-Q.+Yangauthor=S.+J.+Danishefsky&title=Synthetic+development+of+radicicol+and+cycloproparadicicol%3A+highly+promising+anticancer+agents+targeting+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DZ.-Q.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26atitle%3DSynthetic%2520development%2520of%2520radicicol%2520and%2520cycloproparadicicol%253A%2520highly%2520promising%2520anticancer%2520agents%2520targeting%2520Hsp90%26jtitle%3DSynlett%26date%3D2004%26spage%3D1325%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Tietze, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span> </span><span class="NLM_article-title">Natural product hybrids as new leads for drug discovery</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3996</span><span class="NLM_x">–</span> <span class="NLM_lpage">4028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1002%2Fanie.200200553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslSlsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=3996-4028&author=L.+F.+Tietzeauthor=H.+P.+Bellauthor=S.+Chandrasekhar&title=Natural+product+hybrids+as+new+leads+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product hybrids as new leads for drug discovery</span></div><div class="casAuthors">Tietze, Lutz F.; Bell, Hubertus P.; Chandrasekhar, Srivari</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">3996-4028</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Natural products play an important role in the development of drugs, esp. for the treatment of infections and cancer, as well as immunosuppressive compds.  However, the no. of natural products is limited, whereas millions of hybrids as combinations of parts of different natural products can be prepd.  This new approach seems to be very promising in the development of leads for both medicinal and agrochem. applications, as the biol. activity of several new hybrids exceeds that of the parent compds.  The advantage of this concept over a combinatorial chem. approach is the high diversity and the inherent biol. activity of the hybrids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGTkEzD4p1YbVg90H21EOLACvtfcHk0lhXO-GRxN4DIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslSlsrk%253D&md5=b0582d7a40ce53ce5b957b287b74d750</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fanie.200200553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200200553%26sid%3Dliteratum%253Aachs%26aulast%3DTietze%26aufirst%3DL.%2BF.%26aulast%3DBell%26aufirst%3DH.%2BP.%26aulast%3DChandrasekhar%26aufirst%3DS.%26atitle%3DNatural%2520product%2520hybrids%2520as%2520new%2520leads%2520for%2520drug%2520discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D3996%26epage%3D4028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationships for chimeric inhibitors of Hsp90</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">7618</span><span class="NLM_x">–</span> <span class="NLM_lpage">7631</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo061054f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=7618-7631&author=G.+Shenauthor=M.+Wangauthor=T.+R.+Welchauthor=B.+S.+J.+Blagg&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+for+chimeric+inhibitors+of+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo061054f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061054f%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWelch%26aufirst%3DT.%2BR.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520for%2520chimeric%2520inhibitors%2520of%2520Hsp90%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D7618%26epage%3D7631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Purine-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1436</span><span class="NLM_x">–</span> <span class="NLM_lpage">1446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F156802609789895737" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=19860732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1436-1446&author=T.+Taldoneauthor=G.+Chiosis&title=Purine-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Purine-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">Taldone, Tony; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1436-1446</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a mol. chaperone with important roles in regulating the function of several proteins with potential pathogenic activity.  Because many of these proteins are involved in cancer and neurodegenerative promoting pathways, Hsp90 has emerged as an attractive therapeutic target in these diseases.  Mols. that bind to the N-terminal nucleotide pocket of Hsp90 inhibit its activity, and consequently, disrupt client protein function.  A no. of these inhibitors from several chem. classes are now known, and some are already in clin. trials.  This review focuses on the purine class of Hsp90 inhibitors, their discovery through rational design, and on efforts aimed towards their optimization and development into clin. viable drugs for the treatment of cancer.  Their potential towards neurodegenerative diseases will also be touched upon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVLlJs6fJ--rVg90H21EOLACvtfcHk0ljUEANTz3CxbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakurg%253D&md5=346a3ef4c1503aee2d918074c1ecb46c</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.2174%2F156802609789895737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789895737%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DPurine-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1436%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Discovery and development of purine-scaffold Hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">–</span> <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F156802606777812013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=16842155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1183-1191&author=G.+Chiosis&title=Discovery+and+development+of+purine-scaffold+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of purine-scaffold Hsp90 inhibitors</span></div><div class="casAuthors">Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1183-1191</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 allows cancer cells to tolerate the many components of dysregulated pathways in a transformation-specific manner by interacting with several client substrates, such as kinases, hormone receptors and transcription factors that are directly involved in driving multistep malignancy, and also with mutated oncogenic proteins required for the transformed phenotype.  This distinctive broad involvement in maintaining the transformed phenotype has suggested Hsp90 as an important target in cancer therapy.  Discovery of pharmacol. agents that selectively inhibit its function have aided in probing the biol. functions of Hsp90 at the mol. level and in validating it as a novel target for anticancer drug action.  Two natural product derivs., 17-allylamino-17-desmethoxy-geldanamycin (17AAG) and 17-dimethylaminoethylamino-17-desmethoxy-geldanamycin (17DMAG) have further entered clin. trials, proving that Hsp90 may be modulated pharmacol. without causing target related toxicities in humans.  In spite of their usefulness as proof-of-principle compds., the clin. use of these two agents has been encumbered with some limitations due to their structural characteristics and also to less than optimal pharmacol. profiles.  Thus, the identification of Hsp90 inhibitors with improved structural characteristics and better pharmacol. profiles is a major focus of interest in the field.  One such emerging class is the purine-scaffold series.  This review intends to inform the reader on efforts ranging from the discovery to their clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtpMNMTF3zyLVg90H21EOLACvtfcHk0ljUEANTz3CxbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1ejtLw%253D&md5=f619bbb69cd7ac43a2112d56e5a904f2</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.2174%2F156802606777812013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606777812013%26sid%3Dliteratum%253Aachs%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520purine-scaffold%2520Hsp90%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1183%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0508078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=381-390&author=H.+Heauthor=D.+Zatorskaauthor=J.+Kimauthor=J.+Aguirreauthor=L.+Llaugerauthor=Y.+Sheauthor=N.+Wuauthor=R.+M.+Immorminoauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Identification+of+potent+water+soluble+purine-scaffold+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90</span></div><div class="casAuthors">He, Huazhong; Zatorska, Danuta; Kim, Joungnam; Aguirre, Julia; Llauger, Laura; She, Yuhong; Wu, Nian; Immormino, Robert M.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hsp90 is a chaperone protein that allows cancer cells to tolerate the many components of dysregulated pathways.  Its inactivation may result in targeting multiple mol. alterations and, thus, in reverting the transformed phenotype.  The PU-class, a purine-scaffold Hsp90 inhibitor series, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer.  Here, a series of this class was synthesized and evaluated as inhibitors of the chaperone.  The structure-activity relationship and selectivity for tumor Hsp90 of compds. within the series is presented.  The study identifies water sol. derivs. (>5 mM in PBS pH 7.4) of nanomolar potency (IC50 ∼ 50 nM) in cellular and animal models of cancer.  Binding affinities of these compds. for Hsp90 correlate well with their biol. activities.  When administered in vivo to mice bearing MDA-MB-468 human breast cancer xenografted tumors, these agents result in pharmacol. relevant concns. and, accordingly, in modulation of Hsp90-client proteins in tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRwHp1Wo_iW7Vg90H21EOLACvtfcHk0ljUEANTz3CxbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ynsrrF&md5=3bd02ca5bc0a147e9cffa58968433917</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm0508078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0508078%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DShe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potent%2520water%2520soluble%2520purine-scaffold%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D381%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maldonado, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Orally active purine-based inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=817-828&author=M.+A.+Biamonteauthor=J.+Shiauthor=K.+Hongauthor=D.+C.+Hurstauthor=L.+Zhangauthor=J.+Fanauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=A.+A.+Maldonadoauthor=J.+L.+Sensintaffarauthor=Y.-C.+Yangauthor=A.+Kamalauthor=R.+E.+Loughauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=G.+A.+Timonyauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Orally+active+purine-based+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0503087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503087%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DHurst%26aufirst%3DD.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DMaldonado%26aufirst%3DA.%2BA.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DY.-C.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DOrally%2520active%2520purine-based%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D817%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767-2778&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Zehnder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braganza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovalsantos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wythes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span> </span><span class="NLM_article-title">Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1<i>H</i>-pyrazol-1-yl)ethoxy]-6-methylphenyl}-<i>N</i>-(2,2-difluoropropyl)-5,7-dihydro-6<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxamide</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3368</span><span class="NLM_x">–</span> <span class="NLM_lpage">3385</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200128m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3368-3385&author=L.+Zehnderauthor=M.+Bennettauthor=J.+Mengauthor=B.+Huangauthor=S.+Ninkovicauthor=F.+Wangauthor=J.+Braganzaauthor=J.+Tatlockauthor=T.+Jewellauthor=J.+Z.+Zhouauthor=B.+Burkeauthor=J.+Wangauthor=K.+Maegleyauthor=P.+P.+Mehtaauthor=M.-J.+Yinauthor=K.+S.+Gajiwalaauthor=M.+J.+Hickeyauthor=S.+Yamazakiauthor=E.+Smithauthor=P.+Kangauthor=A.+Sistlaauthor=E.+Dovalsantosauthor=M.+R.+Gehringauthor=R.+Kaniaauthor=M.+Wythesauthor=P.-P.+Kung&title=Optimization+of+potent%2C+selective%2C+and+orally+bioavailable+pyrrolodinopyrimidine-containing+inhibitors+of+heat+shock+protein+90.+Identification+of+development+candidate+2-amino-4-%7B4-chloro-2-%5B2-%284-fluoro-1H-pyrazol-1-yl%29ethoxy%5D-6-methylphenyl%7D-N-%282%2C2-difluoropropyl%29-5%2C7-dihydro-6H-pyrrolo%5B3%2C4-d%5Dpyrimidine-6-carboxamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm200128m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200128m%26sid%3Dliteratum%253Aachs%26aulast%3DZehnder%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DBraganza%26aufirst%3DJ.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DJewell%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DJ.%2BZ.%26aulast%3DBurke%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DYin%26aufirst%3DM.-J.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DDovalsantos%26aufirst%3DE.%26aulast%3DGehring%26aufirst%3DM.%2BR.%26aulast%3DKania%26aufirst%3DR.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DKung%26aufirst%3DP.-P.%26atitle%3DOptimization%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520pyrrolodinopyrimidine-containing%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090.%2520Identification%2520of%2520development%2520candidate%25202-amino-4-%257B4-chloro-2-%255B2-%25284-fluoro-1H-pyrazol-1-yl%2529ethoxy%255D-6-methylphenyl%257D-N-%25282%252C2-difluoropropyl%2529-5%252C7-dihydro-6H-pyrrolo%255B3%252C4-d%255Dpyrimidine-6-carboxamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3368%26epage%3D3385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackman, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acquaviva, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, K.</span><span> </span><span class="NLM_article-title">Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1158%2F1535-7163.MCT-11-0755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=22144665" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=475-484&author=W.+Yingauthor=Z.+Duauthor=L.+Sunauthor=K.+P.+Foleyauthor=D.+A.+Proiaauthor=R.+K.+Blackmanauthor=D.+Zhouauthor=T.+Inoueauthor=N.+Tatsutaauthor=J.+Sangauthor=S.+Yeauthor=J.+Acquavivaauthor=L.+S.+Ogawaauthor=Y.+Wadaauthor=J.+Barsoumauthor=K.+Koya&title=Ganetespib%2C+a+unique+triazolone-containing+Hsp90+inhibitor%2C+exhibits+potent+antitumor+activity+and+a+superior+safety+profile+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0755%26sid%3Dliteratum%253Aachs%26aulast%3DYing%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DProia%26aufirst%3DD.%2BA.%26aulast%3DBlackman%26aufirst%3DR.%2BK.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DTatsuta%26aufirst%3DN.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DS.%26aulast%3DAcquaviva%26aufirst%3DJ.%26aulast%3DOgawa%26aufirst%3DL.%2BS.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DKoya%26aufirst%3DK.%26atitle%3DGanetespib%252C%2520a%2520unique%2520triazolone-containing%2520Hsp90%2520inhibitor%252C%2520exhibits%2520potent%2520antitumor%2520activity%2520and%2520a%2520superior%2520safety%2520profile%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D11%26spage%3D475%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span> </span><span class="NLM_article-title">Medicinal chemistry strategies in follow-on drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=516-522&author=H.+Zhaoauthor=Z.+Guo&title=Medicinal+chemistry+strategies+in+follow-on+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DMedicinal%2520chemistry%2520strategies%2520in%2520follow-on%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D516%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bajji, A.; Kim, S.-H.; Tangallapally, R.; Markovitz, B.; Trovato, R.; Anderson, M. B.; Wettstein, D.; Shenderovich, M.</span><span> </span><span class="NLM_article-title">Therapeutic Compounds and Their Use in Treating Diseases and Disorders</span>. WO 2009/065035,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+Bajji&author=S.-H.+Kim&author=R.+Tangallapally&author=B.+Markovitz&author=R.+Trovato&author=M.+B.+Anderson&author=D.+Wettstein&author=M.+Shenderovich&title=Therapeutic+Compounds+and+Their+Use+in+Treating+Diseases+and+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBajji%26aufirst%3DA.%26atitle%3DTherapeutic%2520Compounds%2520and%2520Their%2520Use%2520in%2520Treating%2520Diseases%2520and%2520Disorders%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bajji, A.; Kim, S.-H.; Markovitz, B.; Trovato, R.; Tangallapally, R.; Anderson, M. B.; Wettstein, D.; Shenderovich, M.; Vanecko, J. A.</span><span> </span><span class="NLM_article-title">Therapeutic Compounds and Their Use in Cancer</span>. WO 2007/134298,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Bajji&author=S.-H.+Kim&author=B.+Markovitz&author=R.+Trovato&author=R.+Tangallapally&author=M.+B.+Anderson&author=D.+Wettstein&author=M.+Shenderovich&author=J.+A.+Vanecko&title=Therapeutic+Compounds+and+Their+Use+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBajji%26aufirst%3DA.%26atitle%3DTherapeutic%2520Compounds%2520and%2520Their%2520Use%2520in%2520Cancer%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Legraverend, M.</span><span> </span><span class="NLM_article-title">Recent advances in the synthesis of purine derivatives and their precursors</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">8585</span><span class="NLM_x">–</span> <span class="NLM_lpage">8603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=8585-8603&author=M.+Legraverend&title=Recent+advances+in+the+synthesis+of+purine+derivatives+and+their+precursors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegraverend%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520the%2520synthesis%2520of%2520purine%2520derivatives%2520and%2520their%2520precursors%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26spage%3D8585%26epage%3D8603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">General method for the synthesis of 8-arylsulfanyl adenine derivatives</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3230</span><span class="NLM_x">–</span> <span class="NLM_lpage">3232</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049875c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3230-3232&author=H.+Heauthor=L.+Llaugerauthor=N.+Rosenauthor=G.+Chiosis&title=General+method+for+the+synthesis+of+8-arylsulfanyl+adenine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo049875c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049875c%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DGeneral%2520method%2520for%2520the%2520synthesis%2520of%25208-arylsulfanyl%2520adenine%2520derivatives%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D3230%26epage%3D3232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span> </span><span class="NLM_article-title">Preparation of 8-(arylsulfanyl)adenines with diazonium salts under mild, aerobic conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">720</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo048522a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=717-720&author=M.+A.+Biamonteauthor=J.+Shiauthor=D.+Hurstauthor=K.+Hongauthor=M.+F.+Boehmauthor=S.+R.+Kasibhatla&title=Preparation+of+8-%28arylsulfanyl%29adenines+with+diazonium+salts+under+mild%2C+aerobic+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo048522a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo048522a%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DHurst%26aufirst%3DD.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26atitle%3DPreparation%2520of%25208-%2528arylsulfanyl%2529adenines%2520with%2520diazonium%2520salts%2520under%2520mild%252C%2520aerobic%2520conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D717%26epage%3D720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2892</span><span class="NLM_x">–</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049012b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2892-2905&author=L.+Llaugerauthor=H.+Heauthor=J.+Kimauthor=J.+Aguirreauthor=N.+Rosenauthor=U.+Petersauthor=P.+Daviesauthor=G.+Chiosis&title=Evaluation+of+8-arylsulfanyl%2C+8-arylsulfoxyl%2C+and+8-arylsulfonyl+adenine+derivatives+as+inhibitors+of+the+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm049012b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049012b%26sid%3Dliteratum%253Aachs%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DAguirre%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DU.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DEvaluation%2520of%25208-arylsulfanyl%252C%25208-arylsulfoxyl%252C%2520and%25208-arylsulfonyl%2520adenine%2520derivatives%2520as%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2892%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Takamuro, I.; Sekine, Y.; Tsuboi, Y.; Nogi, K.; Taniguchi, H.</span><span> </span><span class="NLM_article-title">Preparation of Pyrazolopyrimidines as a Small Conductance Potassium Channel (SK Channel) Blocking Agents</span>. WO 2004064721,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=I.+Takamuro&author=Y.+Sekine&author=Y.+Tsuboi&author=K.+Nogi&author=H.+Taniguchi&title=Preparation+of+Pyrazolopyrimidines+as+a+Small+Conductance+Potassium+Channel+%28SK+Channel%29+Blocking+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakamuro%26aufirst%3DI.%26atitle%3DPreparation%2520of%2520Pyrazolopyrimidines%2520as%2520a%2520Small%2520Conductance%2520Potassium%2520Channel%2520%2528SK%2520Channel%2529%2520Blocking%2520Agents%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jablonowski, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. K.</span><span> </span><span class="NLM_article-title">A scalable synthesis of a histamine H3 receptor antagonist</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8115</span><span class="NLM_x">–</span> <span class="NLM_lpage">8117</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo040225i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=8115-8117&author=N.+Maniauthor=J.+A.+Jablonowskiauthor=T.+K.+Jones&title=A+scalable+synthesis+of+a+histamine+H3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=10.1021%2Fjo040225i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo040225i%26sid%3Dliteratum%253Aachs%26aulast%3DMani%26aufirst%3DN.%26aulast%3DJablonowski%26aufirst%3DJ.%2BA.%26aulast%3DJones%26aufirst%3DT.%2BK.%26atitle%3DA%2520scalable%2520synthesis%2520of%2520a%2520histamine%2520H3%2520receptor%2520antagonist%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D8115%26epage%3D8117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Brown, T. H.; Cooper, D. G.</span><span> </span><span class="NLM_article-title"><i>N</i>-Hydrocarbyl-4-Substituted Piperidines, Their Preparation and Use as Calcium Blocking Agents</span>. WO 9202502,<span class="NLM_x"> </span><span class="NLM_year">1992</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&author=T.+H.+Brown&author=D.+G.+Cooper&title=N-Hydrocarbyl-4-Substituted+Piperidines%2C+Their+Preparation+and+Use+as+Calcium+Blocking+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DT.%2BH.%26atitle%3DN-Hydrocarbyl-4-Substituted%2520Piperidines%252C%2520Their%2520Preparation%2520and%2520Use%2520as%2520Calcium%2520Blocking%2520Agents%26date%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sonesson, C.; Swanson, L.; Waters, N.</span><span> </span><span class="NLM_article-title">Preparation of Disubstituted Phenylpiperidines/Piperazines as Modulators of Dopamine Neurotransmission</span>. WO 2005121087,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=C.+Sonesson&author=L.+Swanson&author=N.+Waters&title=Preparation+of+Disubstituted+Phenylpiperidines%2FPiperazines+as+Modulators+of+Dopamine+Neurotransmission"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSonesson%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520Disubstituted%2520Phenylpiperidines%252FPiperazines%2520as%2520Modulators%2520of%2520Dopamine%2520Neurotransmission%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lemoine, R.; Melville, C. R.; Rotstein, D. M.; Wanner, J.</span><span> </span><span class="NLM_article-title">Octahydropyrrolo[3,4-<i>c</i>]pyrrole Derivatives as Antiviral Agents and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of HIV Infection</span>. WO 2008034731,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=R.+Lemoine&author=C.+R.+Melville&author=D.+M.+Rotstein&author=J.+Wanner&title=Octahydropyrrolo%5B3%2C4-c%5Dpyrrole+Derivatives+as+Antiviral+Agents+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Use+in+the+Treatment+of+HIV+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLemoine%26aufirst%3DR.%26atitle%3DOctahydropyrrolo%255B3%252C4-c%255Dpyrrole%2520Derivatives%2520as%2520Antiviral%2520Agents%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Use%2520in%2520the%2520Treatment%2520of%2520HIV%2520Infection%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Blake, J.; Boyd, S.; De Meese, J.; Gaudino, J. J.; Marlow, A.; Seo, J.; Thomas, A.; Tian, H.</span><span> </span><span class="NLM_article-title">Heterobicyclic Thiophene Compounds as Tyrosine Kinase Inhibitors and Their Preparation and Use</span>. U.S. Patent 20070197537 A1, August 23,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+Blake&author=S.+Boyd&author=J.+De+Meese&author=J.+J.+Gaudino&author=A.+Marlow&author=J.+Seo&author=A.+Thomas&author=H.+Tian&title=Heterobicyclic+Thiophene+Compounds+as+Tyrosine+Kinase+Inhibitors+and+Their+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DJ.%26atitle%3DHeterobicyclic%2520Thiophene%2520Compounds%2520as%2520Tyrosine%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparation%2520and%2520Use%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Batey, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D. A.</span><span> </span><span class="NLM_article-title">A general synthetic method for the formation of substituted 5-aminotetrazoles from thioureas: a strategy for diversity amplication</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3237</span><span class="NLM_x">–</span> <span class="NLM_lpage">3240</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol006465b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3237-3240&author=R.+A.+Bateyauthor=D.+A.+Powell&title=A+general+synthetic+method+for+the+formation+of+substituted+5-aminotetrazoles+from+thioureas%3A+a+strategy+for+diversity+amplication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fol006465b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006465b%26sid%3Dliteratum%253Aachs%26aulast%3DBatey%26aufirst%3DR.%2BA.%26aulast%3DPowell%26aufirst%3DD.%2BA.%26atitle%3DA%2520general%2520synthetic%2520method%2520for%2520the%2520formation%2520of%2520substituted%25205-aminotetrazoles%2520from%2520thioureas%253A%2520a%2520strategy%2520for%2520diversity%2520amplication%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D3237%26epage%3D3240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">A general palladium-catalyzed coupling of aryl bromides/triflates and thiols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4587</span><span class="NLM_x">–</span> <span class="NLM_lpage">4590</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol047996t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptVartbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4587-4590&author=T.+Itohauthor=T.+Mase&title=A+general+palladium-catalyzed+coupling+of+aryl+bromides%2Ftriflates+and+thiols"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">A general palladium-catalyzed coupling of aryl bromides/triflates and thiols</span></div><div class="casAuthors">Itoh, Takahiro; Mase, Toshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4587-4590</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient palladium-catalyzed carbon-sulfur bond formation reaction of aryl bromides, triflates, and activated aryl chloride have been developed.  The reaction showed tolerance to a wide variety of aryl thiols and alkyl thiols which gave aryl sulfides, e.g., I, in good yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ47wzYjppQ7Vg90H21EOLACvtfcHk0lhFDax41-Escg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptVartbg%253D&md5=a58e03f1934099065cf2500c276d89a1</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1021%2Fol047996t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol047996t%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DA%2520general%2520palladium-catalyzed%2520coupling%2520of%2520aryl%2520bromides%252Ftriflates%2520and%2520thiols%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4587%26epage%3D4590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">A novel practical synthesis of benzothiazoles via Pd-catalyzed thiol cross-coupling</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3687</span><span class="NLM_x">–</span> <span class="NLM_lpage">3689</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol7015737" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3687-3689&author=T.+Itohauthor=T.+Mase&title=A+novel+practical+synthesis+of+benzothiazoles+via+Pd-catalyzed+thiol+cross-coupling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1021%2Fol7015737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol7015737%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DA%2520novel%2520practical%2520synthesis%2520of%2520benzothiazoles%2520via%2520Pd-catalyzed%2520thiol%2520cross-coupling%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D3687%26epage%3D3689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">Practical thiol surrogates and protective groups for arylthiols for Suzuki–Miyaura conditions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2206</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo052624z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=2203-2206&author=T.+Itohauthor=T.+Mase&title=Practical+thiol+surrogates+and+protective+groups+for+arylthiols+for+Suzuki%E2%80%93Miyaura+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48c&amp;dbid=16384&amp;doi=10.1021%2Fjo052624z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052624z%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DPractical%2520thiol%2520surrogates%2520and%2520protective%2520groups%2520for%2520arylthiols%2520for%2520Suzuki%25E2%2580%2593Miyaura%2520conditions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D2203%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Maitro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prestat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madec, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, G.</span><span> </span><span class="NLM_article-title">Aryl sulfoxides via palladium-catalyzed arylation of sulfenate anions</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">5951</span><span class="NLM_x">–</span> <span class="NLM_lpage">5954</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol062315a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Clu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=5951-5954&author=G.+Maitroauthor=S.+Vogelauthor=G.+Prestatauthor=D.+Madecauthor=G.+Poli&title=Aryl+sulfoxides+via+palladium-catalyzed+arylation+of+sulfenate+anions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl sulfoxides via palladium-catalyzed arylation of sulfenate anions</span></div><div class="casAuthors">Maitro, Guillaume; Vogel, Sophie; Prestat, Guillaume; Madec, David; Poli, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">5951-5954</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Palladium-catalyzed arylation of sulfenate anions generated from β-sulfinyl esters could take place under biphasic conditions.  This hitherto unknown reaction provided a simple, mild, and efficient route to aryl sulfoxides in good yields.  The development of a new pseudo-domino type I procedure involving a sulfinylation followed by a Mizoroki-Heck coupling was also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzlq8BhIJoBbVg90H21EOLACvtfcHk0li9JnNPdakTRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Clu73E&md5=f7ec863ab9c9efa434421a53921db94a</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol062315a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol062315a%26sid%3Dliteratum%253Aachs%26aulast%3DMaitro%26aufirst%3DG.%26aulast%3DVogel%26aufirst%3DS.%26aulast%3DPrestat%26aufirst%3DG.%26aulast%3DMadec%26aufirst%3DD.%26aulast%3DPoli%26aufirst%3DG.%26atitle%3DAryl%2520sulfoxides%2520via%2520palladium-catalyzed%2520arylation%2520of%2520sulfenate%2520anions%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D5951%26epage%3D5954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Oberhauser, T. A</span><span> </span><span class="NLM_article-title">New bromination method for phenols and anisoles: NBS/HBF<sub>4</sub>·Et<sub>2</sub>O in AcCN</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4504</span><span class="NLM_x">–</span> <span class="NLM_lpage">4506</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9622993" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=4504-4506&author=T.+A+Oberhauser&title=New+bromination+method+for+phenols+and+anisoles%3A+NBS%2FHBF4%C2%B7Et2O+in+AcCN"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo9622993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9622993%26sid%3Dliteratum%253Aachs%26aulast%3DOberhauser%26aufirst%3DT.%2BA%26atitle%3DNew%2520bromination%2520method%2520for%2520phenols%2520and%2520anisoles%253A%2520NBS%252FHBF4%25C2%25B7Et2O%2520in%2520AcCN%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D4504%26epage%3D4506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Song, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschaen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabowski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volante, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mase, T.</span><span> </span><span class="NLM_article-title">Practical asymmetric synthesis of a selective endothelin A receptor (ETA) antagonist</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">3357</span><span class="NLM_x">–</span> <span class="NLM_lpage">3360</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol016601s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=3357-3360&author=Z.+J.+Songauthor=M.+Zhaoauthor=L.+Freyauthor=J.+Liauthor=L.+Tanauthor=C.+Y.+Chenauthor=D.+M.+Tschaenauthor=R.+Tillyerauthor=E.+J.+Grabowskiauthor=R.+Volanteauthor=P.+J.+Reiderauthor=Y.+Katoauthor=S.+Okadaauthor=T.+Nemotoauthor=H.+Satoauthor=A.+Akaoauthor=T.+Mase&title=Practical+asymmetric+synthesis+of+a+selective+endothelin+A+receptor+%28ETA%29+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fol016601s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol016601s%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DZ.%2BJ.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DFrey%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DTschaen%26aufirst%3DD.%2BM.%26aulast%3DTillyer%26aufirst%3DR.%26aulast%3DGrabowski%26aufirst%3DE.%2BJ.%26aulast%3DVolante%26aufirst%3DR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26aulast%3DKato%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DNemoto%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DAkao%26aufirst%3DA.%26aulast%3DMase%26aufirst%3DT.%26atitle%3DPractical%2520asymmetric%2520synthesis%2520of%2520a%2520selective%2520endothelin%2520A%2520receptor%2520%2528ETA%2529%2520antagonist%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D3357%26epage%3D3360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Kim, S.-H.; Trovato, R.; Markovitz, B.; Vanecko, J.; Shenderovich, M.; Robinson, R.; McKinnon, R.; Alberts, G.; Austin, H.; Cimbora, D.; Baichwal, V.; Papac, D.; Wettstein, D.; Bajji, A.; Yager, K. M.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kim%2C+S.-H.%3B+Trovato%2C+R.%3B+Markovitz%2C+B.%3B+Vanecko%2C+J.%3B+Shenderovich%2C+M.%3B+Robinson%2C+R.%3B+McKinnon%2C+R.%3B+Alberts%2C+G.%3B+Austin%2C+H.%3B+Cimbora%2C+D.%3B+Baichwal%2C+V.%3B+Papac%2C+D.%3B+Wettstein%2C+D.%3B+Bajji%2C+A.%3B+Yager%2C+K.+M.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.-H." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Regina, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavecchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Befani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostinelli, E.</span><span> </span><span class="NLM_article-title">New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">922</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=922-931&author=G.+L.+Reginaauthor=R.+Silvestriauthor=M.+Articoauthor=A.+Lavecchiaauthor=E.+Novellinoauthor=O.+Befaniauthor=P.+Turiniauthor=E.+Agostinelli&title=New+pyrrole+inhibitors+of+monoamine+oxidase%3A+synthesis%2C+biological+evaluation%2C+and+structural+determinants+of+MAO-A+and+MAO-B+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRegina%26aufirst%3DG.%2BL.%26aulast%3DSilvestri%26aufirst%3DR.%26aulast%3DArtico%26aufirst%3DM.%26aulast%3DLavecchia%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DBefani%26aufirst%3DO.%26aulast%3DTurini%26aufirst%3DP.%26aulast%3DAgostinelli%26aufirst%3DE.%26atitle%3DNew%2520pyrrole%2520inhibitors%2520of%2520monoamine%2520oxidase%253A%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520structural%2520determinants%2520of%2520MAO-A%2520and%2520MAO-B%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D922%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit55a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Watson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span> </span><span class="NLM_article-title">A diastereoselective synthesis of 2,4-disubstituted piperidines: scaffolds for drug discovery</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3679</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol006589o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55a&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVaktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2000&pages=3679&author=P.+S.+Watsonauthor=B.+Jiangauthor=B.+Scott&title=A+diastereoselective+synthesis+of+2%2C4-disubstituted+piperidines%3A+scaffolds+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55aR"><div class="casContent"><span class="casTitleNuber">54a</span><div class="casTitle"><span class="NLM_cas:atitle">A Diastereoselective Synthesis of 2,4-Disubstituted Piperidines: Scaffolds for Drug Discovery</span></div><div class="casAuthors">Watson, Paul S.; Jiang, Bin; Scott, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3679-3681</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The piperidines I [R = allyl, CHMe2, CH2Ph; R1 = Ph, CO2Et, 4-CbzNHC6H4] were prepd. from 4-methoxypyridine and were reduced stereoselectively.  Li-NH3 redn., followed by deblocking gave trans-disubstituted piperidines II [R2 = Ph, CH2OH], whereas deblocking, followed by redn. gave cis-II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ZCVtcb80zLVg90H21EOLACvtfcHk0ljZRecZg_WUiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVaktrk%253D&md5=53f3c6af3a76c2a5aa14ddc5f65e35b2</span></div><a href="/servlet/linkout?suffix=cit55a&amp;dbid=16384&amp;doi=10.1021%2Fol006589o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol006589o%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DP.%2BS.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DB.%26atitle%3DA%2520diastereoselective%2520synthesis%2520of%25202%252C4-disubstituted%2520piperidines%253A%2520scaffolds%2520for%2520drug%2520discovery%26jtitle%3DOrg.%2520Lett.%26date%3D2000%26volume%3D2%26spage%3D3679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit55b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Weintraub, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabol, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borcherding, D. R.</span><span> </span><span class="NLM_article-title">Recent advances in the synthesis of piperidones and piperidines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1016%2FS0040-4020%2803%2900295-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55b&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFCjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=2953&author=P.+M.+Weintraubauthor=J.+S.+Sabolauthor=J.+M.+Kaneauthor=D.+R.+Borcherding&title=Recent+advances+in+the+synthesis+of+piperidones+and+piperidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55bR"><div class="casContent"><span class="casTitleNuber">54b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the synthesis of piperidones and piperidines</span></div><div class="casAuthors">Weintraub, Philip M.; Sabol, Jeffrey S.; Kane, John M.; Borcherding, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2953-2989</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeTP7idpcAM7Vg90H21EOLACvtfcHk0ljZRecZg_WUiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFCjsL8%253D&md5=bbf687c328825595af2a3ca779916398</span></div><a href="/servlet/linkout?suffix=cit55b&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2803%2900295-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252803%252900295-3%26sid%3Dliteratum%253Aachs%26aulast%3DWeintraub%26aufirst%3DP.%2BM.%26aulast%3DSabol%26aufirst%3DJ.%2BS.%26aulast%3DKane%26aufirst%3DJ.%2BM.%26aulast%3DBorcherding%26aufirst%3DD.%2BR.%26atitle%3DRecent%2520advances%2520in%2520the%2520synthesis%2520of%2520piperidones%2520and%2520piperidines%26jtitle%3DTetrahedron%26date%3D2003%26volume%3D59%26spage%3D2953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Raub, T. J.</span><span> </span><span class="NLM_article-title">P-Glycoprotein recognition of substrates and circumvention through rational drug design</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp0500871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=3-25&author=T.+J.+Raub&title=P-Glycoprotein+recognition+of+substrates+and+circumvention+through+rational+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design</span></div><div class="casAuthors">Raub, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is now well recognized that membrane efflux transporters, esp. P-glycoprotein (P-gp; ABCB1), play a role in detg. the absorption, distribution, metab., excretion, and toxicol. behaviors of some drugs and mols. in development.  An investment in screening structure-activity relation (SAR) is warranted in early discovery when exposure and/or target activity in an in vivo efficacy model is not achieved and P-gp efflux is identified as a rate-limiting factor.  However, the amt. of investment in SAR must be placed into perspective by assessing the risks assocd. with the intended therapeutic target, the potency and margin of safety of the compd., the intended patient population(s), and the market competition.  The task of rationally designing a chem. strategy for circumventing a limiting P-gp interaction can be daunting.  The necessity of retaining biol. potency and metabolic stability places restrictions on what can be done, and the factors for P-gp recognition of substrates are complicated and poorly understood.  The parameters within the assays that affect overall pump efficiency or net efflux, such as passive diffusion, membrane partitioning, and mol. interaction between pump and substrate, should be understood when interpreting data sets assocd. with chem. around a scaffold.  No single, functional group alone is often the cause, but one group can accentuate the recognition points existing within a scaffold.  This can be likened to a rheostat, rather than an on/off switch, where addn. or removal of a key group can increase or decrease the pumping efficiency.  The most practical approach to de-emphasize the limiting effects of P-gp on a particular scaffold is to increase passive diffusion.  Efflux pumping efficiency may be overcome when passive diffusion is fast enough.  Eliminating, or substituting with fewer, groups that solvate in water, or decreasing their hydrogen bonding capacity, and adding halogen groups can increase passive diffusion.  Reducing mol. size, replacing electroneg. atoms, blocking or masking H-bond donors with N-alkylation or bulky flanking groups, introducing constrained conformation, or by promoting intramol. hydrogen bonds are all examples of steps to take.  This review discusses our understanding of how P-gp recognizes and pumps compds. as substrates and describes cases where structural changes were made in a chem. scaffold to circumvent the effects of P-gp interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRbEgPosNnxrVg90H21EOLACvtfcHk0ljZRecZg_WUiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlagu7%252FP&md5=cc89be920dfa0e32edb994be94626aa5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fmp0500871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp0500871%26sid%3Dliteratum%253Aachs%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26atitle%3DP-Glycoprotein%2520recognition%2520of%2520substrates%2520and%2520circumvention%2520through%2520rational%2520drug%2520design%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2006%26volume%3D3%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Delorme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducharme, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubé, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lépine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAuliffe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarlane, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffithh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yergey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, Y.</span><span> </span><span class="NLM_article-title">Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure–activity relationship study directed toward the improvement of metabolic stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3951</span><span class="NLM_x">–</span> <span class="NLM_lpage">3970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960301c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=3951-3970&author=D.+Delormeauthor=Y.+Ducharmeauthor=C.+Brideauauthor=C.-C.+Chanauthor=N.+Chauretauthor=S.+Desmaraisauthor=D.+Dub%C3%A9author=J.-P.+Falgueyretauthor=R.+Fortinauthor=J.+Guayauthor=P.+Hamelauthor=T.+R.+Jonesauthor=C.+L%C3%A9pineauthor=C.+Liauthor=M.+McAuliffeauthor=C.+S.+McFarlaneauthor=D.+A.+Nicoll-Griffithhauthor=D.+Riendeauauthor=J.+A.+Yergeyauthor=Y.+Girard&title=Dioxabicyclooctanyl+naphthalenenitriles+as+nonredox+5-lipoxygenase+inhibitors%3A+structure%E2%80%93activity+relationship+study+directed+toward+the+improvement+of+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm960301c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960301c%26sid%3Dliteratum%253Aachs%26aulast%3DDelorme%26aufirst%3DD.%26aulast%3DDucharme%26aufirst%3DY.%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DC.-C.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDub%25C3%25A9%26aufirst%3DD.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DFortin%26aufirst%3DR.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DT.%2BR.%26aulast%3DL%25C3%25A9pine%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMcAuliffe%26aufirst%3DM.%26aulast%3DMcFarlane%26aufirst%3DC.%2BS.%26aulast%3DNicoll-Griffithh%26aufirst%3DD.%2BA.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DYergey%26aufirst%3DJ.%2BA.%26aulast%3DGirard%26aufirst%3DY.%26atitle%3DDioxabicyclooctanyl%2520naphthalenenitriles%2520as%2520nonredox%25205-lipoxygenase%2520inhibitors%253A%2520structure%25E2%2580%2593activity%2520relationship%2520study%2520directed%2520toward%2520the%2520improvement%2520of%2520metabolic%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D3951%26epage%3D3970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit58a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyagi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodeoka, M.</span><span> </span><span class="NLM_article-title">Stereocontrolled and convergent entry to CF<sub>2</sub>-sialosides: synthesis of CF<sub>2</sub>-linked ganglioside GM4</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">15420</span><span class="NLM_x">–</span> <span class="NLM_lpage">15421</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja075738w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=15420-15421&author=G.+Hiraiauthor=T.+Watanabeauthor=K.+Yamaguchiauthor=T.+Miyagiauthor=M.+Sodeoka&title=Stereocontrolled+and+convergent+entry+to+CF2-sialosides%3A+synthesis+of+CF2-linked+ganglioside+GM4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58a&amp;dbid=16384&amp;doi=10.1021%2Fja075738w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja075738w%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DG.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DMiyagi%26aufirst%3DT.%26aulast%3DSodeoka%26aufirst%3DM.%26atitle%3DStereocontrolled%2520and%2520convergent%2520entry%2520to%2520CF2-sialosides%253A%2520synthesis%2520of%2520CF2-linked%2520ganglioside%2520GM4%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D15420%26epage%3D15421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit58b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Prakash, G. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zibinsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashemirov, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oertell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shock, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, G. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of fluorinated deoxynucleotide analogs based on bis-(difluoromethylene)triphosphoric acid</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">15693</span><span class="NLM_x">–</span> <span class="NLM_lpage">15698</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=15693-15698&author=G.+K.+S.+Prakashauthor=M.+Zibinskyauthor=T.+G.+Uptonauthor=B.+A.+Kashemirovauthor=C.+E.+McKennaauthor=K.+Oertellauthor=M.+F.+Goodmanauthor=V.+Batraauthor=L.+C.+Pedersenauthor=W.+A.+Beardauthor=D.+D.+Shockauthor=S.+H.+Wilsonauthor=G.+A.+Olah&title=Synthesis+and+biological+evaluation+of+fluorinated+deoxynucleotide+analogs+based+on+bis-%28difluoromethylene%29triphosphoric+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrakash%26aufirst%3DG.%2BK.%2BS.%26aulast%3DZibinsky%26aufirst%3DM.%26aulast%3DUpton%26aufirst%3DT.%2BG.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26aulast%3DOertell%26aufirst%3DK.%26aulast%3DGoodman%26aufirst%3DM.%2BF.%26aulast%3DBatra%26aufirst%3DV.%26aulast%3DPedersen%26aufirst%3DL.%2BC.%26aulast%3DBeard%26aufirst%3DW.%2BA.%26aulast%3DShock%26aufirst%3DD.%2BD.%26aulast%3DWilson%26aufirst%3DS.%2BH.%26aulast%3DOlah%26aufirst%3DG.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520fluorinated%2520deoxynucleotide%2520analogs%2520based%2520on%2520bis-%2528difluoromethylene%2529triphosphoric%2520acid%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D15693%26epage%3D15698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structural and quantum chemical studies of 8-aryl-sulfanyl adenine class Hsp90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4953</span><span class="NLM_x">–</span> <span class="NLM_lpage">4960</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060297x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4953-4960&author=R.+M.+Immorminoauthor=Y.+Kangauthor=G.+Chiosisauthor=D.+T.+Gewirth&title=Structural+and+quantum+chemical+studies+of+8-aryl-sulfanyl+adenine+class+Hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm060297x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060297x%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructural%2520and%2520quantum%2520chemical%2520studies%2520of%25208-aryl-sulfanyl%2520adenine%2520class%2520Hsp90%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4953%26epage%3D4960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Brazidec, J. -Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">7′-Substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5352</span><span class="NLM_x">–</span> <span class="NLM_lpage">5362</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051146h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5352-5362&author=L.+Zhangauthor=J.+Fanauthor=K.+Vuauthor=K.+Hongauthor=J.+-Y.+Le+Brazidecauthor=J.+Shiauthor=M.+Biamonteauthor=D.+J.+Buschauthor=R.+E.+Loughauthor=R.+Greckoauthor=Y.+Ranauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=K.+Lundgrenauthor=F.+J.+Burrowsauthor=R.+Mansfieldauthor=G.+A.+Timonyauthor=E.+H.+Ulmauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehm&title=7%E2%80%B2-Substituted+benzothiazolothio-+and+pyridinothiazolothio-purines+as+potent+heat+shock+protein+90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm051146h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051146h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DVu%26aufirst%3DK.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DLe%2BBrazidec%26aufirst%3DJ.%2B-Y.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DBiamonte%26aufirst%3DM.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DUlm%26aufirst%3DE.%2BH.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3D7%25E2%2580%25B2-Substituted%2520benzothiazolothio-%2520and%2520pyridinothiazolothio-purines%2520as%2520potent%2520heat%2520shock%2520protein%252090%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5352%26epage%3D5362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0liUraAjXUKpyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Lima, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a useful strategy for molecular modification and drug design</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F0929867053363540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=15638729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=23-49&author=L.+M.+Limaauthor=E.+J.+Barreiro&title=Bioisosterism%3A+a+useful+strategy+for+molecular+modification+and+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Bioisosterism: A useful strategy for molecular modification and drug design</span></div><div class="casAuthors">Lima, Lidia Moreira; Barreiro, Eliezer J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-49</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review aims to demonstrate the role of bioisosterism in rational drug design as well as in the mol. modification and optimization process aiming to improve pharmacodynamic and pharmacokinetic properties of lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe7625guUbh7Vg90H21EOLACvtfcHk0liUraAjXUKpyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOrug%253D%253D&md5=4836e1d51143b240e357548b39f04251</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F0929867053363540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867053363540%26sid%3Dliteratum%253Aachs%26aulast%3DLima%26aufirst%3DL.%2BM.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520useful%2520strategy%2520for%2520molecular%2520modification%2520and%2520drug%2520design%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D23%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Tasker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jae, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Geldern, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calzadila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">WuWong, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opgenorth, T. J.</span><span> </span><span class="NLM_article-title">Potent and selective non-benzodioxole-containing endothelin-A receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960077r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=322-330&author=A.+S.+Taskerauthor=B.+K.+Sorensenauthor=H.+S.+Jaeauthor=M.+Winnauthor=T.+W.+von+Geldernauthor=D.+B.+Dixonauthor=W.+J.+Chiouauthor=B.+D.+Daytonauthor=S.+Calzadilaauthor=L.+Hernandezauthor=K.+C.+Marshauthor=J.+R.+WuWongauthor=T.+J.+Opgenorth&title=Potent+and+selective+non-benzodioxole-containing+endothelin-A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm960077r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960077r%26sid%3Dliteratum%253Aachs%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DSorensen%26aufirst%3DB.%2BK.%26aulast%3DJae%26aufirst%3DH.%2BS.%26aulast%3DWinn%26aufirst%3DM.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26aulast%3DDixon%26aufirst%3DD.%2BB.%26aulast%3DChiou%26aufirst%3DW.%2BJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DCalzadila%26aufirst%3DS.%26aulast%3DHernandez%26aufirst%3DL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DWuWong%26aufirst%3DJ.%2BR.%26aulast%3DOpgenorth%26aufirst%3DT.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520non-benzodioxole-containing%2520endothelin-A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D322%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Murray, M.</span><span> </span><span class="NLM_article-title">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F1389200003339270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=11467081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=67-84&author=M.+Murray&title=Mechanisms+of+inhibitory+and+regulatory+effects+of+methylenedioxyphenyl+compounds+on+cytochrome+P450-dependent+drug+oxidation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span></div><div class="casAuthors">Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-84</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 110 refs.  Cytochrome P 450 (CYP) enzymes catalyze the oxidative conversion of drugs and other lipophilic compds. to hydrophilic metabolites.  Thus, CYPs play a dominant role in the elimination of drugs from the body.  Inhibitory interactions occur when drugs compete for oxidn. by specific CYPs, whereas certain drugs increase the capacity for oxidative biotransformation by inducing the synthesis of new CYPs.  Methylenedioxyphenyl (MDP) compds. have been widely employed as com. important pesticide synergists and a no. of derivs. are found in oils and spices.  MDP compds. are of considerable toxicol. significance because of their capacity to inhibit and induce CYP enzymes in mammals; some derivs. produce neurotoxic and hepatotoxic effects.  Although there are relatively few therapeutic agents of present clin. importance that possess the MDP structural feature, the synthesis and preclin. evaluation of such agents appears to be increasing.  In the context of the existing literature surrounding MDP compds. it is noteworthy that these potential drugs also elicit significant modulatory effects on CYP activities in rat and human liver.  These developments indicate the importance of understanding the chem. mechanisms by which MDPs interact with CYPs.  Thus, the presence of the MDP structure may undermine the potential clin. value of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYAjGf6nf5ZbVg90H21EOLACvtfcHk0lh_tARlUHTtAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D&md5=dcafc824c8bcd0080d256d6dd8c50ae7</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.2174%2F1389200003339270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200003339270%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520inhibitory%2520and%2520regulatory%2520effects%2520of%2520methylenedioxyphenyl%2520compounds%2520on%2520cytochrome%2520P450-dependent%2520drug%2520oxidation%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2000%26volume%3D1%26spage%3D67%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Trachsel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadorn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumberger, F.</span><span> </span><span class="NLM_article-title">Synthesis of fluoro analogues of 3,4-(methylenedioxy)amphetamine (MDA) and its derivatives</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=326-336&author=D.+Trachselauthor=M.+Hadornauthor=F.+Baumberger&title=Synthesis+of+fluoro+analogues+of+3%2C4-%28methylenedioxy%29amphetamine+%28MDA%29+and+its+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrachsel%26aufirst%3DD.%26aulast%3DHadorn%26aufirst%3DM.%26aulast%3DBaumberger%26aufirst%3DF.%26atitle%3DSynthesis%2520of%2520fluoro%2520analogues%2520of%25203%252C4-%2528methylenedioxy%2529amphetamine%2520%2528MDA%2529%2520and%2520its%2520derivatives%26jtitle%3DChem.%2520Biodiversity%26date%3D2006%26volume%3D3%26spage%3D326%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Davies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span> </span><span class="NLM_article-title">Physiological parameters in laboratory animals and humans</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1023%2FA%3A1018943613122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=8378254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=1093-1095&author=B.+Daviesauthor=T.+Morris&title=Physiological+parameters+in+laboratory+animals+and+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological parameters in laboratory animals and humans</span></div><div class="casAuthors">Davies B; Morris T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1093-5</span>
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDDwka3A6hEYYPsCkJIw00fW6udTcc2eZXarpdn9ef1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3szptFaqsg%253D%253D&md5=094cdd17306b58cc17c8cf4fd5db9927</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1023%2FA%3A1018943613122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1018943613122%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DB.%26aulast%3DMorris%26aufirst%3DT.%26atitle%3DPhysiological%2520parameters%2520in%2520laboratory%2520animals%2520and%2520humans%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D1093%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit67a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzarano, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span> </span><span class="NLM_article-title">Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. I. Investigation of potential experimental and mechanistic explanations</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=353-366&author=K.+W.+Wardauthor=L.+M.+Azzaranoauthor=C.+A.+Evansauthor=B.+R.+Smith&title=Apparent+absolute+oral+bioavailability+in+excess+of+100%25+for+a+vitronectin+receptor+antagonist+%28SB-265123%29+in+rat.+I.+Investigation+of+potential+experimental+and+mechanistic+explanations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DAzzarano%26aufirst%3DL.%2BM.%26aulast%3DEvans%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26atitle%3DApparent%2520absolute%2520oral%2520bioavailability%2520in%2520excess%2520of%2520100%2525%2520for%2520a%2520vitronectin%2520receptor%2520antagonist%2520%2528SB-265123%2529%2520in%2520rat.%2520I.%2520Investigation%2520of%2520potential%2520experimental%2520and%2520mechanistic%2520explanations%26jtitle%3DXenobiotica%26date%3D2004%26volume%3D34%26spage%3D353%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit67b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azzarano, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span> </span><span class="NLM_article-title">Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Investigation of potential experimental and mechanistic explanations</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=367-377&author=K.+W.+Wardauthor=L.+M.+Azzaranoauthor=C.+A.+Evansauthor=B.+R.+Smith&title=Apparent+absolute+oral+bioavailability+in+excess+of+100%25+for+a+vitronectin+receptor+antagonist+%28SB-265123%29+in+rat.+II.+Investigation+of+potential+experimental+and+mechanistic+explanations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DAzzarano%26aufirst%3DL.%2BM.%26aulast%3DEvans%26aufirst%3DC.%2BA.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26atitle%3DApparent%2520absolute%2520oral%2520bioavailability%2520in%2520excess%2520of%2520100%2525%2520for%2520a%2520vitronectin%2520receptor%2520antagonist%2520%2528SB-265123%2529%2520in%2520rat.%2520II.%2520Investigation%2520of%2520potential%2520experimental%2520and%2520mechanistic%2520explanations%26jtitle%3DXenobiotica%26date%3D2004%26volume%3D34%26spage%3D367%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Martinez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span> </span><span class="NLM_article-title">A mechanistic approach to understanding the factors affecting drug absorption; a review of fundamentals</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1177%2F00970002042006005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=12043951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD38Xks1OgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=620-643&author=M.+L.+Martinezauthor=G.+L.+Amidon&title=A+mechanistic+approach+to+understanding+the+factors+affecting+drug+absorption%3B+a+review+of+fundamentals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals</span></div><div class="casAuthors">Martinez, Marilyn N.; Amidon, Gordon L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-643</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  This article provides an overview of the patient-specific and drug-specific variables that can affect drug absorption following oral product administration.  The oral absorption of any chem. entity reflects a complex spectrum of events.  Factors influencing product bioavailability include drug soly., permeability, and the rate of in vivo dissoln.  In this regard, the Biopharmaceutics Classification System has proven to be an important tool for predicting compds. likely to be assocd. with bioavailability problems.  It also helps in identifying those factors that may alter the rate and extent of drug absorption.  Product bioavailability can also be markedly influenced by patient attributes such as the integrity of the gastrointestinal tract, physiol. status, site of drug absorption, membrane transporters, presystemic drug metab. (intrinsic variables), and extrinsic variables such as the effect of food or concomitant medication.  Through an awareness of a drug's physicochem. properties and the physiol. processes affecting drug absorption, the skilled pharmaceutical scientist can develop formulations that will maximize product availability.  By appreciating the potential impact of patient physiol. status, phenotype, age, gender, and lifestyle, dosing regimens can be tailored to better meet the needs of the individual patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7090GVIXnsrVg90H21EOLACvtfcHk0lh_tARlUHTtAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xks1OgsLc%253D&md5=65abdd33877aa4cd9295c594a338584e</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1177%2F00970002042006005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F00970002042006005%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DM.%2BL.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26atitle%3DA%2520mechanistic%2520approach%2520to%2520understanding%2520the%2520factors%2520affecting%2520drug%2520absorption%253B%2520a%2520review%2520of%2520fundamentals%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D42%26spage%3D620%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsey, R.</span><span> </span><span class="NLM_article-title">The stress response: implications for the clinical development of hsp90 inhibitors</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.2174%2F1568009033481787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=14529386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2isrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=349-358&author=L.+Whitesellauthor=R.+Bagatellauthor=R.+Falsey&title=The+stress+response%3A+implications+for+the+clinical+development+of+hsp90+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">The stress response: Implications for the clinical development of Hsp90 inhibitors</span></div><div class="casAuthors">Whitesell, Luke; Bagatell, Rochelle; Falsey, Ryan</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-358</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In their role as mol. chaperones, heat shock proteins serve as central integrators of protein homeostasis within cells.  As part of this function, they guide the folding, assembly, intracellular disposition and proteolytic turnover of many key regulators of cell growth, differentiation and survival.  Not surprisingly then, heat shock proteins are over expressed in many types of cancer, and induction of the stress response may actually be required for cells to tolerate the genetic disarray characteristic of malignant transformation.  Regulation of heat shock protein levels via the stress response is complex, but recent data indicate that the mol. chaperone Hsp90 plays a key role.  Specifically, Hsp90 inhibitors alter the multi-chaperone complexes assocd. with Heat Shock Factor 1 (HSF1), the dominant transcription factor controlling induction of the stress response, and stimulate HSF1-activated heat shock gene expression.  Induction of this heat shock response has now emerged as an important consideration in the further clin. development of Hsp90 inhibitors for several reasons.  First, tumors in which the stress response is compromised appear particularly sensitive to Hsp90 inhibition.  Second, induction of the stress response by Hsp90 inhibitors provides a sensitive pharmacodynamic endpoint with which to monitor drug action in individual patients.  Third, Hsp90 inhibitors display important therapeutic interactions with both conventional DNA-targeted chemotherapeutics and newer molecularly targeted agents.  These interactions are, at least in part, due to modulation of the stress response by these drugs.  Lastly, stress response induction by Hsp90 inhibitors may have therapeutic benefits in non-neoplastic disorders such as heart disease, stroke and neurodegenerative diseases.  These benefits are just beginning to be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplWj51nToxhrVg90H21EOLACvtfcHk0livwAAkaqDabg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2isrc%253D&md5=f89ec1c0f23a2bf9369d22fe59e63cc0</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.2174%2F1568009033481787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033481787%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DFalsey%26aufirst%3DR.%26atitle%3DThe%2520stress%2520response%253A%2520implications%2520for%2520the%2520clinical%2520development%2520of%2520hsp90%2520inhibitors%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D349%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Bagatell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paine-Murrieta, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulcini, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjamin, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesell, L.</span><span> </span><span class="NLM_article-title">Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3312</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=10955818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVOmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=3312-3318&author=R.+Bagatellauthor=G.+D.+Paine-Murrietaauthor=C.+W.+Taylorauthor=E.+J.+Pulciniauthor=S.+Akinagaauthor=I.+J.+Benjaminauthor=L.+Whitesell&title=Induction+of+a+heat+shock+factor+1-dependent+stress+response+alters+the+cytotoxic+activity+of+hsp90-binding+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of Hsp90-binding agents</span></div><div class="casAuthors">Bagatell, Rochelle; Paine-Murrieta, Gillian D.; Taylor, Charles W.; Pulcini, Elizabeth J.; Akinaga, Shiro; Benjamin, Ivor J.; Whitesell, Luke</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3312-3318</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">In addn. to its classic role in the cellular stress response, heat shock protein 90 (Hsp90) plays a crit. but less well appreciated role in regulating signal transduction pathways that control cell growth and survival under basal, nonstress conditions.  Over the past 5 yr, the antitumor antibiotics geldanamycin and radicicol have become recognized as selective Hsp90-binding agents (HBA) with a novel ability to alter the activity of many of the receptors, kinases, and transcription factors involved in these cancer-assocd. pathways.  As a consequence of their interaction with Hsp90, however, these agents also induce a marked cellular heat shock response.  To study the mechanism of this response and assess its relevance to the anticancer action of the HBA, we verified that the compds. could activate a reporter construct contg. consensus binding sites for heat shock factor 1 (HSF1), the major transcriptional regulator of the vertebrate heat shock response.  The authors then used transformed fibroblasts derived from HSF1 knock-out mice to show that unlike conventional chemotherapeutics, HBA increased the synthesis and cellular levels of heat shock proteins in an HSF1-dependent manner.  Compared with transformed fibroblasts derived from wild-type mice, HSF1 knock-out cells were significantly more sensitive to the cytotoxic effects of HBA but not to doxorubicin or cisplatin.  Consistent with these in vitro data, the authors found that systemic administration of an HBA led to marked increases in the level of Hsp72 in both normal mouse tissues and human tumor xenografts.  The authors conclude that HBA are useful probes for studying mol. mechanisms regulating the heat shock response both in cells and in whole animals.  Moreover, induction of the heat shock response by HBA will be an important consideration in the clin. application of these drugs, both in terms of modulating their cytotoxic activity as well as monitoring their biol. activity in individual patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCXM1LsRGAfLVg90H21EOLACvtfcHk0livwAAkaqDabg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVOmtL0%253D&md5=3c6f4e392424161b38ddc010ea97afb1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBagatell%26aufirst%3DR.%26aulast%3DPaine-Murrieta%26aufirst%3DG.%2BD.%26aulast%3DTaylor%26aufirst%3DC.%2BW.%26aulast%3DPulcini%26aufirst%3DE.%2BJ.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DBenjamin%26aufirst%3DI.%2BJ.%26aulast%3DWhitesell%26aufirst%3DL.%26atitle%3DInduction%2520of%2520a%2520heat%2520shock%2520factor%25201-dependent%2520stress%2520response%2520alters%2520the%2520cytotoxic%2520activity%2520of%2520hsp90-binding%2520agents%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D3312%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Samlowski, W. E.; Papadopoulos, K.; Olszanski, A. J.; Cimbora, D.; Baichwal, V.; Shawbell, S.; Evans, B.; Balch, A.; Mather, G.; Beelen, A.</span><span> </span><span class="NLM_article-title">Phase 1 Study of the Hsp90 Inhibitor MPC-3100 in Subjects with Refractory or Recurrent Cancer</span>. Presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, San Francisco, CA, November 12–16, 2011. Myrexis Inc. Web site: <a href="http://www.myriadpharma.com/images/stories/product-pipeline/mpc-3100/mpc-3100-aacr-eortc-nci-2011-a96.pdf" class="extLink">http://www.myriadpharma.com/images/stories/product-pipeline/mpc-3100/mpc-3100-aacr-eortc-nci-2011-a96.pdf</a> (accessed July 02,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=W.+E.+Samlowski&author=K.+Papadopoulos&author=A.+J.+Olszanski&author=D.+Cimbora&author=V.+Baichwal&author=S.+Shawbell&author=B.+Evans&author=A.+Balch&author=G.+Mather&author=A.+Beelen&title=Phase+1+Study+of+the+Hsp90+Inhibitor+MPC-3100+in+Subjects+with+Refractory+or+Recurrent+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSamlowski%26aufirst%3DW.%2BE.%26atitle%3DPhase%25201%2520Study%2520of%2520the%2520Hsp90%2520Inhibitor%2520MPC-3100%2520in%2520Subjects%2520with%2520Refractory%2520or%2520Recurrent%2520Cancer%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm3004619&amp;key=10.1177%2F1087057104265995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm3004619&amp;key=15296636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm3004619&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=375-381&author=J.+Kimauthor=S.+Feltsauthor=H.+Heauthor=H.+Huezoauthor=N.+Rosenauthor=G.+Chiosis&title=Development+of+a+fluorescence+polarization+assay+for+the+molecular+chaperone+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span></div><div class="casAuthors">Kim, Joungnam; Felts, Sara; Llauger, Laura; He, Huazhong; Huezo, Henri; Rosen, Neal; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone with essential functions in maintaining transformation, and there is increasing interest in developing Hsp90 inhibitors as cancer therapeutics.  In this study, the authors describe the development and optimization of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization.  The assay is based on the competition of fluorescently (BODIPY) labeled geldanamycin (GM) for binding to purified recombinant Hsp90α (GM is a natural product that binds to the ATP/ADP pocket in the amino terminal of Hsp90).  The authors show that GM-BODIPY binds Hsp90α with high affinity.  Even at low Hsp90α concns. (30 nM), the measured polarization value is close to the max. assay range of 160 mP, making measurements very sensitive.  Its performance, as judged by signal-to-noise ratios (> 10) and Z and Z' values (> 0.5), suggests that this is a robust and reliable assay.  GM, PU24FCl, ADP, and ATP, all known to bind to the Hsp90 pocket, compete with GM-BODIPY for binding to Hsp90α with EC50s in agreement with reported values.  These data demonstrate that the Hsp90-FP-based assay can be used for high-throughput screening in aiding the identification of novel Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTTKuW5DgFIbVg90H21EOLACvtfcHk0li6_yhRqliCUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D&md5=e6e13d80237b2b5c65a78d20d2f3c4bc</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1177%2F1087057104265995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104265995%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence%2520polarization%2520assay%2520for%2520the%2520molecular%2520chaperone%2520Hsp90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2004%26volume%3D9%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosser, M. F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarden, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Sensitivity of mature ErbB2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">3702</span><span class="NLM_x">–</span> <span class="NLM_lpage">3708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=3702-3708&author=W.+Xuauthor=E.+Mimnaughauthor=M.+F.+N.+Rosserauthor=C.+Nicchittaauthor=M.+Marcuauthor=Y.+Yardenauthor=L.+Neckers&title=Sensitivity+of+mature+ErbB2+to+geldanamycin+is+conferred+by+its+kinase+domain+and+is+mediated+by+the+chaperone+protein+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMimnaugh%26aufirst%3DE.%26aulast%3DRosser%26aufirst%3DM.%2BF.%2BN.%26aulast%3DNicchitta%26aufirst%3DC.%26aulast%3DMarcu%26aufirst%3DM.%26aulast%3DYarden%26aufirst%3DY.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DSensitivity%2520of%2520mature%2520ErbB2%2520to%2520geldanamycin%2520is%2520conferred%2520by%2520its%2520kinase%2520domain%2520and%2520is%2520mediated%2520by%2520the%2520chaperone%2520protein%2520Hsp90%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D3702%26epage%3D3708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Tikhomirov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G.</span><span> </span><span class="NLM_article-title">Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=39-43&author=O.+Tikhomirovauthor=G.+Carpenter&title=Identification+of+ErbB-2+kinase+domain+motifs+required+for+geldanamycin-induced+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTikhomirov%26aufirst%3DO.%26aulast%3DCarpenter%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520ErbB-2%2520kinase%2520domain%2520motifs%2520required%2520for%2520geldanamycin-induced%2520degradation%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UYI','PDB','1UYI'); return false;">PDB: 1UYI</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i75"><a href="/doi/suppl/10.1021/jm3004619">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16012"></div></div></div></div></div><hr /></hr><p class="last">Procedures for molecular modeling, synthesis of compounds <b>24d</b>–<b>e</b>, and <sup>1</sup>H NMR spectra and HPLC traces for selected compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3004619/suppl_file/jm3004619_si_001.pdf">jm3004619_si_001.pdf (935.46 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3004619&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-17%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm3004619%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3004619" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799bd9b69e63db8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
